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Abstract
This dissertation consists of three projects that make use of latent variable modeling tech-
niques. One of the focuses of this dissertation research has been in the area of spatial and spatio-
temporal modeling. The specific topics and motivating problems in this study have been fully
supported and motivated by the Companion Animal Parasite Council (CAPC). In particular, the
CAPC has developed a rather extensive database, which houses several common dog disease data
sets collected throughout the conterminous United States. This data exists at a county level and
was collected monthly over a span of 5 consecutive years, and exhibits strong spatial and temporal
correlation structures. Further, due to non-reporting counties a significant portion of the data is
missing, both in the spatial and temporal domain. The goal of our work in this area was to identify
risk factors significantly related to the prevalence of the various diseases and to develop models
which could be used to accurately forecast future disease trends nationwide. No similar work has
been completed for these diseases on the spatio-temporal scale that we consider. To accomplish this
task, we developed and implemented a Bayesian spatio-temporal regression model to analyze the
data. Due to the relatively large spatial scale and complex structure of the data, a key challenge
was developing computationally efficient algorithms that could be used to implement Markov chain
Monte Carlo (MCMC) techniques. Once this was completed, we implemented our models to assess
the relevance of the considered covariates and to forecast future trends. In addition to the spa-
tial and spatio-temporal modeling problems, this dissertation research also focus on developing new
modeling techniques for data collected on pooled specimens. The concept of using pooling as a more
cost effective data collection technique is becoming pervasive in the biological sciences and elsewhere.
In particular pooled data is collected by first amalgamating several specimens (e.g., blood, urine,
etc.), collected from individuals, into a pooled sample, this pooled sample is then measured for a
characteristic of interest; e.g., in infectious disease studies the pooled outcome is typically binary
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indicating disease status and in biological marker (i.e., biomarker) evaluation studies the outcome is
continuous. In either case, information on several individuals is obtained at the expense of making
only one measurement, thus reducing the cost of data collection. However, the statistical analysis of
measurements (either binary or continuous) taken on pools is often fraught with many challenges.
In my dissertation research, I have considered developing regression methods for both continuous
and binary outcomes measured on pools. For continuous outcomes, I proposed a general regression
framework which can be used to analyze pooled outcomes under practically all parametric models.
This was accomplished through the use of an advanced Monte Carlo sampling algorithm, which was
implemented to approximate the observed data likelihood. Proceeding in this fashion, also allows
us to account for measurement error, which has not been accounted for previously, and led to the
development of computationally efficient software which can be used to implement the proposed
approach. For binary outcomes (usually referred to as group testing data), I developed a novel
Bayesian generalized additive model. Specifically, the proposed approach assumes the linear predic-
tor depends on several unknown smooth functions of some covariates as well as linear combinations
of other covariates. In addition, our model can account for imperfect testing, and can be used to
analyze data collected according to any group testing process.
iii
Dedication
No words can express how grateful I am to my parents and my wife Xiaoyan Yang, for their




First and foremost, I would like to express my sincere gratitude to my advisors Dr. Christo-
pher S. McMahan, Dr. Colin M. Gallagher and Dr. Robert B. Lund, for their incredible amount
of help and support of my Ph.D study and research, for their patience, kindness, enthusiasm, and
immense knowledge. Without their guidance, the completion of this dissertation would not have
been possible.
Secondly, I would like to sincerely thank Dr. Xiaoqian Sun, for his advice and suggestions
throughout this work, and also for his help and support for my job searching.
I also want to thank the Department of Mathematical Sciences and the Companion Animal
Parasite Council (CAPC) for the generous support. I am full of gratitude to all faculty members,
staff and my fellow students, who make the past five years really enjoyable.
v
Table of Contents
Title Page . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . i
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
Dedication . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv
Acknowledgments . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
List of Tables . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
List of Figures . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Latent Variables as Measurement Error . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Latent Variables as Unobserved Factors . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.3 Latent Variables in Statistical Computing . . . . . . . . . . . . . . . . . . . . . . . . 4
1.4 Summary of Remaining Chapters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
2 A general framework for the regression analysis of pooled biomarker assessments 8
2.1 Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2 Asymptotic properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.3 Simulation study . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.4 Data application . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
3 Bayesian Spatio-temporal model for Canine diseases . . . . . . . . . . . . . . . . . 30
3.1 Background and Collected Data . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.2 Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3 Sampling Details . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.4 Factor Forecasting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.5 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4 A Bayesian generalized additive model for group testing data . . . . . . . . . . . 82
4.1 Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84
4.2 Posterior Sampling Algorithm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
4.3 Simulation Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.4 Real Data Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
Appendices . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .107
A Chapter 2 Supplementary Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
vi
List of Tables
2.1 Presented results include the empirical bias (Bias) of the 500 estimated regression
coefficients and there sample standard deviation (SD) obtained from analyzing data
generated according to models M1-M5, for all considered pool sizes when J = 100 in
the absence of measurement error. Also included are the average estimated standard
errors (SE) and the empirical coverage probabilities (Cov) associated with 95% Wald
confidence intervals. Three model fitting procedures were implemented, the proposed
methodology (MCMLE), the analytical approach described in Section 2.3 (MLE), and
the MCEM algorithm, with the latter two techniques only being applicable for models
M1 and M2, respectively. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 100 in the presence of measurement error (τ = 0.05). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Section 2.3 (MLE), with the latter technique only being applicable for
model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.3 Data application: The top five models according to their AIC values for all 12 con-
sidered scenarios, where a Xdenotes that a particular predictor was included in the
model. The predictor variables x1, x2, and x3 represent the participant’s age, race,
and miscarriage status, respectively. Note, the presence (absence) of “ ∗” indicates
that the MCMLE accounted for (ignored) the effect of measurement error. . . . . . . 27
2.4 Data application: Presented results include the regression parameter estimates (Est.),
the estimated standard errors (SE), and the corresponding p-values (P-value), under
all 12 considered scenarios. Also included are the analogous results obtained from the
artificial constructed homogeneous pooling data (HPD). Note, the presence (absence)
of “ ∗” indicates that the MCMLE accounted for (ignored) the effect of measurement
error. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
3.1 Factors purported to influence heartworm prevalence. For further discussion, includ-
ing the source of each factor, see Wang et al. (2014a). . . . . . . . . . . . . . . . . . 33
3.2 Factors purported to influence disease prevalence in domestic dogs. . . . . . . . . . . 38
3.3 Parameter estimates for the full model of heartworm . . . . . . . . . . . . . . . . . . 59
3.4 Parameter estimates for the reduced model of heartworm . . . . . . . . . . . . . . . 59
3.5 Parameter estimates from the full model of Ehrlichia seroprevalence . . . . . . . . . 65
3.6 Parameter estimates from the selected model of Ehrlichia seroprevalence . . . . . . . 66
3.7 Parameter estimates for the full model of Anaplasma spp. seroprevalence. . . . . . . 73
3.8 Parameter estimates for the selected model of Anaplasma spp. seroprevalence. . . . 74
vii
4.1 Simulation study: Presented results include the empirical bias (Bias) of the 500 point
estimates of regression coefficients, there sample standard deviation (SD), the average
of 500 posterior variance (SE), the empirical coverage probabilities (CP) associated
with 95% credible intervals, and average model fitting time (Time, in seconds), when
N = 5000. Each dataset was analyzed using two proposed model fitting procedures
(i.e., GP and GPP) when sensitivity and specificity are fixed. . . . . . . . . . . . . . 98
4.2 Simulation study: Presented results include the empirical bias (Bias) of the 500 point
estimates of regression coefficients, there sample standard deviation (SD), the average
of 500 posterior variance (SE) and the empirical coverage probabilities (CP) associated
with 95% credible intervals, when N = 5000. Each dataset was analyzed using two
proposed model fitting procedures (i.e., GP and PP) when sensitivity and specificity
are unknown. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.3 Real Data Analysis: Presented results include the estimates (i.e., posterior mean) of
regression coefficients, and their the 95% highest posterior density(HPD) interval. . . 105
4 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 50 in the absence of measurement error. Also included are the average esti-
mated standard errors (SE) and the empirical coverage probabilities (Cov) associated
with 95% Wald confidence intervals. Three model fitting procedures were imple-
mented, the proposed methodology (MCMLE), the analytical approach described in
Appendix A.1.3 (MLE), and the MCEM algorithm, with the latter two techniques
only being applicable for models M1 and M2, respectively. . . . . . . . . . . . . . . . 121
5 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 200 in the absence of measurement error. Also included are the average
estimated standard errors (SE) and the empirical coverage probabilities (Cov) asso-
ciated with 95% Wald confidence intervals. Three model fitting procedures were im-
plemented, the proposed methodology (MCMLE), the analytical approach described
in Appendix A.1.3 (MLE), and the MCEM algorithm, with the latter two techniques
only being applicable for models M1 and M2, respectively. . . . . . . . . . . . . . . . 122
6 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 50 in the presence of measurement error (τ = 0.05). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
7 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 200 in the presence of measurement error (τ = 0.05). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 124
viii
8 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 50 in the presence of measurement error (τ = 0.10). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
9 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 100 in the presence of measurement error (τ = 0.10). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
10 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 200 in the presence of measurement error (τ = 0.10). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
11 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 50 in the presence of measurement error (τ = 0.20). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
12 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 100 in the presence of measurement error (τ = 0.20). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 129
ix
13 Simulation study: Presented results include the empirical bias (Bias) of the 500 esti-
mated regression coefficients and there sample standard deviation (SD) obtained from
analyzing data generated according to models M1-M5, for all considered pool sizes
when J = 200 in the presence of measurement error (τ = 0.20). Also included are
the average estimated standard errors (SE) and the empirical coverage probabilities
(Cov) associated with 95% Wald confidence intervals. Two model fitting procedures
were implemented, the proposed methodology (MCMLE) and the analytical approach
described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 130
x
List of Figures
2.1 Simulation study: Average model fitting times required by the proposed methodology
and the MCEM algorithm developed in Mitchell et al. (2014) for data generated under
model M2 which is not subject to measurement error. Presented results are stratified
by pool size (c) and the number of pools (J). . . . . . . . . . . . . . . . . . . . . . . 22
3.1 County by county heartworm raw prevalences aggregated over 2011-2015 . . . . . . . 34
3.2 Head-banged baseline map showing heartworm prevalences for an average year during
2011-2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.3 County by county ehrlichiosis raw prevalences aggregated over 2011-2015 . . . . . . . 39
3.4 Head-banged baseline map showing ehrlichiosis prevalences for an average year during
2011-2015 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
3.5 Empirical county-by-county Anaplasma spp. seroprevalence aggregated over 2011-
2015. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.6 Baseline map of Anaplasma spp. seroprevalence. . . . . . . . . . . . . . . . . . . . . 46
3.7 Model-based heartworm prevalences. . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
3.8 Observed heartworm prevalence for 2015 . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.9 Forecasted heartworm prevalence for 2015 . . . . . . . . . . . . . . . . . . . . . . . . 62
3.10 Forecasted heartworm prevalence for 2016 . . . . . . . . . . . . . . . . . . . . . . . . 64
3.11 Model-based Ehrlichia seroprevalences. . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.12 Observed Ehrlichia seroprevalence in domestic dogs for 2015 . . . . . . . . . . . . . . 68
3.13 Forecasted Ehrlichia seroprevalence in domestic dogs for 2015 . . . . . . . . . . . . . 70
3.14 Forecasted Ehrlichia seroprevalence in domestic dogs for 2016 . . . . . . . . . . . . . 72
3.15 Aggregated model-based estimates of Anaplasma spp. seroprevalence. . . . . . . . . 75
3.16 2015 forecasted Anaplasma spp. seroprevalence. . . . . . . . . . . . . . . . . . . . . 76
3.17 2015 observed Anaplasma spp. seroprevalence. . . . . . . . . . . . . . . . . . . . . . 77
3.18 2016 forecasted Anaplasma spp. seroprevalence. . . . . . . . . . . . . . . . . . . . . 78
4.1 Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the first function, under model
M1 when N = 5000 and sensitivity and specificity are fixed. From top to bottom
corresponds to IT, MT, DT and AT data, respectively. Left and right columns corre-
spond to GP and GPP approaches, respectively. . . . . . . . . . . . . . . . . . . . . 99
4.2 Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the second function, under
model M1 when N = 5000 and sensitivity and specificity are fixed. From top to
bottom corresponds to IT, MT, DT and AT data, respectively. Left and right columns
correspond to GP and GPP approaches, respectively. . . . . . . . . . . . . . . . . . . 100
xi
4.3 Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the first function, under model
M2 when N = 5000 and sensitivity and specificity are fixed. From top to bottom
corresponds to IT, MT, DT and AT data, respectively. Left and right columns corre-
spond to GP and GPP approaches, respectively. . . . . . . . . . . . . . . . . . . . . 101
4.4 Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the second function, under
model M2 when N = 5000 and sensitivity and specificity are fixed. From top to
bottom corresponds to IT, MT, DT and AT data, respectively. Left and right columns
correspond to GP and GPP approaches, respectively. . . . . . . . . . . . . . . . . . . 102
4.5 Pointwise quantile curves of four functions. The dashed, solid, and dash-dotted lines
correspond to the 2.5%, 50%, and 97.5% quantiles of the posterior samples, respectively.104
4.6 Pointwise quantile curves of age. The dashed, solid, and dash-dotted lines correspond




A Latent variable model typically involves latent variables, which are not directly observed
but are assumed to affect the actual observed variables. The origin of latent variable models typically
dates back to Spearman’s seminal work on the measure of general intelligence by common factor
analysis Spearman (1904). Some more recent application of latent variable models can be found
in Wiley (1973); Jöreskog (1973); Keesling (1972). Latent variable models have become one of the
most important concepts in statistics and have been applied in almost all regression models. Latent
variables are included in statistical models for various purposes.
1.1 Latent Variables as Measurement Error
Latent variables can be used to account for measurement error. Generally, measurement
error (or observational error) is the difference between the measurement of a quantity and its true
value. It contains two components: systematic error and random error. For instance, consider
measuring the mass of an apple using a pair of balances, if the balance is not calibrated well and
off by 0.5 pound, then there is systematic error that will result in the apple’s mass to be off by 0.5
pound. On the other hand, if assuming the balance is accurate and measuring the mass of the apple
multiple times using the same balance, each time the measurement may not be exactly the same, due
to the change of environmental factors (e.g., humidity, temperature) or different interpretation of the
instrumental reading. Now there exists random error. In practice, people realize that measurement
error is almost unavoidable and ignoring it would lead to bias in parameter estimation or losing
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power for testing the significance of predictor variables in regression model. Herein, latent variables
representing measurement error would be introduced in the statistical model. For example, in
regression models, measurement error could exist in both independent variables (i.e., covariates, or
predictor variables) and dependent variables (i.e., outcomes or responses). Each type of the error has
been extensively discussed and studied in the literature. For more examples and theories, see Fuller
(1987); Carroll et al. (2006).
1.2 Latent Variables as Unobserved Factors
Latent variables can be used to represent the effect of unobserved factors or covariates and
then account for the hidden heterogeneity between subjects. There are many types of models that
make use of latent variables, such as factor analysis models (Loehlin, 1998), item response theory
models (Embretson and Reise, 2013), generalized linear mixed models (McCulloch and Neuhaus,
2001), latent Markov model (Bartolucci et al., 2012), and latent growth/curve models (Duncan et al.,
2013), etc. All of the aforementioned modeling techniques usually introduce many latent variables
to account for the hidden effects due to unobserved variables. Recent developments in computing
technology, software tools and sampling techniques (e.g, Markov chain Monte Carlo computing)
allow researchers to specify and build more sophisticated latent variable models. In doing so, the
model can reflect the complex realities of data and provide more precise inference.
The type of latent variable modes that are of particular interest, and also be studied in one
of the chapters of this dissertation, is the Bayesian hierarchical spatial/spatio-temporal model. In
today’s world, the data that exhibits spatial or/and temporal correlations is becoming increasingly
common and researchers in different areas such as epidemiology, ecology, climatology and parasitol-
ogy are faced with more and more tasks of analyzing this type of data. For example, the data for
many types of diseases, such as lung cancer, breast cancer, and Lyme disease are usually available at
county level on monthly or yearly basis. In addition, some information at the individual (e.g., smok-
ing history, age, gender), county (e.g., population density, median household income), or other levels
can also be obtained. With these data, people are usually interested in the statistical inferences such
as estimating the disease prevalence, modeling the disease trends, performing the hypothesis test,
or predicting the disease prevalence at unobserved locations or time. To accomplish these goals,
traditional regression analysis (i.e., linear regression or generalized linear regression) cannot provide
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accurate results because the residuals, or the information unexplained by the covariates, still exhibit
strong spatial or/and temporal correlation. Herein, Bayesian hierarchical models are used to model
the data with complex spatial/spatio-temporal structure. The first comprehensive book in the area
of spatial/spatio-temporal analysis is the work by Cressie and Wikle (2011). Here, two common
types of spatial data are introduced; i.e., point-referenced data (often referred to as geocoded data)
and areal data.
For the first type of data, the observations are often taken at a geographic location, or point.
For example, the measurements collected by monitoring stations, such as temperature, precipita-
tion, and air quality data (e.g, PM2.5 concentration), are typically viewed as geocoded data. The
hierarchical model for this type of data often use Gaussian process to capture the underlying spatial
correlation. A main application of point-referenced Bayesian hierarchical model is performing the
statistical downscaling. Statistical downscaling is a procedure that uses information available at
large scales to make predictions at local or finer scales via statistical models. In practice, the col-
lected data is often spatially or temporally sparse. Statistical downscaling provides a way to obtain
data at higher resolution across space and time, which has been shown to benefit epidemiological
studies that involved geocoded data (Kloog et al., 2012). Some other applications of statistical
downscaling techniques include reducing the bias presented in the estimates of ozone and PM2.5
concentration level generated by numerical models (Berrocal et al., 2010b,a).
In the second case, areal data usually are summaries over an lattice. The lattice could
be regular, such as agricultural field trials or rectangular (or square) pixel lattice. It could also
be irregular, such as a collection of counties, or states. For example, the population and median
household income of each county in the contiguous United States, or the value of pixels in a 2-D
map or voxels in a 3-D map, are areal data. Typically, statistical approaches use Gaussian Markov
random fields to model the inherent spatial correlation in the data collected from different areas.
The application of areal spatial/spatio-temporal model is very broad, ranging from mapping of
disease incidence and prevalence (Lawson, 2013), to neuroimaging and functional magnetic resonance
imaging data analysis (Woolrich et al., 2004, 2009; Bowman et al., 2008). Additionally, in many
cases, the areal data are collected with many missing values, the Bayesian hierarchical model can be
used to infill the missing values by just estimating the associated latent variables. For more details,
see Besag (1974), Cressie and Wikle (2011), and Banerjee et al. (2014).
It is noted that sometimes, both geocoded and areal data are presented and simultaneous
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analysis of this type of data usually provide better results. For example, Chang et al. (2014)
implemented statistical downscaling techniques to predict daily PM2.5 estimates at any location
based on the ground monitoring station data (which is point-referenced data) and satellite-retrieved
aerosol optical depth that is available on dense grid cells. In particular, the author developed a
Bayesian spatio-temporal hierarchical model that addresses the issues of spatial misalignment (i.e,
can incorporate data sets collected on different spatial scales). The model has also been demonstrated
to be able to accurately predict PM2.5 concentration at locations and on days without monitoring
PM2.5 data.
1.3 Latent Variables in Statistical Computing
When conducting the statistical inference, we are often faced with many common prob-
lems, such as finding the maximizer of the observed likelihood function (i.e., finding the maximum
likelihood estimate (MLE)), or drawing samples from a given distribution. However, solving these
problems are usually not straightforward. For example, for the most cases, the closed form of the
MLE is not available, and also most of the distributions of continuous random variables are not easy
to sample from, except for several common distributions; e.g., Beta, Normal, Gamma, and Weibull
distributions. To overcome these issues, many methods have been proposed and extensively stud-
ied in the literature. For instance, people have implemented numerical optimization methods (e.g.,
Nelder-Mead, Broyden-Fletcher-Goldfarb-Shanno algorithm) to obtain the MLE by optimizing the
likelihood function directly. Nowadays, the method based on latent variable modeling techniques
have been used more and more as alternatives to aforementioned numerical methods. Here, the data
augmentation method is of particular interest.
Data augmentation usually refers to the method that construct iterative optimization or
sampling algorithm through the use of latent variables. In the paradigm of frequentist statistics, a
very popular data augmentation method is the one proposed by Dempster, Laird, and Rubin on the
expectation-maximization (EM) algorithm (Dempster et al., 1977). In specific, consider the task of
obtaining the MLE of unknown parameter θ (denoted by θ̂) by maximizing the observed likelihood
function L(θ; X) = p(X|θ), where X is the observed data. However, θ̂ is often intractable due to
complex likelihood function. The basic idea of EM algorithm is to introduce a set of unobserved
latent variables Z which leads to the completed data likelihood function L(θ|X,Z) = P (X,Z|θ),
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and then apply the following two steps iteratively until the convergence condition was satisfied,
E step: Calculate the expectation of the likelihood function, with respect to the conditional
distribution of Z given X under the current value of the parameters θ(t):
Q(θ|θ(t)) = EZ|X,θ(t) [L(θ|X,Z)]
M step: Find the value of θ that maximize the Q function in previous step:
θ(t) = arg max
θ
Q(θ|θ(t))
If latent variables are introduced appropriately, the E and M steps will be tractable, which makes
the entire process very efficient.
Another popular application of the data augmentation technique is to facilitate data gener-
ation from a given distribution. In routine use of Bayesian methods, it is often required to generate
samples from a posterior distribution p(θ|X), where X is the observed data. However, it is well
known that even under common distributional assumptions, the posterior distribution may become
complex so that sampling from it is not trivial. By appropriately introducing some latent variable
Z representing unobserved data, the conditional distributions p(θ|Z,X) and p(Z|θ,X) will be both
analytically tractable, and numerically sample from these two distributions become possible. Con-
sequently, a classic two-stage Gibbs sampler is implemented. Start with an initial value θ(0), the
following iterative sampling process
Z(t+1) ∼ p(Z|θ(t),X)
θ(t+1) ∼ p(θ|Z(t+1),X)
will generate a Markov chain {(θ(t),Z(t)), t ≥ 0}. It has been shown that under some standard reg-
ularity conditions (Roberts, 1996), the limiting distribution of (θ(t),Z(t)) is p(θ,Z|X). For example,
a widely used regression model for binary response data is the Bayesian probit model proposed by
Albert and Chib (1993). In their work, the authors used data augmentation technique (i.e., appro-
priately introducing latent variables) to make the posterior distribution of parameters easy to be
sampled from.
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1.4 Summary of Remaining Chapters
In this dissertation, several models involving latent variables were proposed and investi-
gated. In chapter 2, a general framework was proposed for the regression analysis of pooled bio-
logical marker (biomarker) assessments. As a cost efficient data collection mechanism, the process
of assaying pooled biospecimens is becoming increasingly common in epidemiological research; e.g.
pooling has been proposed for the purpose of evaluating the diagnostic efficacy of biological markers
(biomarkers). To this end, several authors have proposed techniques that allow for the analysis
of continuous pooled biomarker assessments. Regretfully, most of these techniques proceed under
restrictive assumptions, are unable to account for the effects of measurement error, and fail to con-
trol for confounding variables. These limitations are understandably attributable to the complex
structure that is inherent to measurements taken on pooled specimens. Consequently, in order to
provide practitioners with the tools necessary to accurately and efficiently analyze pooled biomarker
assessments, herein a general Monte Carlo maximum likelihood based procedure is presented. The
proposed approach allows for the regression analysis of pooled data under practically all parametric
models and can be used to directly account for the effects of measurement error. Through simu-
lation, it is shown that the proposed approach can accurately and efficiently estimate all unknown
parameters and is more computational efficient than existing techniques. This new methodology is
further illustrated using monocyte chemotactic protein-1 data collected by the Collaborative Perina-
tal Project in an effort to assess the relationship between this chemokine and the risk of miscarriage.
Chapter 3 aims at modeling the prevalence of several common dog diseases in the United
States. In this study, for each disease, millions of test results were collected for counties within the
48 contiguous United States during 2011-2015. Through some explanatory studies of the raw data,
strong spatial and temporal correlation were observed. A Bayesian hierarchical spatio-temporal
model was used here. In particular, conditional autoregressive structure was used to capture the
spatial dependence, and autoregressive model of order 1 (i.e., AR(1) model) was used to model
temporal correlation. In addition, information of several explanatory variables that may affect the
disease prevalence were collected on the same spatial and temporal scales, and included in the
proposed model. The model was then used to identify the significant risk factors and forecast the
disease prevalence. The fidelity of the forecasting technique was also assessed.
In contrast to Chapter2, Chapter 4 focuses on the binary outcome collected from pooled
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specimens, which is usually referred to as group testing data. The origins of group testing are often
traced to Dorfman (1943), who used pooling as a cost effective method for the purpose of screening
military inductees for syphilis during world war II. Since this pioneering work, group testing has
become a very popular method in various areas, such as infectious disease screening, animal disease
testing, and environmental monitoring. One of the main uses of group testing data is to estimate the
characteristic of interest at the population level; e.g., disease prevalence. With this purpose, many
models have been developed. More recently, several nonparametric and semiparametric regression
modeling techniques were proposed. However, most of these techniques are developed only using a
single type of group testing data. Motivated by these nonparametric and semiparametric techniques,
here we proposed a Bayesian generalized additive model, which can incorporate data from any group
testing algorithm. The Markov chain Monte Carlo procedure of our proposed model is facilitated
through the use of data augmentation technique.
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Chapter 2
A general framework for the
regression analysis of pooled
biomarker assessments
In resource limited environments, the process of assaying pooled biospecimens (i.e., a sam-
ple comprised of several individual specimens) has become a cost effective alternative to assaying
specimens one-by-one. The origins of group (or pool) testing are commonly attributed to Dorfman
(1943), where it was proposed as a means to reduce the cost of screening military inductees for
syphilis during the Second World War. Since its advent, pool testing has been adopted for the pur-
poses of screening for various infectious diseases Cardoso et al. (1998); Lewis et al. (2012); Van et al.
(2012); Stramer et al. (2013) and the incidence of bioterrorism Schmidt et al. (2005), identifying
lead compounds in drug discovery Remlinger et al. (2006), and detecting rare mutations in genetics
Gastwirth (2000). The general advantages of collecting data on pools are three-fold: a reduction
in the cost associated with measuring the outcome of interest, the ability to preserve irreplaceable
specimens, and the means to collect information in a more timely fashion. Further, these advantages
persist when the outcome of interest is continuous. For example, Caudill (2012) reports that the
2005-2006 National Health and Nutrition survey reduced the number of analytical measurements
required to characterize the distribution of polychlorinated and polybrominated compounds within
the population of the United States from 2201 to 228 by pooling, which translated to a savings of
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$2.78 million in testing cost.
Thompson (1962) was the first to consider modeling outcomes obtained from assaying pooled
specimens in order to estimate population level characteristics; i.e., binary outcomes, measured on
pools, were used to estimate the proportion of individuals within a population who possessed a
characteristic of interest. In this context, the process of pooling offers a cost effective data collection
mechanism, and for this reason has received a great deal of attention among the statistical literature;
e.g., see Walter et al. (1980); Brookmeyer (1999) and the references therein. Extending this earlier
work, Farrington (1992) proposed a regression framework which relates binary outcomes measured
on pools to covariate information. The work of Farrington (1992) has since seen numerous gener-
alizations; to include allowing for random pooling and imperfect testing Vansteelandt et al. (2000),
confirmatory testing Xie (2001), random effects Chen et al. (2009), and covariate measurement error
Huang and Tebbs (2009), as well as the development of techniques that allow for a nonparametric
Delaigle and Meister (2011); Delaigle and Hall (2012) and semiparametric Wang et al. (2014b);
Delaigle et al. (2014) regression analysis of group testing data. Note, all of the aforementioned
techniques were specifically developed for binary outcomes measured on pools.
Broadening the utilitarian nature of pooling as a cost effective data collection mechanism,
techniques for analyzing continuous outcomes obtained from assaying pooled specimens have been
proposed. For example, in an effort to reduce cost, several authors have proposed methods of ana-
lyzing pooled measurements in order to evaluate the efficacy of a biological marker (biomarker) as a
diagnostic tool; e.g., see Schisterman et al. (2001); Faraggi et al. (2003); Liu and Schisterman (2003);
Mumford et al. (2006); Bondell et al. (2007); Vexler et al. (2008); Malinovsky et al. (2012). More
recently, this research area has shifted to consider the regression analysis of continuous biomarker
measurements taken on pools; e.g., see Ma et al. (2011) and Malinovsky et al. (2012). It is worth-
while to point out that the aforementioned regression techniques were developed under the rather
stringent assumption that the biomarker levels of the individuals, and hence the pools, are condi-
tionally Gaussian, given the covariate information. In most practical applications, biomarker levels
tend to follow a right-skewed continuous distributions with positive support. Consequently, Mitchell
et al. (2014) proposed an Monte Carlo expectation maximization (MCEM) algorithm which could
be used to conduct the regression analysis of pooled biomarker assessments under the assumption
that the individual biomarker levels conditionally, given the covariates, follow a log-normal distri-
bution. Further, these authors investigated several pooling strategies with respect to estimation
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efficiency, with their findings resounding the work of Zhang et al. (2013) in the binary regression
group testing literature; i.e., measurements taken on pools that are formed homogeneously, with re-
spect to covariate information, can be used to construct estimators that are nearly as efficient as the
analogous estimators based on individual level data. Regretfully, the technique proposed by these
authors allows for the regression analysis under a single parametric model and does not account for
measurement error, which is omnipresent in biomarker evaluation studies.
The regression analysis of continuous outcomes measured on pools is fraught with many
complexities, thus the potential benefits from using pooling as a cost efficient data collection mecha-
nism has been largely untapped when the response variable of interest is continuous. To circumvent
this hurdle, herein a general regression methodology for continuous pooled biomarker assessments
is proposed. Unlike previously proposed techniques, this methodology allows for the regression
analysis under many common parametric models, to include distributions belonging to the class of
generalized linear models, and can easily account for measurement error in the response variable,
when it is present. Further, the proposed technique is more computationally efficient than other
existing methods; e.g., MCEM algorithm of Mitchell et al. (2014). The asymptotic properties of the
proposed approach are established, and through simulation studies the new methodology is shown
to accurately and efficiently analyze pool response data, both subject to and free of measurement
error, under several different parametric models.
The remainder of this chapter is organized as follows. Section 2.1 presents the general
modeling framework which can be used to perform a regression analysis of continuous outcomes
measured on pooled specimens. The asymptotic properties of the proposed approach are provided
in Section 2.2, and Section 2.3 provides a simulation study which investigates the finite sample
performance of the new methodology. In Section 2.4 the proposed approach is used to analyze
monocyte chemotactic protein-1 data collected by the Collaborative Prenatal Project (CPP). Section
2.5 concludes with a summary discussion. All of the theoretical proofs and additional technical details
are provided in the Appendix A.
2.1 Methodology
In what follows a general methodology is proposed for the regression analysis of continuous
outcomes measured on pooled specimens. In this context the observed data consists of J measure-
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ments taken on pools, where the jth pool is formed by amalgamating cj specimens collected from
individuals. Let Ỹij denote the biomarker level of the ith individual in the jth pool, for i = 1, ..., cj
and j = 1, ..., J . When assessments are being made on pools the Ỹij are latent, and the observed
data consists of either the biomarker level of the pool, which is denoted by Ỹpj , or an error contam-
inated measurement of Ỹpj , which is denoted by Ypj . In order to relate the Ỹij to the Ỹpj , herein it
is assumed that the biomarker level of the jth pool is the arithmetic average of the biomarker levels




i=1 Ỹij . This assumption is
common among the literature Bondell et al. (2007); Vexler et al. (2008); Mitchell et al. (2014) and
is reasonable as long as pools are formed from specimens of equal volume.
For modeling purposes, it is assumed that xij = (1, xij1, ..., xijp)
′, a (p + 1) × 1 vector
of covariates, is available for each individual. Given the covariate information, it is assumed that
the biomarker levels of the individuals are (conditionally) independent and follow a continuous
distribution with probability density function f(·|xij ,θ0); i.e., Ỹij
ind.∼ f(·|xij ,θ0), for i = 1, ..., cj





′ denotes the collection of model parameters, β0 = (β00 , ..., β0p)
′
is a vector of regression coefficients, and γ0 is a set of nuisance parameters. The generality in the
assumed parametric model for Ỹij is meant to illustrate the broad applicability of the proposed
approach; e.g., f(·|xij ,θ0) could belong to the class of generalized linear models, with Ỹij being
related to xij in the usual fashion McCullagh and Nelder (1989), or the regression analysis could
be performed under other common parametric models for biomarker data, such as the Weibull and
log-normal distributions; e.g., see Mitchell et al. (2014).
If the individual biomarker levels were observed, the maximum likelihood estimator (MLE) of
θ0 could be obtained through traditional techniques once the parametric model is assumed. However,
when pooled assessments are being made, the Ỹij are latent and the observed data consists of either
Ỹpj or Ypj , depending on whether or not the measured biomarker levels are subject to measurement
error. Under the aforementioned assumptions, the probability density function of Ỹpj , for a given
value of θ = (β′,γ′)′, can be expressed as














f(ỹij |xij ,θ)dỹ(−1)j , (2.1)
where ỹ(−1)j = (ỹ2j , . . . , ỹcjj) and xj = (x1j , . . . ,xcjj). In the presence of measurement error, it is
common to assume that the conditional distribution of the observed measurement, given the true
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level, is known; cf., Carroll et al. (2006). Let fε(·|Ỹpj ) denote the conditional probability density
function of Ypj , given Ỹpj . Thus, the density of Ypj can be expressed as









f(ỹij |xij ,θ)dỹj , (2.2)
where ỹj = (ỹ1j , . . . , ỹcjj)




i=1 ỹij . Note, under most of the common parametric
models for biomarker data, expressions for fj(·|xj ,θ) and gj(·|xj ,θ) do not exist in closed form, but
they can be evaluated through the use of numerical integration.
For ease of exposition, herein the proposed method is presented under the assumption that
the observed pooled assessments are subject to measurement error. Although, it is worthwhile to
point out that this approach is still applicable when the true biomarker levels are observed, as is
demonstrated in Sections 4 and 5. Under the aforementioned modeling assumptions, the log of the




log{gj(Ypj |xj ,θ)}, (2.3)
where Y p = (Yp1 , ..., YpJ )
′ and x = (x1, ...,xJ). By maximizing (2.3) one can obtain the MLE
of θ0, which is denoted by θ̂; i.e., θ̂ = arg maxθ∈Θ l(θ|Y p,x). If gj(·|xj ,θ) could be expressed
in closed form, obtaining the MLE of θ0 would be relatively straightforward. Alternatively, if
gj(·|xj ,θ) does not exist in closed form, numerical integration techniques (e.g., adaptive Gaussian
quadrature) could be used to evaluate gj(·|xj ,θ) at Ypj , and thus facilitate the maximization of
(2.3). However, it is well known Kuonen et al. (2003) that the computational burden associated
with implementing these numerical techniques rapidly increases with the dimension of the integral,
making this approach infeasible for cj > 2; for further discussion see Mitchell et al. (2014). Further,
numerical integration techniques, like the adaptive Gaussian quadrature, may perform poorly for
peaked-integrand distribution functions Genz and Kass (1997). Consequently, it is not recommended
that these techniques be used to facilitate the maximization of (2.3).
To overcome the drawbacks of implementing numerical integration methods, such as adap-
tive Gaussian quadrature, the proposed approach uses a Monte Carlo technique to approximate the
value of gj(·|xj ,θ) when evaluated at Ypj . Note, the value of gj(Ypj |xj ,θ) can be viewed as the
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expected value of fε(Ypj |Ỹpj ) with respect to Ỹ j = (Ỹ1j , ..., Ỹcjj)′; i.e.




fε(Ypj |ỹpj )hj(ỹj |xj ,θ)dỹj , (2.4)
where hj(ỹj |xj ,θ) =
∏cj
i=1 f(ỹij |xij ,θ) is the joint density of Ỹ j . Let Ỹ
1
j , . . . , Ỹ
M
j be a random




1j , . . . , Ỹ
m
cjj






ij . A Monte
Carlo estimate of gj(Ypj |xj ,θ) can then be obtained as





fε(Ypj |Ỹ mpj ). (2.5)
Consequently, a Monte Carlo approximation of the log-likelihood, when evaluated at a specific value
of θ, can be obtained as
lM (θ|Y p,x) =
J∑
j=1
log{gMj (Ypj |xj ,θ)}. (2.6)
By numerically maximizing (2.6), one can obtain the Monte Carlo Maximum Likelihood Estimator
(MCMLE) of θ0, which is denoted by θ̂M ; i.e., θ̂M = arg maxθ∈Θ lM (θ|Y p,x). Further, under mild
regularity conditions, see Section 3, it can be shown that θ̂M
p→ θ̂, as M →∞.
Regretfully, for the purposes of maximizing (2.6), when (2.5) is being used to approximate
gj(Ypj |xj ,θ), numerical optimization algorithms can often be unreliable; i.e., these algorithms have
the propensity to converge before reaching θ̂M . This is a byproduct of the fact that these algorithms
require that the Monte Carlo log-likelihood be evaluated at multiple values of θ, and at each value
of θ a new random sample from hj(Ỹ j |xj ,θ), for j = 1, ..., J , has to be taken in order to evaluate
(2.6). Due to the inherent variability in each of the random samples, this process results in a coarse
(non-smooth) objective function which is difficult to numerically optimize; for further discussion see
Robert and Casella (2005). To circumvent this issue, Robert and Casella (2005) suggests that a single
random sample, for each j, be drawn from a predetermined importance distribution h∗j (·|xj ,θ
∗),
where θ∗ is a known set of parameters. This random sample would then be used to evaluate (2.6)
for each value of θ, thus insuring that the Monte Carlo log-likelihood is a smooth function and that
optimization algorithms can be used reliably to obtain θ̂M .
Proceeding in this fashion, let Ỹ
1
j , . . . , Ỹ
M





on this sample a Monte Carlo estimate of gj(Ypj |xj ,θ) can be obtained as















j |xj ,θ)/h∗j (Ỹ
m
j |xj ,θ
∗). The corresponding Monte Carlo log-
likelihood is given by
lM (θ|Y p,x,θ∗) =
J∑
j=1
log{gMj (Ypj |xj ,θ,θ
∗)}, (2.8)
and the MCMLE of θ0 can be obtained as θ̂M = arg maxθ∈Θ lM (θ|Y p,x,θ
∗). Note, this process is
identical to the approach described above, with the exception of the distributions from which the
Monte Carlo samples were drawn.
Theoretically, there are very few restrictions on the choice of the importance distribution
h∗j (·|xj ,θ
∗), but its specification can dramatically impact the computational efficiency of the pro-
posed approach. In general, the computational burden associated with the proposed approach is
due to the size of the Monte Carlo sample being drawn to construct the estimator in (2.7). That
is, obtaining the MCMLE can be computationally inefficient if M is too large, and alternatively
imprecise if M is to small. In Section 3, guidance is provided on how to choose the value of M in
order to insure that a specified level of precision is attained, under a specific importance distribution.
Note, the Monte Carlo sample size required to attain the specified level of precision is inherently
tied to the choice of the importance distribution; i.e., a well specified importance distribution results
in a smaller value of M , and vice versa. In general, h∗j (·|xj ,θ
∗) should have the same support as
hj(·|xj ,θ0), and the two densities should be similar in shape and center. Further, h∗j (·|xj ,θ
∗) should
be easy to sample from. In Sections 4 and 5, the importance distributions were selected according
to the strategies considered in Frigyik et al. (2010) and Mitchell et al. (2014); for further discus-
sion see Appendix A.1. Note, under specific types of measurement error (e.g., additive) other more




It is important to note that the Monte Carlo log-likelihood lM (θ|Y p,x,θ∗) is evaluated using
a random sample from the importance distribution and, as such, different random samples will yield
different values of θ̂M . Therefore, θ̂M is a non-deterministic approximation of θ̂ whose variability
is referred to as Monte Carlo error Booth and Hobert (1999). As was previously mentioned, the
Monte Carlo sample size M plays a significant role with respect to determining the precision of θ̂M ;
i.e., the Monte Carlo error decreases as M is increased, and vice versa. By quantifying the Monte
Carlo error, one can determine a value of M which will ensure that the approximation of θ̂ attains a
specified level of precision. To this end, the asymptotic properties of θ̂M , as M →∞, are presented
and are further used to develop a method of identifying M which controls the Monte Carlo error at
a specified level.
Throughout the remainder of this article, it is assumed that θ consists of k components and
that the parameter space Θ is a compact subset of Rk. From Kolmogorov’s Strong Law of Large
Numbers (SLLN), under standard regularity conditions, it is easy to establish that ∀ θ ∈ Θ, the
Monte Carlo log-likelihood function (2.8) converges, as M → inf, to the true log-likelihood function
with probability 1 (w.p.1). However, this point-wise convergence does not guarantee the consistency
of θ̂M ; i.e., it does not establish that θ̂M
p→ θ̂. A sufficient condition under which consistency can





|lM (θ|Y p,x,θ∗)− l(θ|Y p,x)| = 0, w.p.1,
and Theorem 1 provides this result.





|lM (θ|Y p,x,θ∗)− l(θ|Y p,x)| = 0, w.p.1.
For a proof of Theorem 1 see Beskos et al. (2009). Given the uniform convergence established in
Theorem 1, the following result provides the consistency of θ̂M .
Corollary 1: Let θ̂ denote the unique element Θ, such that θ̂ = arg maxθ∈Θ l(θ|Y p,x), and let
{θ̂M}M be a sequence of maximizers of {lM (θ|Y p,x,θ∗)}M , then θ̂M
p→ θ̂, as M →∞.
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For a proof of Corollary 1 see Beskos et al. (2009). Given the consistency of θ̂M , the asymptotic
normality is established.









where Σ = B−1AB−1 and B = −∇2l(θ̂|Y p,x).
The proof of Theorem 2 is classical (Geyer, 1994) and a sketch is provided in Appendix A.3. Further,
it is worthwhile to point out that it relatively easy to show that all of the parametric models
considered herein adhere to the regularity conditions provided in Appendix A.3.
Establishing Theorem 2 provides two primary benefits; i.e., a means to identify the Monte
Carlo sample size that maintains a specified level of precision and it allows one to perform typical
large sample inference. Using the covariance matrix Σ, an asymptotic approximation of the Monte
Carlo error associated with estimating θ̂ can be obtained. Consequently, a natural strategy for
choosing the Monte Carlo sample size would be to specify M so that the Monte Carlo error is
bounded by a predetermined value, say d2; i.e., choose M such that σ2maxM
−1 ≤ d2, where σ2max is
the maximum diagonal element of Σ. Regretfully, in general a closed form expression for Σ does
not exist, but it can be estimated. Under the regularity condition provided in Appendix A.2, a
consistent estimator of B is given by B̂(θ̂M |θ∗) = −∇2lM (θ̂M |Y p,x,θ∗), and in Appendix A.3 an
estimator of A, which is denoted by Â(θ̂M |θ∗), is developed. Thus, an estimator of the covariance
matrix Σ is given by
Σ̂(θ̂M |θ∗) = B̂(θ̂M |θ∗)−1Â(θ̂M |θ∗)B̂(θ̂M |θ∗)−1. (2.9)
Using this estimator, M can be chosen such that σ̂2maxM
−1 ≤ d2, where σ̂2max is the maximum
diagonal element of Σ̂(θ̂M |θ∗). Further, B̂(θ̂M |θ∗)−1 is a consistent estimator of the observed Fisher
information matrix; i.e., B̂(θ̂M |θ∗)−1
p→ B−1, where B = −∇2l(θ̂|Y p,x). Using this estimator, one
can conduct typical Wald type inference.
16
One will note that the process of estimating Σ relies on obtaining θ̂M , which in turn depends
on M . Consequently, for determining the appropriate Monte Carlo sample size, it is suggested that
the following approach be implemented to ensure that a specified level of precision is attained.
Step 1: Choose a value of d2, the initial Monte Carlo sample size M0, and θ
∗.
Step 2: Find the MCMLE, θ̂M0 , and calculate Σ̂(θ̂M0 |θ
∗).
Step 3: Based on σ̂2max, the maximum diagonal element of Σ̂(θ̂M0 |θ
∗):









Step 4: Reselect θ∗ based on θ̂M0 and recompute Σ̂(θ̂M0 |θ
∗).
Step 5: Choose M such that σ̂2maxM
−1 ≤ d2 and find θ̂M , the MCMLE of θ̂.
Note, depending on the goals of the study, one could use this procedure either to control the precision
of the whole parameter vector, or a subset of interest.
2.3 Simulation study
A simulation study was conducted in order to assess the finite sample performance of the
proposed methodology. In this study, the following models for the biomarker levels of the individuals
were considered:
M1: Ỹij |xij ∼ N(µij , σ2), µij = x′ijβ, and β = (β0, β1, β2)′ = (4, 1, 2)′;





, µij = x
′
ijβ, and β = (β0, β1, β2)
′ = (−1, 1, 2)′;
M3: Ỹij |xij ∼ ST(µij , ν), µij = x′ijβ, and β = (β0, β1, β2)′ = (4, 1, 2)′;
M4: Ỹij |xij ∼ Gamma
{
1/σ2, (σ2µij)
−1}, µij = η−11 (x′ijβ), and β = (β0, β1, β2)′ = (−1, 1, 2)′;
M5: Ỹij |xij ∼ Gamma
{
1/σ2, (σ2µij)
−1}, µij = η−12 (x′ijβ), and β = (β0, β1, β2)′ = (0.5, 0.1, 0.2)′;
for i = 1, ..., cj and j = 1, ..., J , where η1(·) and η2(·) are the inverse and log links, respectively,
xij = (1, xij1, xij2)
′, σ = 0.5, and ν = 4. Note, ST(µ, ν) denotes the shifted t-distribution, which
has mean µ and degrees of freedom ν. The two covariates were independently sampled: one, xij1,
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from a standard normal distribution (which was supposed to emulate a standardized age effect) and
the other, xij2, from a Bernoulli distribution having success probability 0.5 (which was supposed to
correspond to a gender effect). For the purposes of this study, a common pool size c was specified,
where c ∈ {1, ..., 5}; i.e., cj = c, for j = 1, ..., J , where J ∈ {50, 100, 200, 500}. These choices
were made to investigate the performance of the proposed approach across a broad spectrum of
characteristics which could be encountered when modeling pooled biomarker data. In particular,
the simulation configurations consider models both within (M1, M4, and M5) and outside (M2 and
M3) of the class of generalized linear models which are commonly used to analyze biomarker data.
Further, the different combinations of (c, J) provide an assessment of the impact of the pool and
sample size on estimation and inference.
In both the binary group testing Zhang et al. (2013) and the pooled biomarker regression
Mitchell et al. (2014) literature it has been shown that pool composition, with respect to the covari-
ates, has the potential to influence estimation efficiency. That is, randomly assigning subjects to
pools, so that pools are heterogeneous with respect to covariate composition, can result in a loss in
efficiency, while homogeneous pooling strategies (i.e., strategies which specify the pooling of subjects
with similar covariates) maintain a high level of efficiency. For this reason, herein homogeneous pool-
ing was used to assign subjects to pools. Once pool assignment was complete, the biomarker levels
of the pools were determined as Ỹpj = c
−1∑c
i=1 Ỹij , for j = 1, ..., J . To investigate the effect of mea-
surement error, an error contaminated measurement of Ỹpj was obtained as Ypj |Ỹpj ∼ N(Ỹpj , τ2), for
j = 1, ..., J and τ ∈ {0.05, 0.10, 0.20}. Combining these simulated values two separate pooled data
sets were created: {(Ỹpj ,xj), j = 1, ..., J} and {(Ypj ,xj), j = 1, ..., J}. This process was repeated
500 times for each model and configuration of (c, J, τ), resulting in 200,000 simulated data sets.
The methodology proposed in Section 2 was then implemented to analyze each of the afore-
mentioned data sets. Throughout, the importance distributions for models M1-M5 were selected
according to the strategies outlined in Frigyik et al. (2010) and Mitchell et al. (2014); see Appendix
A.1 for their explicit forms and further discussion. To implement the model fitting approach de-
scribed in Section (2.2), an initial Monte Carlo sample size of M0 = 2000 was used and the tolerance
was specified to be d2 = 0.01. Note: to model the non-error contaminated data, minor alterations
to the proposed approach are necessary. In particular, the density of Ỹpj , which is given in (2.1),
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was approximated by


























2j , ..., Ỹ
m
cjj
)′, for m = 1, ...,M , is a random sample from the importance distri-
bution h∗j (·|xj ,θ
∗). Replacing gMj (Ypj |xj ,θ,θ
∗) in (2.8) by fMj (Ỹpj |xj ,θ,θ
∗) and maximizing with
respect to θ results in obtaining an MCMLE of θ0 when the pooled assessments are non-error laden.
To complete model fitting for the error contaminated data it was assumed, as is common in the
literature Schisterman et al. (2001); Vexler et al. (2008), that the distribution of the measurement
error was known. In practice this assumption may not be reasonable, but the true form of this distri-
bution could be replaced by an estimate, which can be obtained through standard techniques; e.g.,
see Carroll et al. (2006). Further, this approach is implemented in Section 5. Note, since additive
measurement error is assumed the alternate formulation of (2.4), which is presented in Appendix
A.1.2, is implemented herein.
In order to assess the performance of the proposed approach, it is first noted that when c = 1
and the Ỹpj are observed (i.e., the individual level data is observed without measurement error),
standard regression techniques are applicable, and were implemented. This was done in order to
provide a baseline by which comparisons could be made. Further, under the considered simulation
configurations for model M1 it is possible to obtain an analytical expression for the MLE of θ0
based on either {(Ỹpj ,xj), j = 1, ..., J} or {(Ypj ,xj), j = 1, ..., J}, for c = 1, ..., 5; see Appendix A.4
for further details. Consequently, both the proposed approach and the aforementioned analytical
techniques were used to analyze the simulated data created under model M1. Comparisons between
the results obtained from these two techniques allows one to assess the error that is introduced into
the analysis by stochastically estimating the MLE through the proposed methodology. Lastly, the
MCEM algorithm proposed in Mitchell et al. (2014) was used to analyze the non-error contaminated
data under model M2; i.e., {(Ỹpj ,xj), j = 1, ..., J}. This competing approach was specifically de-
signed for analyzing data of this form and this comparison allows one to assess the performance of
the proposed methodology with respect to an existing technique.
Table 2.1 summarizes the estimates of the regression coefficients (i.e., β) that were obtained
from analyzing the non-error contaminated pooled observations via the proposed approach and the
alternate techniques, for all considered models and values of c, when J = 100. In particular, Table 2.1
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Table 2.1: Presented results include the empirical bias (Bias) of the 500 estimated regression coefficients and
there sample standard deviation (SD) obtained from analyzing data generated according to models M1-M5,
for all considered pool sizes when J = 100 in the absence of measurement error. Also included are the
average estimated standard errors (SE) and the empirical coverage probabilities (Cov) associated with 95%
Wald confidence intervals. Three model fitting procedures were implemented, the proposed methodology
(MCMLE), the analytical approach described in Section 2.3 (MLE), and the MCEM algorithm, with the
latter two techniques only being applicable for models M1 and M2, respectively.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.96(0.07) 0.94(0.05) 0.94(0.04) 0.95(0.03) 0.92(0.03)
M1(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.96(0.05) 0.95(0.04) 0.93(0.03) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.94(0.07) 0.94(0.06) 0.94(0.05) 0.93(0.04)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.96(0.07) 0.95(0.05) 0.94(0.04) 0.95(0.04) 0.92(0.03)
M1(MLE) β1
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.96(0.05) 0.96(0.04) 0.94(0.03) 0.95(0.03) 0.94(0.02)
β2
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.95(0.07) 0.94(0.06) 0.94(0.05) 0.93(0.04)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.07) 0.95(0.05) 0.95(0.04) 0.94(0.04) 0.94(0.03)
M2(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.94(0.04) 0.95(0.03) 0.94(0.03) 0.94(0.02)
β2
Bias(SD) 0.01(0.10) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.95(0.10) 0.93(0.07) 0.96(0.06) 0.97(0.05) 0.96(0.05)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.07) 0.95(0.05) 0.95(0.04) 0.93(0.04) 0.94(0.03)
M2(MCEM) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.94(0.04) 0.94(0.03) 0.94(0.03) 0.94(0.02)
β2
Bias(SD) 0.01(0.10) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.95(0.10) 0.92(0.07) 0.96(0.06) 0.97(0.05) 0.96(0.05)
β0
Bias(SD) 0.00(0.16) -0.01(0.12) 0.00(0.11) 0.00(0.10) 0.00(0.09)
Cov(SE) 0.96(0.16) 0.95(0.13) 0.94(0.11) 0.95(0.09) 0.94(0.08)
M3(MCMLE) β1
Bias(SD) 0.00(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.06) 0.00(0.06)
Cov(SE) 0.94(0.12) 0.94(0.09) 0.96(0.08) 0.95(0.07) 0.94(0.06)
β2
Bias(SD) 0.01(0.24) 0.01(0.18) 0.00(0.16) 0.00(0.14) 0.00(0.13)
Cov(SE) 0.94(0.23) 0.93(0.18) 0.93(0.15) 0.95(0.13) 0.95(0.12)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.96(0.07) 0.94(0.05) 0.94(0.04) 0.94(0.03) 0.94(0.03)
M4(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.96(0.05) 0.98(0.04) 0.93(0.03) 0.95(0.03) 0.93(0.02)
β2
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.95(0.10) 0.95(0.07) 0.95(0.06) 0.95(0.05) 0.95(0.04)
β0
Bias(SD) 0.01(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.94(0.04) 0.94(0.02) 0.95(0.02) 0.92(0.02) 0.96(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.94(0.03) 0.94(0.02) 0.95(0.01) 0.96(0.01) 0.97(0.01)
β2
Bias(SD) 0.00(0.06) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.06) 0.95(0.04) 0.94(0.03) 0.93(0.03) 0.97(0.03)
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summarizes the empirical bias and the sample standard deviation of the 500 point estimates of the
regression coefficients stratified by model and pool size. The average of the 500 estimated standard
errors, and the estimated coverage probability associated with 95% Wald confidence intervals are
also included. Web Tables 1 and 2 in the Appendix A provide the analogous results for J = 50 and
200, respectively. From these results, one will first notice that the point estimates obtained by the
proposed approach exhibit little if any evidence of bias. Secondly, the sample standard deviation
and the average standard error of the 500 estimates are predominantly in agreement. Further,
the estimated coverage probabilities are all at their nominal level. These finding suggest that the
approach proposed in Section 2.2 for estimating the asymptotic variance performs well for finite
samples, and could subsequently be used to reliably conduct Wald-type inference.
To assess the effect that pooling has on parameter estimation and inference, one may com-
pare the parameter estimates obtained from the individual level data (i.e., when c = 1) to those
obtained from the pooled data (i.e., when c > 1). These comparisons reveal two striking features
of the proposed methodology. First, the estimates of the regression coefficients based on the pooled
data are more efficient (i.e., have a smaller sample standard deviation and average standard error)
than the estimates obtained from analyzing the individual level data. Moreover, the efficiency of the
estimators tends to increase with the pool size c. This finding suggests that the process of analyzing
biomarker assessments made on pools, rather than individuals, will result in more precise estimation
and inference, when a fixed number of assessments J is mandated. Secondly, this comparison also
suggests that the error that is introduced by approximating the observed data likelihood through
the expression in (2.8), is appropriately controlled by the approach presented in Section 2.2. This
assertion is reinforced when one considers the comparison between the estimates obtained from the
proposed methodology and the analytical form of the MLE under model M1. In particular, the
summary measures of the estimated regression coefficients obtained from these two techniques are
practically identical. This finding provides evidence that the approach developed in Section 2.2 can
be used to appropriately control the precision of the MCMLE.
Table 2.1 also provides a summary of the estimated regression coefficients obtained from
the MCEM algorithm proposed by Mitchell et al. (2014), for model M2. In comparing these results
to the those obtained from the proposed methodology one will note that the two procedures are
practically identical in terms of estimation and inference. Though similar in terms of estimation
and inference, an advantage of the proposed methodology over that of the MCEM algorithm arises
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in the computational time required to complete model fitting. Figure 2.1 provides the average
model fitting time for both the proposed approach and the MCEM algorithm, for all considered
combinations of (c, J) under model M2. From these results one will note that the proposed approach
is able to complete model fitting roughly 5 to 8 times faster than the MCEM algorithm, on average.
Moreover, it appears that the average model fitting time for the MCEM algorithm increases more
rapidly with both the sample size (J) and pool size (c). Note, the aforementioned comparisons
between the proposed approach and the MCEM algorithm were implemented using code written
solely in R, which used no advanced computing techniques (e.g., interfacing R with C++, parallel
processing, etc.), and was run on a Optiplex 790 desktop running Windows 7 with an Intel i7-2600
3.40 GHz CPU and 16GB of RAM. Further, these comparisons are for data that are not subject to




























Figure 2.1: Simulation study: Average model fitting times required by the proposed methodology
and the MCEM algorithm developed in Mitchell et al. (2014) for data generated under model M2
which is not subject to measurement error. Presented results are stratified by pool size (c) and the
number of pools (J).
Table 2.2 summarizes the estimates of the regression coefficients that were obtained from
analyzing the error contaminated pooled observations via the proposed approach, for all considered
models and values of c, when J = 100 and τ = 0.05. Web Tables 3-10 in the Appendix A provides
the analogous results for the other considered values of J and τ . The results from this study reinforce
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all of the main findings discussed above; i.e., the proposed approach can be used to accurately and
efficiently analyze pooled biomarker data, while correcting for the effects of measurement error. In
summary, the results of this study highlight the three definitive advantages of the proposed method-
ology, when compared to other existing techniques: first, the proposed technique can account for
data subject to measurement error; second, the methodology outlined in Section 2.1 can be imple-
mented under many different parametric models to conduct the regression analysis of measurements
taken on pools; and third, the proposed methodology is far less computationally burdensome when
compared to existing techniques.
2.4 Data application
The Collaborative Perinatal Project (CPP) was a longitudinal study, conducted from 1957
to 1974, which was aimed at assessing multiple hypotheses regarding varying aspects of maternal
and child health (Hardy, 2003). The data collected by this study constitutes an important resource
for biomedical research in many areas of perinatology and pediatrics. In 2007 data from the CPP
was used in a nested case-control study which examined whether circulating levels of chemokines are
related to miscarriage risk; for further details see Whitcomb et al. (2007). In particular, this study
considered measuring cytokine levels, to include monocyte chemotactic protein-1 (MCP1), on stored
serum samples from CPP participants who had experienced a miscarriage (cases) and those who
had not (controls), where cases and controls were matched based on gestational age. This analysis
focuses on the MCP1 measurements obtained in the aforementioned study and considers only the
participants for which full covariate information was available, where the selected explanatory vari-
ables consist of age (standardized; denoted by x1), race (1=Africa American/0=otherwise; denoted
by x2), and miscarriage status (1=yes/0=no; denoted by x3).
This data set possess two unique features which are of particular interest; i.e., MCP1 mea-
surements were taken on both individual and pooled specimens, in duplicate. Consequently, the data
available from this study can be divided into two separate data sets: the pooled data (PD) which
consists of 81 and 350 MCP1 measurements taken on individual and pooled (with cj = 2 for all j)
specimens, respectively, and the individual data (ID) which consists of 752 measurements taken on
individual specimens. This feature allows one to asses the effect of pooling on parameter estimation,
a characteristics that could not be examined if only pooled data was considered. Further, within the
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Table 2.2: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated re-
gression coefficients and there sample standard deviation (SD) obtained from analyzing data generated
according to models M1-M5, for all considered pool sizes when J = 100 in the presence of measurement
error (τ = 0.05). Also included are the average estimated standard errors (SE) and the empirical cover-
age probabilities (Cov) associated with 95% Wald confidence intervals. Two model fitting procedures were
implemented, the proposed methodology (MCMLE) and the analytical approach described in Section 2.3
(MLE), with the latter technique only being applicable for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.93(0.07) 0.96(0.05) 0.94(0.04) 0.91(0.04) 0.94(0.03)
M1(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.94(0.04) 0.97(0.03) 0.93(0.03) 0.94(0.02)
β2
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.96(0.07) 0.94(0.06) 0.93(0.05) 0.92(0.05)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.94(0.07) 0.96(0.05) 0.94(0.04) 0.92(0.04) 0.95(0.03)
M1(MLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.95(0.04) 0.97(0.03) 0.93(0.03) 0.95(0.02)
β2
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.96(0.07) 0.95(0.06) 0.93(0.05) 0.93(0.05)
β0
Bias(SD) 0.02(0.08) 0.00(0.06) 0.01(0.05) 0.01(0.05) 0.01(0.04)
Cov(SE) 0.94(0.08) 0.94(0.06) 0.94(0.05) 0.93(0.05) 0.94(0.04)
M2(MCMLE) β1
Bias(SD) -0.01(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.96(0.06) 0.93(0.04) 0.96(0.03) 0.94(0.03) 0.94(0.03)
β2
Bias(SD) -0.01(0.10) 0.00(0.08) 0.00(0.06) -0.01(0.06) 0.00(0.05)
Cov(SE) 0.95(0.10) 0.94(0.08) 0.94(0.07) 0.94(0.06) 0.94(0.05)
β0
Bias(SD) 0.00(0.17) -0.01(0.13) 0.00(0.11) 0.00(0.09) 0.00(0.09)
Cov(SE) 0.93(0.17) 0.94(0.13) 0.94(0.11) 0.94(0.09) 0.94(0.08)
M3(MCMLE) β1
Bias(SD) 0.00(0.12) 0.00(0.09) -0.01(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.12) 0.94(0.09) 0.95(0.08) 0.93(0.07) 0.94(0.06)
β2
Bias(SD) -0.01(0.24) 0.01(0.19) 0.00(0.15) 0.00(0.13) 0.00(0.12)
Cov(SE) 0.95(0.24) 0.94(0.18) 0.95(0.15) 0.95(0.13) 0.95(0.12)
β0
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.95(0.08) 0.97(0.06) 0.95(0.05) 0.93(0.04) 0.96(0.04)
M4(MCMLE) β1
Bias(SD) -0.01(0.06) -0.01(0.04) -0.01(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.05) 0.95(0.04) 0.93(0.03) 0.92(0.03) 0.95(0.03)
β2
Bias(SD) -0.01(0.11) 0.00(0.08) 0.00(0.06) -0.01(0.06) 0.00(0.05)
Cov(SE) 0.92(0.10) 0.95(0.08) 0.94(0.06) 0.94(0.06) 0.94(0.05)
β0
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.96(0.04) 0.94(0.02) 0.94(0.02) 0.94(0.02) 0.93(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.96(0.03) 0.96(0.02) 0.96(0.02) 0.94(0.01) 0.95(0.01)
β2
Bias(SD) 0.00(0.06) 0.00(0.04) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.06) 0.95(0.04) 0.93(0.03) 0.95(0.03) 0.94(0.03)
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PD and ID the MCP1 measurements were taken in duplicate for most of the specimens (pooled and
individual), which allowed for the detection and subsequently the estimation of the measurement
error (Carroll et al., 2006). In particular, through differencing the replicated MCP1 measurements it
was found that it was reasonable to assume that additive measurement error was present, and that
the error terms followed a normal distribution with mean 0 and variance τ2. From these differences,
τ2 was estimated to be 0.0442 and 0.0502 based on the ID and PD, respectively.
As with many cytokines, the MCP1 measurements are positive and seem to follow a right-
skewed distribution. For this reason, three parametric models were considered for the MCP1 levels:
a log-normal regression model and a gamma regression model under two different link functions,
namely the log and inverse links. The linear predictor of the full model was specified to be
η = β0 + β1x1 + β2x2 + β3x3 + β4x
2
1 + β5x1x2 + β6x1x3 + β7x2x3,
where β = (β0, . . . , β7)
′ are the regression coefficients. To identify the final model, best subsets
regression, driven by the Akaike information criterion, was implemented to evaluate each of the
27 = 128 submodels. In order to assess the effect of measurement error, this process, for each
parametric model, was completed both acknowledging and ignoring measurement error for both
data sets (i.e., ID and PD). Consequently, this analysis considers 12 different scenarios, each of
which required the fitting of 128 models. For all of these analyses, the proposed methodology was
implemented in the same fashion as was discussed in Section 2.3.
Table 2.3 provides the top 5 models (ranked according to their AIC values) within each
scenario. From these results, it can be seen that under all considered parametric models, both for the
ID and PD, the collection of predictor variables most frequently selected include age (x1), miscarriage
status (x3), and the interaction between miscarriage status and race (x2x3). For this reason, the
final model under all scenarios was chosen to possess these predictor variables. For comparative
purposes, the MCEM algorithm proposed by Mitchell et al. (2014) was also implemented to perform
model fitting and evaluation for the PD under the log-normal regression model, assuming that the
observed outcomes were non-error laden. The model estimates, and consequently the AIC values,
obtained by both the MCEM algorithm and the proposed methodology were practically identical.
The marked difference between these two competing techniques arose in the computational time
required to complete best subsets regression. In particular, the MCEM algorithm required 74 hours
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to complete this process, while the proposed approach took only 7. Consequently, based on these
findings it is conjectured that the proposed methodology would likely be preferred in practice due to
its computational efficiency, especially for the purposes of completing model selection via automated
search algorithms.
Table 2.4 provides the estimates of the regression coefficient along with their estimated
standard errors and p-values for the final model, across the 12 different scenarios. These results
warrant several comments, first one will note that ignoring measurement error in this application
impacted both estimation and inference, for both the ID and PD; i.e., there were 4 (1) cases for the ID
(PD) in which a regression coefficient was deemed to be significant (at the α = 0.05 significance level)
when measurement error was accounted for but were found to be insignificant when it was ignored.
Secondly, the estimates obtained from the PD are in general agreement with the estimates resulting
from the ID, across all of the considered configurations. Although, in some instances discrepancies
were observed; e.g., under the gamma regression model with the inverse link, the estimates of the
regression coefficient associated with the interaction term obtained from the ID and PD were 1.972
and 7.002, respectively.
One plausible explanation for these deviations involves the pooling strategy considered in
the original study; i.e. cases were randomly pooled with cases and controls with controls. In order
to investigate this assertion, a second pooled data (HPD) set was artificially constructed using the
ID, where pools, of size 2, were formed homogeneously with respect to the participants covariate
information and the MCP1 measurement for each pool was taken to be the average of the MCP1
measurements for the individuals of which it was comprised. Table 2.4 provides the parameter
estimates obtained from the analysis of the HPD, and from these results one will note that the
use of homogeneous pooling has practically resolved all of the aforementioned discrepancies; i.e.,
the regression parameter estimates based on ID and HPD are practically identical. Further, the
regression parameter estimates obtained from the HPD were generally more accurate and efficient
than those based on the PD which contains 80 more observations.
The aforementioned analysis illustrates the primary strengths of the proposed approach;
i.e., this new methodology can be used to conduct the regression analysis of pooled data under a
variety of parametric models, it can be used to directly account for the effects of measurement error,
and it is computationally efficient. Further, this study also illustrates that in order to obtain the
most accurate estimation and inference homogeneous pooling should be implemented in practice.
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Table 2.3: Data application: The top five models according to their AIC values for all 12 considered
scenarios, where a Xdenotes that a particular predictor was included in the model. The predictor
variables x1, x2, and x3 represent the participant’s age, race, and miscarriage status, respectively.
Note, the presence (absence) of “ ∗” indicates that the MCMLE accounted for (ignored) the effect
of measurement error.
Model Data set x1 x2 x3 x
2
1 x1x2 x1x3 x2x3
Log-normal
ID
X X X X
X X X
X X X
X X X X X
X X X X X
ID∗
X X X
X X X X
X X X X





X X X X




X X X X
X X X X
X X X X X




X X X X
X X X X
X X X X
X X X X
ID∗
X X X
X X X X
X X X X
X X X X
X X X X
PD
X X X X
X X X X X
X X X X X
X X X X X
X X X X X X
PD∗
X X X X
X X X X X
X X X X X
X X X X




X X X X
X X X X
X X X X
X X X X
ID∗
X X X
X X X X
X X X X
X X X X
X X X X
PD
X X X X
X X X X X
X X X X X
X X X X X
X X X X X
PD∗
X X X X
X X X X X
X X X X X
X X X X X
X X X X X
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Table 2.4: Data application: Presented results include the regression parameter estimates (Est.),
the estimated standard errors (SE), and the corresponding p-values (P-value), under all 12 con-
sidered scenarios. Also included are the analogous results obtained from the artificial constructed
homogeneous pooling data (HPD). Note, the presence (absence) of “ ∗” indicates that the MCMLE
accounted for (ignored) the effect of measurement error.
Model Data set Intercept Age Miscarriage Race∗Miscarriage
Lognormal
ID
Est.(SE) -2.130(0.055) 0.111(0.039) 0.271(0.087) -0.508(0.122)
P-value 0.000 0.005 0.002 0.000
ID∗
Est(SE) -2.091(0.053) 0.117(0.037) 0.220(0.082) -0.409(0.119)
P-value 0.000 0.002 0.007 0.001
PD
Est.(SE) -2.438(0.070) 0.105(0.066) 0.314(0.116) -0.822(0.225)
P-value 0.000 0.112 0.007 0.000
PD∗
Est.(SE) -2.365(0.077) 0.155(0.065) 0.262(0.115) -0.681(0.246)
P-value 0.000 0.018 0.023 0.006
HPD∗
Est.(SE) -2.116(0.059) 0.110(0.041) 0.220(0.089) -0.360(0.128)




Est.(SE) -1.592(0.075) 0.099(0.054) 0.227(0.119) -0.406(0.167)
P-value 0.000 0.066 0.056 0.015
ID∗
Est.(SE) -1.615(0.053) 0.100(0.038) 0.232(0.084) -0.403(0.119)
P-value 0.000 0.008 0.006 0.000
PD
Est.(SE) -1.680(0.061) 0.171(0.058) 0.305(0.099) -0.976(0.207)
P-value 0.000 0.003 0.002 0.000
PD∗
Est.(SE) -1.708(0.067) 0.176(0.063) 0.311(0.109) -1.033(0.249)
P-value 0.000 0.005 0.004 0.000
HPD∗
Est.(SE) -1.601(0.058) 0.097(0.042) 0.230(0.091) -0.407(0.130)




Est.(SE) 4.922(0.365) -0.424(0.227) -0.959(0.511) 1.947(0.892)
P-value 0.000 0.062 0.061 0.029
ID∗
Est.(SE) 5.033(0.265) -0.437(0.163) -0.989(0.369) 1.972(0.647)
P-value 0.000 0.008 0.007 0.002
PD
Est.(SE) 5.365(0.322) -0.667(0.228) -1.301(0.447) 6.429(1.915)
P-value 0.000 0.003 0.004 0.001
PD∗
Est.(SE) 5.518(0.368) -0.703(0.253) -1.350(0.503) 7.002(2.507)
P-value 0.000 0.006 0.007 0.005
HPD∗
Est.(SE) 4.964(0.286) -0.418(0.177) -0.977(0.398) 1.973(0.705)
P-value 0.000 0.018 0.014 0.005
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Similar findings were reported in Mitchell et al. (2014).
2.5 Discussion
In this work, a general framework for the regression analysis of assessments taken on pools
has been developed. The proposed approach allows for the regression analysis under practically all
parametric models, can be used to account for the effects of measurement error if present, and is
computationally efficient. The asymptotic properties of the proposed technique have been estab-
lished. Through simulation studies the proposed approach was shown to obtain precise estimates
and accurate inference under several common parametric models, as well as to be superior, with
respect to computational efficiency, to existing techniques. Further, the simulation study indicated
that the regression analysis of pooled data can result in parameter estimates that are more efficient
than those which are based on individual level data, if pools are formed homogeneously and a fixed
number of assessments, J , are to be made. Similarly, from the data application one will observe
that for a fixed population size, there is practically no loss in estimation efficiency when analyzing
homogeneously pooled outcomes. In order to further disseminate this work, software, programmed
in R, which implements the proposed methodology has been developed and is available upon request.
The primary focus of the work presented in this manuscript was placed on developing a
general methodology for conducting the regression analysis of pooled assessments, based on an
assumed parametric model for the latent individual level data. A topic for future research could
involve developing techniques which can be used to evaluate the selected parametric model; e.g.,
goodness-of-fit tests. Further, similar to Ma et al. (2011), future research in this area could focus
on developing pooling algorithms which attempt to minimize the loss in estimation efficiency that





This chapter aims at modeling the prevalence of three common types of diseases in domestic
dogs, i.e., heartworm, ehrlichiosis, and anaplasmosis, in the United States using climate, geographic,
and societal factors. We then use this model to forecast the prevalence of each disease in dogs for
2016. The data available for this study consists of millions of test results for each disease, collected
at the county level within the 48 contiguous United States from 2011-2015. Using the collected data,
a baseline prevalence map was constructed through the use of spatial smoothing techniques after
temporal aggregation; i.e., head-banging and Kriging. In addition, several covariates purported to be
associated with the prevalence of these diseases were collected on the same spatio-temporal granular-
ity, and include forestation, elevation, water coverage, temperature, relative humidity, precipitation,
population density, and median household income. A Bayesian spatio-temporal conditional autore-
gressive (CAR) model was used to analyze these data, for the purposes of identifying significant risk
factors and for constructing disease forecasts. The fidelity of the forecasting technique was assessed
using historical data, and a disease forecast for dogs in 2016 was constructed. The fidelity of the fore-
casting technique was assessed in the usual fashion; i.e., the 2011-2014 data was used to forecast the
2015 county level prevalence, with comparisons between observed and predicted being made. The
weighted (to acknowledge sample size) correlation between 2015 county level observed prevalence
and 2015 forecasted prevalence is then calculated and appealing. The forecast for the prevalence
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of these four diseases in domestic dogs in 2016 are also provided. The forecast presented from this
model can be used to alert veterinarians in areas likely to see above average disease prevalence in
dogs in the upcoming year.
3.1 Background and Collected Data
3.1.1 Heartworm
Heartworm disease, caused by the mosquito-borne filarial nematode Dirofilaria immitis, is
arguably the most medically important parasitic infection of domestic dogs in the United States (US),
affecting at least 115,000 dogs in 2015. Beyond the US, heartworm disease is a global veterinary
healthcare problem, with D. immitis affecting dogs in many parts of South America, Europe, Asia,
and Australia (Simón et al., 2009; Morchón et al., 2012). Infection is associated with life-threatening
complications and significant financial burden, costing millions in veterinary care annually for disease
treatment (Bowman and Atkins, 2009; Bowman, 2009; Colby et al., 2011; Maxwell et al., 2014;
Wolstenholme et al., 2015). Although less common and less studied, heartworm disease is also
a health concern for other mammals such as domestic cats, domestic ferrets, and some wildlife
species (Venco et al., 2015). Clinical signs of heartworm disease in domestic dogs include exercise
intolerance, coughing, dyspnea, cachexia, anorexia, epistaxis, and ascites. Dogs with a high burden
of adult heartworms can suffer from pulmonary arterial occlusion and inflammation, leading to
pulmonary hypertension and potentially right heart failure. Cats and ferrets may experience similar
signs but acute death is not uncommon, even with very low worm burdens. Humans can also be
infected with D. immitis, but infections are rare, with fewer than 100 cases reported in the US
over the last 60 years (Lee et al., 2010). Human infection is most commonly asymptomatic, with
people considered dead-end hosts for the parasite. While rare, human D. immitis infection is highly
problematic in that it most often manifests as “coin lesions” in the lungs that may be mistaken for a
neoplasm on chest radiographs; surgical excision is necessary to differentiate the two entities (Orihel
and Eberhard, 1998).
Heartworm disease in dogs is most commonly diagnosed through the detection of circulating
D. immitis antigen in the blood (Bowman and Atkins, 2009; Little et al., 2014). The prevalence
of heartworm infection in the US varies considerably by geographical region. The prevalence of
heartworm infection in the US varies considerably by geographical region. Two nationwide surveil-
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lance studies of D. immitis infection prevalence in domestic dogs found the highest prevalence in
the Southeast and the lowest in the Northeast (Little et al., 2014). For unknown reasons, a noted
decrease in the prevalence of D. immitis occurred between the 2001-2007 and 2010-2012 in these
studies. Importantly, regardless of time period and even within areas where heartworm infection is
considered common, there can be considerable local variation, with prevalence reaching as high as
13% (Yabsley et al., 2004; Levy et al., 2011).
Numerous factors are purported to be associated with regional and local variations in D.
immitis prevalence in domestic dogs. Highly effective commercially available anthelmintics (e.g.,
macrocyclic lactones (ML) (Bowman and Atkins, 2009), including the avermectins (ivermectin, se-
lamectin) and the milbemycins (moxidectin, milbemycin oxime) can be administered monthly to
prevent the development of immature stages into adult worms. Year-round preventive use is rec-
ommended throughout the US, yet the majority of dogs only receive seasonal treatment (Gates and
Nolan, 2010). Even within highly endemic regions, anthelminthic use varies based on client compli-
ance, knowledge, or dog owner’s demographics. In addition, resistance of D. immitis to ML has been
recently documented and is a growing concern in the Gulf States, but the current extent of resis-
tant phenotypes remains unknown (Wolstenholme et al., 2015; Bourguinat et al., 2015). D. immitis
can be transmitted by over 70 species of mosquitoes, although certain species (e.g., Aedes trivit-
tatus, Aedes sierrensis and Culex quinquefasciatus) are considered more important vectors (Wang
et al., 2014a). Because the density of mosquitoes and community composition of competent vector
species is influenced greatly by habitat use and climate, these factors should be considered when
investigating factors influencing heartworm disease. In support of this, a previous study found that
temperature, median household income, population density, precipitation, elevation, relative humid-
ity, forestation coverage, and surface water coverage all significantly influence D. immitis prevalence
in dogs (Wang et al., 2014a).
Clearly, it would be advantageous to accurately forecast D. immitis prevalence on a local
scale, providing an a priori alert to veterinarians in problem areas where immediate remediation
measures could be taken. Annual forecasts of emergent infection will also inform veterinary and
public health officials to shifting areas of infection, particularly in temperate regions of the US
where D. immitis in generally absent, rare, or prevalence is highly influenced by annual variation in
biotic or abiotic factors.
The data studied here contain 31,345,244 heartworm antigen test results from dogs in the
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Factors Data period Scale Notation Numerical scale
Annual temperature 1895 - 2015 Climate Division Xst,1
Annual precipitation 1895 - 2015 Climate Division Xst,2 Continuous
Annual relative humidity 2006 - 2015 Climate Division Xst,3
Elevation 2012 County Xst,4
Percentage forest coverage 2012 County Xst,5 Continuous
Percentage surface water coverage 2010 County Xst,6
Population density 2011-2014 County Xst,7 Continuous
Median household income 1997-2014 County Xst,8
Aedes aegypti 2008 County Xst,9
Xst,k = 1 if present
Xst,k = 0 otherwise
Aedes albopictus 2012 County Xst,10
Aedes canadensis 2004 County Xst,11
Aedes sierrensis 2004 County Xst,12
Aedes trivittatus 2004 County Xst,13
Anopheles punctipennis 2004 County Xst,14
Anopheles quadrimaculatus 2004 County Xst,15
Culex quinquefasciatus 2004 County Xst,16
Table 3.1: Factors purported to influence heartworm prevalence. For further discussion, including
the source of each factor, see Wang et al. (2014a).
conterminous United States from 2011-2015, and various climate, geographic, and socio-economic
factors purported to influence heartworm prevalence. The raw tests were obtained from the Antech
and IDEXX corporations (Antech, 2015; IDEXX, 2015). Over all five years in the study, 384,905 of
the tests were positive (1.23%). The test data contain the county/parish of the testing clinic and
the month when the tests were conducted; however, no measure of uncertainty is given with the
individual test results.
The test data were aggregated into the number of positive and negative tests for each year
in each conterminous United States county/parish. Table 3.1 lists 16 explanatory factors that are
purportedly related to the dog heartworm prevalence, as well as their time period of record and
geographic scale of collection. These 16 factors include the climatic variables of annual temperature,
precipitation and relative humidity, the geographic variables of county elevation, forestation coverage,
and surface water coverage, the socio-economic variables of county population density and median
household income, and the presence of eight mosquito vectors. For more details on these factors,
see Stich et al. (2014).
Figure 3.1 displays county-level raw heartworm prevalences obtained by dividing the number
of positive cases by the number of tests over all five years in the study. The raw prevalences









Figure 3.1: County by county heartworm raw prevalences aggregated over 2011-2015
prevalences. Significant temporal dependence is also present in the data: the current prevalence is
similar to past prevalence. Therefore, this data set requires a statistical model with both spatial
and temporal dependence. Figure 3.2 provides a spatially smoothed prevalence map, using a head-
banging smoothing procedure, based of the Figure 3.1 proportions. In the head-banging smoothing
procedure, 45 triples were employed. The smoothing was also weighted proportionally to the number
of tests taken in each county over the five-year period. This prevents the map from signaling a
high/low prevalence that is more likely attributed to a small sample (one positive out of three tests
has the same prevalence as one hundred positive in three hundred tests, though the latter is more
indicative of infection risk). Details on head-banging smoothing and its uses in disease mapping are
contained in Wang et al. (2014a). Figure 3.2 serves as a contemporary depiction of the “baseline”









Figure 3.2: Head-banged baseline map showing heartworm prevalences for an average year during
2011-2015
3.1.2 Ehrlichiosis
Ehrlichia species are intracellular gram-negative bacteria that are maintained in a complex
life cycle involving vertebrate hosts as reservoirs and ticks as vectors (Varela et al., 2005; Yabsley
et al., 2003, 2002; Little, 2010). In North America, multiple Ehrlichia spp. reportedly infect dogs,
including Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia ewingii, Ehrlichia sp., Panola Mountain
Ehrlichia (PME), or coinfection with multiple Ehrlichia species. Most of these bacteria (E. chaffeen-
sis, E. ewingii, and Ehrlichia sp. PME) are maintained in nature in white-tailed deer (Odocoileus
virginianus) reservoirs and are transmitted by Amblyomma americanum (lone star ticks). Ehrlichia
canis is primarily transmitted among domestic dogs by Rhipicephalus sanguineus (brown dog ticks).
Dermacentor variablis (the American dog tick) is a potential vector of E. chaffeensis and E. canis
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(Bremer et al., 2005; Little, 2010; Yabsley, 2010; Qurollo et al., 2014; Starkey et al., 2014). In the
absence of coinfection, E. chaffeensis produces relatively mild canine disease (Little, 2010); however,
E. chaffeensis is most commonly cited as the causative agent in human monocytic ehrlichiosis (Yab-
sley, 2010). While E. canis was historically believed to be the predominant Ehrlichia spp. to infect
dogs, recent data on exposure of dogs to Ehrlichia spp. using species specific peptides has shed
light on the spatial variation and prevalence of Ehrlichia exposure in dogs (Qurollo et al., 2014).
Qurollo et al. (2014) found in the Southern, Mid-Atlantic, Northeastern and Midwestern U.S., dogs
were predominantly exposed to E. ewingii and E. chaffeensis. In contrast, canine E. canis seroreac-
tivity was low in these regions, and was the predominant, or only, Ehrlichia species responsible for
Ehrlichia seroconversion in the western US.
Veterinary wellness exams commonly include annual screening for exposure to Ehrlichia
spp.; Anaplasma spp., Borrelia burdgorferi (Lyme disease agent) and infection with Dirofilaria immi-
tis (Heartworm disease agent) using a rapid, in-house enzyme-linked immunosorbent assay (ELISA)
platform (SNAPr3Dxr, SNAPr4Dxr and SNAPr4Dxr Plus, IDEXX Laboratories, Inc.). This
in-house assay, while highly specific and sensitive for exposure to Ehrlichia spp., uses recombinant
peptides of major E. canis and E. ewingii outer membrane proteins (Qurollo et al., 2014; Starkey
et al., 2014), thus precluding speciation of seroreactivity. As such, these tests are interpreted by
veterinary clinicians to indicate tick exposure and a history of transmission of Ehrlichia spp. and
possibly other tick-borne pathogens. Of four million dogs tested for exposure to Ehrlichia in 2015,
over 100,000 dogs were seropositive for Ehrlichia spp. CAPC (2015). Clinical ehrlichiosis in dogs
can manifest in one or more ways: acute, subclinical and chronic (Kakoma et al., 2000; McClure
et al., 2010). The acute phase occurs within 1-3 weeks after tick transmission of Ehrlichia and
includes enlarged lymph nodes, weakness, lethargy, depression, anorexia, labored breathing, and
limb edema. Some dogs do not develop clinical signs of acute ehrlichiosis. After the acute phase
dogs enter a subclinical phase in which infection may persist for months or years without clinical
signs. Finally, during the chronic phase, dogs may experience abnormal bleeding such as epistaxis,
become anemic, or have cyclic thrombocytopenia. They may also experience severe weight loss,
fever, difficulty breathing due to lung inflammation, shifting leg lameness due to joint inflammation
and pain, or kidney failure and paralysis (Cohn, 2003).
Canine ehrlichiosis has been reported throughout the contiguous United States; however,
the geographic range of different Ehrlichia spp. varies considerably, influenced by the range and
36
density of their primary vectors. For example, the highest concentration of E. canis cases have been
reported in southwestern and Gulf Coast regions of the United States, whereas the highest incidence
of E. chaffeensis and E. ewingii cases occur in the Midwestern and Southeastern United States, a
place where A. americanum occurs in high densities. The distribution and number of ehrlichiosis
cases have increased six-fold over the last five years (Qurollo et al., 2014; Starkey et al., 2014); cases
have been found in states as far north as Maine and as far west as Arizona, California, and Nevada
(CAPC, 2015). The dynamic change in prevalence in non-endemic regions have led to speculation
on possible changing tick populations, which may be influenced by factors such as climate change,
encroaching urbanization, and increasing urban/suburban populations of wildlife reservoirs.
In developing our approach, a Bayesian spatio-temporal conditional autoregressive (CAR)
model is utilized to assess the putative factors and forecast future trends in Ehrlichia spp. prevalence.
In this venue, Bayesian modeling offers a number of advantages over classical approaches (Harrison
and West, 1999; Stern et al., 2007; Gelman et al., 2014). First, the probabilistic likelihood-based
methods here are highly flexible, and are able to adapt to data availability problems. The methods
are also capable of assessing predictive significance of various covariate factors. Second, the use
of data augmentation Markov chain Monte Carlo (MCMC) methods to sample from a posterior
distribution provides the opportunity to treat missing data, such as absence of serologic data from
certain counties, as latent (missing) variables, even in large populations (Hosking et al., 2008; Besag
and Mondal, 2013). Finally, these methods are directly amendable to forecasting future trends in
seroprevalence, conditional on the past history of data. The Bayesian methods capably quantify un-
certainty both in terms of the potential stochasticity of the disease process and the model parameter
estimates.
In what follows, eight factors previously purported to influence canine Ehrlichia seropreva-
lence will be examined: annual precipitation, annual relative humidity, annual temperature, eleva-
tion, percentage forest coverage, percentage surface water coverage, population density, and median
household income (Stich et al., 2014). After a predictive model is developed from these factors,
annual Ehrlichia seroprevalence forecasts are constructed and a comparison between the 2015 actual
versus predicted Ehrlichia prevalence was conducted. Intended uses of annual Ehrlichia seropreva-
lence forecasts include: 1) to encourage the use of tick preventive to reduce exposure using an
evidence-based tool, 2) to promote the use of annual use of diagnostic testing in areas where the
disease is emerging, and 3) to potentially extend the use of canine data as a surveillance tool for
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physicians to assess potential threats to human health from Ehrlichia species.
The data included in this study were canine serologic test results for antibodies to Ehrlichia
spp. in the contiguous United States from 2011-2015, and various climate, geographic, and socio-
economic factors purported to influence Ehrlichia seroprevalence. The dataset, obtained from
IDEXX Laboratories, Inc. (IDEXX, 2011-2015), contained 11,967,465 tests, 305,409 of which were
positive (2.55%) for Ehrlichia spp. antibodies, and the county of the testing clinic. No information
was available on demographic details of the individuals tested, such as age, sex or breed of dog, nor
the travel or testing history of the dog, or the reason why the tests were conducted.
The test data were aggregated into the number of positive and negative tests for each year
in each contiguous United States county or parish. The explanatory factors chosen for inclusion
are those purported to be associated with canine Ehrlichia seroprevalence and for which data are
readily available on a wide geographical scale in the United States (Stich et al., 2014). Table 3.2
lists eight considered factors, the time period of recording, and the geographic scale of collection.
These eight factors can be grouped into climatic variables (annual temperature, precipitation, and
relative humidity), geographic variables (county elevation, forestation coverage, and surface water
coverage), and socio-economic variables (population density and median household income), and are
discussed in more detail in Wang et al. (2014a).
Table 3.2: Factors purported to influence disease prevalence in domestic dogs.
Factor Data period Scale Notation
Annual temperature 1895 - 2015 Climate Division Xst,1
Annual precipitation 1895 - 2015 Climate Division Xst,2
Annual relative humidity 2006 - 2015 Climate Division Xst,3
Elevation 2012 County Xst,4
Percentage forest coverage 2012 County Xst,5
Percentage surface water coverage 2010 County Xst,6
Population density 2011-2014 County Xst,7
Median household income 1997-2014 County Xst,8
For further discussion, including the source of each factor, see Wang et al. (2014a).
The county-by-county raw seroprevalence aggregated over the five-year data record are
shown in Figure 3.3. The raw seroprevalence in Figure 3.3 exhibits apparent positive spatial de-
pendence: counties near each other tend to report similar prevalences. Also, prevalence at a fixed
county is often similar in adjacent years (this structure cannot be discerned from Figure 3.3, but is










Figure 3.3: County by county ehrlichiosis raw prevalences aggregated over 2011-2015
correlation exists in our data. In the next section, a statistical model that accounts for spatial and
temporal correlation is developed to analyze these data. Figure 3.4 displays a map of the raw sero-
prevalences after a head-banging smoothing procedure was applied to produce a “baseline” (average
year) map. Twenty triples and weights that are proportional to the number of observations taken
in each county over the five-year period were used in the smoothing. Down weighting counties with
a small number of tests helps account for sample size effects, preventing the map from signaling
a high/low prevalence that is more likely attributed to a small sample size (e.g., one positive out
of three tests has the same prevalence as one hundred positives in three hundred tests, though the
latter has more certainty with respect to risk). A review of head-banging smoothing and its uses in
disease mapping is contained in Wang et al. (2014a). Note, in order to provide a spatially complete
map in Figure 3.4, Kriging was implemented in ArcGIS using the default parameters. In general,
Kriging is a standard spatial interpolation method for which the interpolated values are modeled









Figure 3.4: Head-banged baseline map showing ehrlichiosis prevalences for an average year during
2011-2015
that spatial variability in the data is related to the distance between observations, and that values
in unsampled areas can be predicted as a weighted average of observations at nearby locations.
The map in Figure 3.4 shows a band of high prevalence stretching from Western Texas and
Eastern New Mexico, through Northern Texas, Eastern Oklahoma, Arkansas, Missouri, Northern
Mississippi, and Western Tennessee. Another zone of high prevalence is seen in Eastern North
Carolina and Virginia; this zone ceases over the Southern Appalachian Mountains. Other isolated
high-prevalence regions occur in Central Georgia and the Northern Rockies. The Western United
States generally has lower prevalence compared with the Southeastern United States, but isolated
foci of seropositive dogs exist in many areas of the country. Several factors, including habitat, hosts,
microclimate, etc., may be associated with the presence and location of theses isolated foci (Schulze
and Jordan, 2005) but nonetheless, Figure 3.4 should serve as an accurate depiction of the baseline
ehrlichiosis risk for dogs.
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3.1.3 Anaplasmosis
Canine anaplasmosis is caused by gram-negative intracellular bacteria of the family Anaplas-
mataceae within the order Rickettsiales (Dumler et al., 2001). Anaplasma spp. bacteria are trans-
mitted through the bite of infected ticks, with different tick species transmitting distinct types of
Anaplasma bacteria in different regions of the country. A. phagocytophilum is transmitted by Ixodes
scapularis and I. pacificus and maintained in a vectorreservoir-host system similar to that of Bor-
relia burgdorferi (the causative agent of Lyme disease), with the highest canine A. phagocytophilum
seroprevalence reported in the Northeast, upper Midwest and along the west coast of California
(Qurollo et al., 2014). Although an important canine pathogen, A. phagocytophilum is also zoonotic
and causes human disease in the same regions where Lyme disease occurs. In contrast, A. platys is
presumed to be transmitted by Rhipicephalus sanguineus, and has relatively low prevalence across
the contiguous United States with a slightly higher prevalence seen in the southern states (Qurollo
et al., 2014). Dogs in the southern U.S. (Florida, Georgia, North and South Carolina, Tennessee
and Texas) show equivalent seroconversion to both A phagocytophilum and A. platys (Qurollo et al.,
2014), suggesting exposure to multiple tick vectors. Veterinary wellness exams commonly include
annual screening for exposure to Anaplasma spp., as well as Ehrlichia spp., Borrelia burdgorferi and
Dirofilaria immitis (heartworm disease agent) using a rapid, in-house enzyme-linked immunosorbent
assay (ELISA) platform (SNAPr4Dxr and SNAPr4Dxr Plus Test, IDEXX Laboratories, Inc.,
Westbrook, ME, USA) (Drouin et al., 2004; O’Connor et al., 2006). These tests detect antibodies
to both A. phagocytophilum and A. platys on a single spot and therefore no in-house speciation is
possible. Of four million dogs tested for exposure to Anaplasma spp. in 2015, over 100,000 dogs
were seropositive. Seroreactivity on these tests are interpreted by veterinary clinicians to indicate
tick exposure and a history of transmission of Anaplasma spp.
Many, if not most, dogs remain asymptomatic following exposure to Anaplasma spp.. For
example, in areas such as the northeastern US where disease is endemic, as many as 60% of dogs
may have antibodies specific for Anaplasma spp. and the majority of these dogs do not have overt
evidence of clinical disease (Beall et al., 2008; Bowman et al., 2009). When symptomatic, dogs
infected with A. phagocytophilum most commonly present with lethargy, fever and anorexia (Little,
2010). Thromobocytopenia is a hallmark of symptomatic A. phagocytophilum and A. platys infection
(Greig et al., 1996; Kohn et al., 2008; Poitout et al., 2005), presumably because of platelet destruction
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(Lilliehook et al., 1998). Both splenomegaly and lymphadenopathy are reported and are thought to
be associated with reactive lymphoid hyperplasia (Lilliehook et al., 1998); however it is critical to
note that this is not specific to anaplasmosis as experimental infection of dogs with Ehrlicia canis,
E. chaffeensis, A. platys and A. phagocytophilum results in similar histopathological lesions in lung,
liver and spleen (Nair et al., 2016). Finally, lameness due to neutrophilic polyarthritis, vomiting,
diarrhea, neurologic abnormalities and epistaxis have been described (Greig et al., 1996; Poitout
et al., 2005; Kohn et al., 2008; Eberts et al., 2011). Because the majority of seropositive dogs are
asymptomatic, current recommendations for veterinary care in Anaplasma spp. seroreactive dogs
include a complete blood count with platelet count to determine if treatment is necessary (Little,
2010).
Illnesses caused by tick-borne pathogens in animals and humans have increased over the last
decade (Adams et al., 2015), due in part to the geographic expansion of tick populations beyond
previously recognized endemic zones (Eisen et al., 2016). In a previous study, we evaluated potential
explanatory factors for Anaplasma seroreactivity in dogs and and found seroprevalence increases with
increasing precipitation and forestation coverage and decreases with increasing temperature, popu-
lation density, relative humidity, and elevation (McMahan et al., 2016). Also, socioeconomic status
and deer/vehicle collisions were positively and negatively correlated with canine Anaplasma spp.
seroprevalence, respectively (McMahan et al., 2016). Given that many Anaplasma spp. infections
are asymptomatic or mild, the relative distribution of disease risk is likely under-appreciated, par-
ticularly in non-endemic zones. As such, it would be advantageous to accurately forecast Anaplasma
spp. seroprevalence on a local scale, providing an a priori alert to veterinarians in emerging areas
of disease. Annual forecasts of emergent infection can inform veterinary and public health officials
to shifting areas of infection, particularly in temperate regions of the US where Anaplasma spp.
seroprevalence is generally absent, rare, or prevalence is highly influenced by annual variation in
biotic or abiotic factors.
In the current study, we utilize the explanatory variables derived from our previous study
to develop an Anaplasma spp. seroprevalence forecast model that uses Bayesian methods to account
for the strong spatial and temporal dependencies that exist in Anaplasma spp. seroprevalence
between counties and across time. Controlling for this autocorrelation, e.g. the similarity between
observations as a function of time, provides us with estimates conducive to forecasting changes in
the prevalence of exposure to Anaplasma spp. in space and time. The model described herein
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considers the climate, geographical, and societal factors included in the previous model, with the
exception of deer/vehicle collisions, as potential predictors. We report on the fidelity of the forecast
model by analyzing the relationship between predicted and actual Anaplasma spp. prevalence in
2015, and forecast the prevalence for 2016. Finally, we discuss the potential of canine Anaplasma
seroprevalence to inform human practitioners, as human anaplasmosis is growing in recognition as
a significant problem when present as a co-infection with Borrelia burgdorferi and is implicated in
complicated, protracted Lyme disease (Caulfield and Pritt, 2015).
The data analyzed in this section consists of 11,437,537 Anaplasma spp. serology test results
for dogs (obtained from IDEXX Laboratories, Inc. IDEXX (2011-2015)). The tests were conducted
in the contiguous United States from 2011 to 2015 and 3.21% were positive (i.e., 367,663 positive
tests) for antibodies to Anaplasma spp. Along with the binary outcomes (positive or negative)
the data also provides the county in which the test was conducted, and subsequently the analysis
presented herein considers the county level aggregated totals; i.e., the number of positive and negative
test results observed within each of the contiguous United States counties during the years of 2011
to 2015. No information is given on the travel or testing history of the dogs or the reason why the
tests were conducted.
The explanatory factors considered here are those believed to be related to Anaplasma spp.
seroprevalence in dogs, for which up to date data are available on a wide geographic scale. Table 3.2
presents the factors considered in our statistical analysis; i.e., climatic variables (annual temperature,
precipitation, and relative humidity), geographic variables (county elevation, forestation coverage,
and surface water coverage), and socio-economic variables (population density and median household
income). For further details about these factors, such as their geographical distributions, please see
McMahan et al. (2016). Fine scale data on tick population levels is desirable for this analysis, but,
to our knowledge, does not exist.
Fig 3.5 provides a spatial depiction of the empirical Anaplasma spp. seroprevalence, after
aggregating over the five years of available data. Here the empirical prevalence for each county is
defined to be the number of positive tests divided by the total number of tests conducted. This
figure tends to suggest a large degree of spatial correlation; i.e., empirical prevalences from counties
close to each other tend to be similar. Moreover, within a given county the empirical prevalences also
possess this property across time. These observations lead to the belief that both positive spatial
and temporal correlation exists in our data. Thus, to offer a reliable evaluation of the putative
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factors, as well as to develop a predictive model, these effects must be taken into account. In the
next section, a Bayesian regression model which acknowledges and accounts for both the spatial and
temporal correlation is presented. It is worthwhile to note that some counties report relatively small
number of test results, thus the interpretation of the empirical estimates depicted in Fig 3.5 may
be slightly misleading, if one does not consider this effect. That is, a county reporting only 20 test
results, with 1 being positive, results in an empirical estimate of 5%, whereas the same empirical
estimate would be obtained for a county reporting 2000 test results, with 100 being positive. The
salient point, more faith should be placed in the latter estimate, when compared to the former, since
it is derived from a higher sample size.
Figure 3.5: Empirical county-by-county Anaplasma spp. seroprevalence aggregated over 2011-2015.
In order to create a “baseline” map for Anaplasma spp. seroprevalence, the empirical
estimates depicted in Fig 3.5 were further processed through a series of spatial smoothing techniques.
First, a weighted head-banging algorithm was applied to the empirical prevalences. This procedure
accomplishes two primary tasks; first, it acknowledges spatial correlation by forming a spatially
oriented prevalence estimate through incorporating information from surrounding areas, and second,
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it down weights the influence of prevalence estimates which are derived from a relatively small number
of tests. For example, in Colorado during 2015, 14,908 test results were reported, of which 112 were
positive, translating to an observed prevalence of approx 0.75% for the state. Further, in Gunnison
county, Colorado, only 3 test results were reported, of which 1 was positive, translating to an observed
prevalence of 33%, which is obviously a small sample size issue. Weighted head banging directly
acknowledges the available sample size from each county when computing the spatially oriented
prevalence estimate. Weighted head banging was implemented using thirteen triples and the county
level weights were chosen to be proportional to the number of county level observations which were
reported over the five-year period; i.e., counties reporting more data were given more weight. In order
to render a spatially complete map, Kriging (a common spatial interpolation technique) was used to
interpolate prevalence estimates for counties not reporting data. This technique was implemented
in ArcGIS using the default settings. Fig 3.6 provides our “baseline” map for Anaplasma spp.
seroprevalence in domestic dogs within the contiguous United States. The “baseline” map presented
in Fig 3.6 suggests two endemic zones of canine Anaplasma seroprevalence in the North-Central and
Northeastern US, with lower but apparent seroprevalence in the Mid-Atlantic region, the Dakotas,
and Western Texas.
3.2 Models
This section describes the statistical model and the techniques used to fit it. The purpose
of the model is twofold: to identify environmental and societal risk factors which are significantly
associated with the prevalence of diseases (i.e., Heartworm, Ehrlichiosis and Anaplasmosis) for dogs
and to predict future trends in the disease prevalence for dogs.
Let Yst and nst denote the number of positive and total tests conducted in county s during
year t, respectively, for counties s ∈ {1, . . . , S} and years t ∈ {1, . . . , T}. It is important to note
that these values are the raw counts available in the data set; i.e., they are not the post smoothed
values resulting from the construction of the baseline map. The available serologic data exhibits both
positive spatial and temporal correlation; that is, prevalences in adjacent counties or in successive
years tend to have similar values. Thus, to account for these effects this analysis considers using a
spatio-temporal model to analyze these data; for additional information about spatial and spatio-









Figure 3.6: Baseline map of Anaplasma spp. seroprevalence.
et al. (2008); López-Quılez and Munoz (2009); Cressie and Wikle (2011); Banerjee et al. (2014). In
particular, this paper uses a Bayesian hierarchical model, which models spatio-temporal dependence
through the use of random effects. The details of the distribution of these random effects are
described in totality below. In the considered model, the number of positive tests were assumed to
follow a Poisson distribution, which is a common choice for modeling count data (Xia and Carlin,
1998; Nobre et al., 2005; Mart́ınez-Beneito et al., 2008; López-Quılez and Munoz, 2009). Under this
specification, the number of tests which are serologically positive for the disease in county s during
year t (i.e., Yst) is assumed to be distributed as
Yst|nst, pst ∼ Poisson {nstpst} , (3.1)
log {pst} = β0 +
p∑
k=1
βkXst,k + ξst, (3.2)
where log(·) denotes the natural logarithm, ′ denotes the transpose of a matrix (or vector), ∼ reads
“has the distributional type,” and | reads “given.” Thus, Eq (3.1) reads “Yst given nst and pst
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follows a Poisson distribution with mean nstpst.” Furthermore, Xst = (Xst,1, . . . , Xst,p)
′ is a vector
of covariate information for county s at time t, β = (β0, . . . , βp)
′
is the corresponding vector of
regression coefficients, and pst is interpreted as the disease prevalence in dogs residing in county s at
time t. The random effects, ξst, are used to account for the spatio-temporal dependence, so that the
positive test counts (i.e., Yst’s) are conditionally independent of each other given the total number
of tests, the factor information, and the random effects. Note, this does not imply that the Yst’s
are independent across varying space s or time t, only that they are conditionally independent once
the spatio-temporal correlation is accounted for through the random effects and the other covariate
information.
Eq (3.2) specifies the relationship between the prevalence pst and the covariate information
Xst and the random effect ξst. This specification is standard for Poisson regression models (Xia
and Carlin, 1998; Nobre et al., 2005; Mart́ınez-Beneito et al., 2008; López-Quılez and Munoz, 2009).
In general, different spatio-temporal models specify different structures for the {ξst}. By far, one
of the most popular models for areal data is the conditional autoregresive (CAR) model, and it is
the one used here (Banerjee et al., 2014). To further expound on how the CAR model is used in
this analysis, it is noted that both spatial and temporal correlation is accounted for through the
following multivariate autoregressive model
ξ1 = φ1, (3.3)
ξt = ϕξt−1 + φt, for t = 2, . . . , T, (3.4)
φt ∼ CAR(τ2; ρ), for t = 1, . . . , T, (3.5)
where ξt = (ξ1t, . . . , ξSt)
′
and φt = (φ1t, . . . , φSt)
′
are random vectors. Eq (3.5) specifies that
φt are independent and identically distributed random vectors whose distribution follows a CAR
model (Besag, 1974; Banerjee et al., 2014). From Eq (3.4) it is apparent how the model accounts
for temporal correlation. That is, in the multivariate autoregressive model depicted above, time-
dependence is modeled through a temporal autoregressive model of order one (AR(1)), which is a
staple among time series analysis (Brockwell and Davis, 2002). Eq (3.4) relates year t to year t− 1.
The parameter ϕ is the temporal correlation between consecutive years and lies within (−1, 1). This
ensures a causal and stationary solution to the time series model (Brockwell and Davis, 2002).
To examine the treatment of spatial correlation, let φ = (φ1, ..., φS)
′ follow a CAR model,
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where for the ease of exposition the dependence on t has been suppressed, and it is noted that the
subscripts correspond to the S spatial locations. There are several different kinds of CAR models.
Usually, CAR models are defined by assigning a univariate distribution for each φs, whose mean and
variance depends on the spatial relationship between location s and the other locations. This paper
uses the CAR model proposed in Besag (1974), which specifies the conditional distribution for each
φs to be










, for s = 1, . . . , S. (3.6)
Here, φ−s = (φ1, . . . , φs−1, φs+1, . . . , φS)
′
is an S − 1 dimensional vector that includes every φs′
except φs. N(µ, σ
2) denotes a normal distribution with mean µ and variance σ2. The S ×S matrix
W is defined by W = {ws,s′}, where ws,s′ = 1 if the s′th and sth counties are adjacent and ws,s′ = 0
otherwise.
The parameter τ2 in Eq (3.6) scales the variance structure. Moreover, the conditional
variance of φs, given φ−s, is inversely proportional to the number of counties bordering it. That is,
the φs for counties with more neighbors have a smaller overall variance. This agrees with intuition; if
county s has many neighbors, the model has more information to use in estimating φs, and thus the
variance of φs should be smaller. In Eq (3.6), ρ ∈ [0, 1] controls the correlation between bordering
counties. The conditional mean of φs, given φ−s, is the average of the φs′ of the neighboring counties
weighted by ρ. Thus, as ρ increases so does the degree of dependence between φs and the φs′ of the
neighboring counties.
Using Eq (3.6), it can be shown that the joint distribution of φ is given by the following
multivariate normal distribution
φ ∼ N(0,Γ), Γ = τ2 (D− ρW)−1 ,
where W is the adjacency matrix described above and D is an S × S diagonal matrix whose sth
diagonal element is the number of neighboring counties for county s.
The model is fit using Bayesian Markov Chain Monte Carlo (MCMC) techniques, with
posterior samples being used to derive point estimates of the parameters (β, ϕ, ρ, and τ2). Thus, to
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complete the Bayesian model formulation, the following prior distributions are specified
βk ∼ N(0, 1000), for k = 0, . . . , p; (3.7)
ϕ ∼ Uniform(−1, 1); (3.8)
ρ ∼ Uniform(0, 1); (3.9)
τ−2 ∼ Gamma(0.5, 0.05). (3.10)
In particular, a diffuse prior distribution is placed on βk, for k = 0, ..., p. This specification permits
the prior to exert little, if any, influence on the posterior distribution, thus allowing the data to pri-
marily drive the analysis and subsequently the conclusions. Uninformative (flat) prior distributions
are assigned for ϕ and ρ, for the same reasons. Here “uninformative” means that all possible values
of the parameter have equal probability under the prior distribution. The prior for τ−2 is chosen as
a conjugate prior. Here “conjugate” means that the posterior and prior distributions are from the
same distributional family, which simplifies computation. A posterior sampling algorithm was de-
veloped, in the usual fashion, to sample all model parameters and random effects from the posterior
distributions. This MCMC sampling algorithm uses a combination of Gibbs and Metropolis-Hastings
steps. To complete model fitting, Yst for counties not reporting test results were treated as latent
variables, and were sampled along with the model parameters. The posterior sampling algorithm
was conducted using code written in R and C++. For more information about Bayesian models and
MCMC methods, see Gelman et al. (2014).
3.3 Sampling Details
In this section, the details of Markov chain Monte Carlo sampling algorithm are provided.
The spatiao-temporal structure can be expressed as follows,





with initial value ξ1 ∼ N(µ0, τ2(D− ρW)−1),
where D is an S × S diagonal matrix whose sth diagonal element is denoted by ds, and µ0 =
(µ10, . . . , µS0)
′.
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3.3.1 Complete Data Likelihood
For notation convenience, let Y = (Y11, . . . , YS1, Y12, . . . , YS2, . . . , Y1T , . . . , YST )




X is the collection of all covariate information and ηst = log(nst) + X
′
stβ + ξst, then the complete
data likelihood is given by
p(Y,β, ξ, ϕ, τ2, ρ | X) = p(Y | β, ξ, ϕ, τ2, ρ,X)p(ξ | ϕ, τ2, ρ)π(β)π(ϕ, τ2, ρ)






















− (ξ1 − µ0)
′(D− ρW)(ξ1 − µ0)
2τ2
}
π(β, ϕ, τ2, ρ).
3.3.2 Posterior Sampling for β
First, the full conditional distribution of β is derived and given by





























It is noted that sampling from the posterior distribution of β is not trivial, because of the nonlinear
term exp(X′stβ). Therefore, Metropolis-Hastings algorithm is used to sample β. To find the proposal
distribution (i.e., the distribution where the sample will be generated from), Taylor expansion up to
second order is first applied to the nonlinear term, which leads to
exp {X′stβ} ≈ exp(X′stβ0) + exp(X′stβ0)X′st(β − β0) +
1
2
exp(X′stβ0)(β − β0)′XstX′st(β − β0),
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therefore, by substituting exp(X′stβ) to (3.11) by its Taylor expansion approximation, we have the
following proposal distribution




















































Thus if we specify a multivariate normal distribution as the prior distribution of β (i.e., β ∼
MVN(a,Σ)), the proposal distribution is also normal and given by






















{Yst − nst exp(ξst + X′stβ0)(1−X′stβ0)}X′st
)
.
3.3.3 Posterior Sampling for Hyper-parameters ϕ, τ, ρ
















ϕ2ξ′t−1 (D− ρW) ξt−1 − 2ϕξ
′




Since it is assumed that the prior of ϕ is Uniform distribution between -1 and 1, the posterior
distribution of ϕ is TN(µϕ, σ
2
ϕ;−1, 1); i.e., truncated normal distribution with mean µϕ, variance
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ξ′t (D− ρW) ξt−1.
Therefore, posterior samples of ϕ will be generated from the truncated normal distribution. For τ2,
the full conditional distribution is










− (ξ1 − µ0)




It is obvious that τ2 has conjugate prior which is inverse Gamma distribution and denoted by
IG(c0, d0), thus the posterior sample of τ
2 will be generated from IG(c∗, d∗), where c∗ = c0 + ST/2
and
d∗ = d0 +
∑T
t=2(ξt − ϕξt−1)′ (D− ρW) (ξt − ϕξt−1) + (ξ1 − µ0)′(D− ρW)(ξ1 − µ0)
2
.
For the parameter ρ which reflects the strength of spatial correlation, its full conditional distribution
is given by
p(ρ|ϕ, τ2,β, ξ,Y,X)



















t=2(ξt − ϕξt−1)′W(ξt − ϕξt−1) + (ξ1 − µ0)′W(ξ1 − µ0)
2τ2
.
It is noted that ρ is involved in both the exponential and the square root of terms, and no off-the-shelf
method can be used to draw samples directly from the posterior distribution. Thus, the Metropolis
algorithm is adopted. Since the range of ρ is between (0, 1), to facilitate the sampling process, first
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was transformed such that its range is the entire real number line (i.e., (−∞,+∞)). In particular,
let γ = log( ρ1−ρ ) and then generate γ
∗ ∼ N(γ(m), σ2γ), where γ(m) is the value of γ in the previous
iteration and σ2γ is the tuning parameter. Then ρ









log(1− ρ∗λs)− log(1− ρ(m)λs)
]








ρ∗ with probability p∗,
ρ(m+1) with probability 1− p∗,
Finally, update γ(m+1) = log( ρ
(m+1)
1−ρ(m+1) ).
3.3.4 Posterior Sampling for Spatio-temporal Random Terms
The full conditional distributions of ξt, for t ∈ {1, . . . , T}, are derived in what follows. First,
when t = T , we have





YsT ξsT − nsT exp(X′sTβ) exp(ξsT )
}
−



























where ξ(−T ) is the part of vector ξ without ξT . Next, the full conditional distributions of ξt where
2 ≤ t ≤ T − 1, is





Tstξst − nst exp(X′stβ) exp(ξst)
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ds(ξs,t+1 + ξs,t−1)− ρ
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Finally, for ξ1, we have the following full conditional distribution





Ys1ξs1 − ns1 exp(X′s1β) exp(ξs1)
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− (ϕ























ds(ϕξs2 + µs0)− ρ
∑





Based on the full conditional distributions (3.12), (3.13) and (3.14), it is noted that gener-
ating posterior samples for ξt, t = 1, . . . , T , is not trivial. Herein, the adaptive Metropolis-Hastings
algorithm is used to draw posterior samples and details are given below. First, for t = T , and
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s = 1, . . . , S, we have
p(ξsT | ϕ, τ2, ρ, ξ(−s),T ,β, ξ(−T ),Y,X) ∝
exp













sT +BsT ξsT + CsT exp(ξsT )
}
,
where AsT = −ds/(2τ2), BsT = YsT + {ϕdsξs,T−1 + ρ
∑
s′ 6=s ws′,s(ξs′T − ϕξs′,T−1)}/τ2 and CsT =
−nsT exp(X′sTβ). To obtain the proposal distribution for ξsT , we again obtain the Taylor expansion
of exp(ξsT ). After some basic algebraic operations, the following proposal distribution is obtained,







where HsT = AsT + CsT exp(ξ
0
sT )/2, GsT = BsT + CsT exp(ξ
0
sT )(1 − ξ0sT ), and ξ0sT is the value of
ξsT in the previous iteration. Then the full conditional distribution of ξst, 2 ≤ t ≤ T − 1, is
p(ξst | ϕ, τ2, ρ, ξ(−s),t,β, ξ(−t),Y,X)



















st +Bstξst + Cst exp(ξst)
}
,
where Ast = −(1 + ϕ2)ds/(2τ2), Cst = −nst exp(X′stβ), and
Bst = Yst +








Again, using the Taylor expansion, we can obtain the proposal distribution of ξst which is given by







where Hst = Ast +Cst exp(ξ
0
st)/2, Gst = Bst +Cst exp(ξ
0
st)(1− ξ0st), and ξ0st is the value of ξst in the
55
previous iteration. Finally, the full conditional distribution of ξs1 is given by
p(ξs1 | ϕ, τ2, ρ, ξ(−s)1,β, ξ(−1),Y,X)



















s1 +Bs1ξs1 + Cs1 exp(ξs1)
}
,
where As1 = −(1 + ϕ2)dk/(2τ2), Cs1 = −ns1 exp(X′s1β) and
Bs1 = Ys1 +








Therefore, again using Taylor expansion, the proposal distribution of ξs1 is given by







where Hs1 = As1+Cs1 exp(ξ
0
s1)/2, Gs1 = Bs1+Cs1 exp(ξ
0
s1)(1−ξ0s1) and ξ0s1 is the value of ξs1 in the
previous iteration. With all of these derivation, the proposal distribution for any spatio-temporal
random term ξst is normal distribution with the following uniform form








It is worth mentioning that Gst and Hst possess different forms which depends on t.
3.4 Factor Forecasting
Under the Bayesian spatio-temporal model, forecasting disease prevalence in domestic dogs
is tantamount to forecasting the factor levels and the spatio-temporal random effects. In this section,
the methods used to forecast these variables are elucidated. First, since the primary goal of this
work is to provide for a one year ahead forecast, it is reasonable to assume that certain risk factors
are static; i.e., the current years value can be used as the forecasted value since expected changes
are negligible. These variables include, Mosquito species presence, forestation, water coverage, and
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elevation. Thus, the risk factors that need to be forecasted for each county are annual temperature,
precipitation, relative humidity, population density and median household income.
To forecast annual temperature and precipitation, historical temperature and precipitation
records were collected from 1895 to 2015 for each county and modeled as an AR(1) model. The
AR(1) model for an annual temperature (previously denoted by {Xst,1}) or precipitation (previously
denoted by {Xst,2}) series {Ft} , for county s and time t) adheres to the following difference equation
Ft = δ + γFt−1 + ωt,
where {ωt} is zero mean white noise. Standard statistical software packages (e.g., R and SAS) can
be used to easily fit AR(1) models. Let δ̂ and γ̂ denote estimates of δ and γ, respectively, and
using these estimates a prediction of the annual temperature or precipitation at year t + 1 from
temperatures or precipitation from year 1 to year t is obtained as
F̂t+1 = δ̂ + γ̂Ft.
In the proposed forecasting method, F̂t+1 is used as next year’s annual temperature or precipitation
value. For more information, see Harrison and West (1999).
A simple linear regression model was used to forecast next year’s relative humidity and
median household income in each county. Historical relative humidity from 2006-2015 and median
household incomes from 1997-2014 were used to fit the regression model in each county:
It = α+ κt+ ηt,
where {It} denotes the relative humidity (previously denoted by {Xs,3(t)}) or median household
incomes (previously denoted by {Xst,8}) at time t, {ηt} is zero mean random noise. Least squares
estimators of α and κ, denoted by α̂ and κ̂, respectively, were computed from the data at each
county. The forecasted value for year t+ 1 is simply
Ît+1 = α̂+ κ̂(t+ 1).
Forecasting the county population density for next year requires the county areas and their
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recent population counts. The US Census provides reliable county population counts for 2010 and
estimated state populations for the years of 1969-2014. A simple linear regression model, with time
being the independent variable, was fitted to this state level population data. From this model the
county population can be forecasted by first predicting the state population and then partitioning
this value into the counties within the state at a proportion that agrees with 2010 Census. The
forecasted population density is then obtained by dividing the county population by the county’s
area.
To forecast the spatial and temporal random effects a year in advance, Eq (3.4) is used. In
particular, since the φt’s are independent and identically distributed over various years, given values
of τ2 and ρ (available from the posterior samples), φt+1 is generated randomly from the multivariate
normal distribution N(0, τ2(D − ρW)−1). Then ξt+1 is set to ξt+1 = ϕξt + φt+1. This process is
repeated for each pair of ρ and τ2 available from the posterior sample, thus yielding a sample of the
next year’s random effects, for further details see Gelman et al. (2014); Harrison and West (1999).
3.5 Results
3.5.1 Heartworm
The spatio-temporal Poisson regression model in (3.1) and (3.2) has 16 explanatory factors,
all of which may not have predictive power. To assess this issue, a full model with all 16 factors was
first fitted. Credible intervals, Bayesian analogs to confidence intervals in frequentist statistics, were
then created for the parameters of interest. Table 3.3 summarizes our full model findings, showing 16
regression coefficients estimates (posterior median) and their 95% highest posterior density (HPD)
intervals. For further details about credible and HPD intervals, see Gelman et al. (2014); Banerjee
et al. (2014).
Table 3.3 implies that not all factors are significant; e.g., 95% HPD intervals of annual
precipitation, elevation, percentage surface water coverage, and all mosquito presence factors ex-
cept A. albopictus contain zero. To develop a parsimonious model with only significant factors, all
explanatory variables whose 95% HPD intervals contains zero were removed and the model was re-
fitted. This leaves a “reduced model” with the six explanatory factors: annual temperature, annual
relative humidity, percentage forest coverage, population density, median household income, and A.
albopictus absence/presence. Parameter estimates (posterior median) and 95% HPD intervals for
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Factor Estimate 95% HPD Interval
Annual temperature 0.052 [0.038, 0.066]
Annual precipitation 0.008 [-0.031, 0.047]
Annual relative humidity 0.007 [0.003, 0.013]
Elevation 0.013 [-0.013, 0.039]
Percentage forest coverage 2.482 [1.664, 3.317]
Percentage surface water coverage 0.036 [-0.215, 0.277]
Population density -5.086×10−5 [-6.744×10−5, -3.367×10−5]
Median household income -0.018 [-0.021, -0.016]
Aedes aegypti -0.095 [-0.255, 0.059]
Aedes albopictus -0.158 [-0.237, -0.071]
Aedes canadensis 0.185 [-0.039, 0.402]
Aedes sierrensis -0.112 [-0.414, 0.204]
Aedes trivittatus 0.169 [-0.094, 0.414]
Anopheles punctipennis -0.065 [-0.321, 0.182]
Anopheles quadrimaculatus -0.076 [-0.246, 0.109]
Culex quinquefasciatus 0.099 [-0.099, 0.295]
Table 3.3: Parameter estimates for the full model of heartworm
Parameters Median 95% HPD Interval
Annual temperature 0.042 [0.027, 0.062]
Annual relative humidity 0.007 [0.002, 0.012]
Percentage forest coverage 2.599 [1.82, 3.473]
Population density -5.177×10−5 [-7.074×10−5, -3.550×10−5]
Median household income -0.018 [-0.021, -0.016]
Aedes albopictus -0.165 [-0.246, -0.081]
Table 3.4: Parameter estimates for the reduced model of heartworm
the regression parameters for the reduced model are shown in Table 3.4. The estimates (posterior
median) of the other model parameters are ϕ = 0.914, ρ = 0.998, and τ2 = 0.802.
Most of the significant factors have an intuitive interpretation. For example, the positive
regression coefficient for the temperature and relative humidity factors implies that heartworm is
more prevalent in warmer and humid locations. On the other hand, as is seen by negative regres-
sion coefficients, heartworm prevalence decreases with increasing population densities and median
household incomes. Given the presence of relative humidity in the model, it is not overly surprising
that precipitation drops out of the model fit. Finally, the negative regression coefficient on A. al-
bopictus presence is not a contradiction: in the presence of all other factors (which include space and
time prevalence histories), presence of this mosquito is associated with lessened heartworm preva-
lence. In a separate analysis (results not shown) a model with only A. albopictus was fitted, and the









Figure 3.7: Model-based heartworm prevalences.
To assess the overall performance of our reduced model, Figure 3.7 graphically portrays our
fitted model by plotting the average (over all 5 years) of model-estimated prevalence for each county
after smoothing (standard Kriging with default parameters were used here). The model-estimated
prevalence in Figure 3.7 compares well to the head-banging smoothed baseline in Figure 3.2. In
fact, the correlation between the Figures 3.2 and 3.7 graphics is 0.727 (only counties reporting at
least one test during the five year study period were used in this calculation). Clarifying further,
our correlation between the two observation sets {As}Ss=1 and {Bs}Ss=1 is
Corr({As}, {Bs}) =
∑S
s=1 ns(As − Ā)(Bs − B̄)√∑S
s=1 ns(As − Ā)2
∑S












are the sample-size weighted averages of {As}Ss=1 and {Bs}Ss=1, and ns is the number of tests con-
ducted in county s. Since the correlation here is between smoothed and model-estimated prevalence
(these are non sample size dependent quantities), the weights were taken as ns ≡ 1 (and not the
county-by-county sample sizes). The 0.727 correlation achieved indicates that the regression model
has explained most of the data’s structure.
The fitted model has a number of uses. Next, the fitted model is used to construct annual
heartworm prevalence forecasts. The model could also be used to extrapolate how climate change
could alter heartworm disease risk. Figures 3.8 and 3.9 compare observed and forecasted heartworm
prevalence during 2015. One can discern where heartworm is forecasted to be higher/lower than
normal by comparing Figures 3.2 and 3.8. The correlation between the Figure 3.8 and 3.9 prevalence,
as measured in (3.16), is 0.940. Hence, the model is accurately forecasting in locations that report








Figure 3.8: Observed heartworm prevalence for 2015
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Generally, the management of emerging infectious diseases is approached reactively, with
efforts focused on managing disease outbreaks after onset. The ability to reliably forecast trans-
mission risk, particularly for diseases subject to changes based on dynamic factors such as climate,
could shift our paradigm from reaction to that of prevention across a wide range of veterinary or
public health threats. This is particularly true for vector borne diseases, as specific environmental
needs for vector survival are well documented (Parham et al., 2015). One approach to infectious
disease modeling is to use these factors to predict transmission and model the data in both space
and time. This has been used successfully to estimate the incidence of malaria during eradication
campaigns in Namibia and cutaneous leishmaniasis in high-risk areas of Columbia (Alegana et al.,








Figure 3.9: Forecasted heartworm prevalence for 2015
Although preventable, heartworm disease is a relatively common and serious vector-borne
disease of domestic dogs. Annual disease incidence, as reported by IDEXX and Antech, averages
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greater than 100,000 new cases annually. Annual data likely represent the true annual incidence of
heartworm infection in domestic dogs because when diagnosed with heartworm, most dogs are either
treated, or in some cases euthanized, due to poor outcome or financial constraints (Polak and Smith-
Blackmore, 2014). While fulminant infection with D. immitis may be due to lack of owner compliance
in use of preventive, it also may be due in part to misunderstanding of disease risk as mosquito vectors
are known to be dynamic in their range and survival under changing climatic conditions. In support
of enhancing veterinary client education and the evidence-based use of preventive, we identified
factors associated with D. immitis transmission (Brown et al., 2012; Wang et al., 2014a) and used
these factors to create a spatial-temporal conditional autoregressive forecast model of heartworm
infection risk. Based on a comparison of actual vs. forecasted heartworm disease observed in 2015,
our model has a high degree of fidelity in describing disease risk. This may be attributed, in part, to
the fact that many of the factors used to forecast heartworm prevalence and distribution are relatively
stable or can confidently be forecast annually (e.g., forest coverage, population density, household
income). Temperature and humidity can generally be accurately forecasted and these data have been
used to model disease risk (Beugnet et al., 2009); however, we anticipate unexpected environmental
or climate catastrophe (e.g., regional climate shifts, flooding, hurricanes) could impact the actual
heartworm incidence in a given year. Finally, mosquito populations can greatly fluctuate annually
because they depend on numerous local land-use and environmental factors and some competent
vectors of D. immitis are still expanding in their range in the US (Ogden et al., 2014). Unexpectedly,
several mosquito species data were not included in our final model; however, this may be because
our currently available data is only presence/absence whereas the density of these mosquito species
varies annually at a local level. More accurate mosquito density data would greatly enhance our
ability to accurately forecast the local risk of D. immitis transmission. In addition, human activities
such as unexpected treatment abatement programs may greatly impact mosquito densities. Since
the introduction of West Nile virus into the US, many government bodies developed or expanded
mosquito control programs, including reducing breeding habitats and application of pesticides. With
increased concern over Chikungunya virus, and more recently, Zika virus, it is possible that increased
mosquito control may be initiated in the coming year(s) which would lead to perceived errors in our










Figure 3.10: Forecasted heartworm prevalence for 2016
In conclusion, our 2016 heartworm disease forecast (Figure 3.10) has many items of par-
ticular interest for veterinary practitioners including an increased predicted probability of positive
tests in northern California, eastern Montana and central New Mexico compared with previous
years. Also, we predict that a relatively small increase in risk exists for heartworm disease in some
areas where heartworm is likely under appreciated, such as parts of North and South Dakota and
Nebraska. Importantly, our data indicates that most regions of the US have some risk for dog in-
fections so these maps and forecasts provides veterinarians with evidence-based recommendations
for use of preventive in non-endemic regions of the US, as well as support the recommendations for
year-round use of preventive in areas of known high disease risk. Ultimately, we believe that these
methods can be used to forecast multiple vector-borne diseases with veterinary and human health
impacts, including Lyme disease, ehrlichiosis and anaplasmosis. Currently, the Companion Animal
Parasite Council (CAPC) provides monthly updates of heartworm diagnoses. A recent study by
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Factor Estimate 98.75% HPD Interval
Annual temperature 0.022 [0.003, 0.042]
Annual precipitation -0.008 [ -0.060, 0.049]
Annual relative humidity -0.004 [-0.010, 0.004]
Elevation 0.025 [-0.001, 0.056]
Percentage forest coverage 3.295 [2.171, 4.499]
Percentage surface water coverage 0.519 [0.173, 0.804]
Population density -3.578×10−5 [-5.692×10−5, -1.301×10−5]
Median household income -0.003 [-0.007, -0.001]
Table 3.5: Parameter estimates from the full model of Ehrlichia seroprevalence
CAPC found that when pet owners are provided real-time updates of new heartworm cases in their
area they were more likely to bring their pets to a veterinarian for a check-up which would include
heartworm testing and provision of anthelmintics (Chris Carpenter, personal communication). We
believe that through a combination of real-time updates and forecasting prevention efforts can be
maximized, leading to fewer cases of heartworm disease in dogs and cats.
3.5.2 Ehrlichiosis
Eight explanatory factors are available for inclusion in the spatio-temporal Poisson regression
model in (3.1). To assess which factors significantly influence Ehrlichia seroprevalence, a “full”
model with all eight factors was first fitted and credible intervals for all regression parameters were
calculated from the MCMC posterior samples. Table 1 shows estimates of these eight regression
coefficients (posterior median) and their 98.75% highest posterior density (HPD) intervals. These
HPD intervals were adjusted to account for multiple comparisons using the standard Bonferroni
correction with a family wise error rate of 10%. For HPD interval details, see Gelman et al. (2014).
The HPD intervals in Table 3.5 show that not all factors are significant; for example, cred-
ible intervals for annual precipitation, annual relative humidity, and elevation contain zero. As a
parsimonious model with only significant factors is desired, eight models were fitted, each containing
a combination of the three questionable factors of annual precipitation, annual relative humidity,
and elevation, along with the other five factors. In all additional model fits, these three factors
were deemed insignificant. To further investigate these three insignificant factors, three additional
models were fit, each using only the dismissed factor as the only covariate. From these analyses, it
was judged that each of these factors were indeed insignificant. In particular, 95% HPD intervals
associated with the regression coefficients for annual precipitation, annual relative humidity, and
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Parameters Median 95% HPD Interval
Annual temperature 0.021 [0.007, 0.030]
Percentage forest coverage 3.276 [2.407, 4.223]
Percentage surface water coverage 0.458 [0.242, 0.718]
Population density -3.578×10−5 [-5.123×10−5, -1.789×10−5]
Median household income -0.004 [-0.006, -0.001]
Table 3.6: Parameter estimates from the selected model of Ehrlichia seroprevalence
elevation were [-0.057,0.035], [-0.007,0.002], and [-0.013,0.038], respectively. Therefore, our parsimo-
nious model includes the five factors of annual temperature, percentage forest coverage, percentage
surface water coverage, population density, and median household income. Parameter estimates
(posterior median) and 95% HPD intervals for the regression parameters in this model are pre-
sented in Table 3. The estimates (posterior median) of the other model parameters are ϕ = 0.893,
ρ = 0.999, and τ2 = 0.574.
Our parsimonious five factor model in Table 3.6 shows that Ehrlichia seroprevalence in-
creases with increasing annual temperature, forest coverage, and surface water coverage while sero-
prevalence decreases with increasing population density and median household income. Figure 3.11
graphically portrays our fitted model by plotting the average model-predicted prevalence (over all
years) after smoothing (Kriging with default parameters were used in the software ArcGIS). The
picture compares well to the head-banging smoothed baseline in Figure 3.4. In fact, the correlation
between the Figure 3.4 and Figure 3.11 graphics is 0.842 (this correlation is taken over counties
reporting at least one test during the five year study period). Our correlation between the two
observation sets is calculated by 3.16. Note, this expression denotes the usual weighted sample
correlation and directly accounts for sample size differences (i.e., different values of ns). Because
the correlation here is between smoothed and model-estimated prevalence (these are not sample size
dependent quantities), the weights were taken as ns ≡ 1, which causes (3.16) to revert to the usual
sample correlation. The 0.842 correlation achieved indicates that the regression model has explained









Figure 3.11: Model-based Ehrlichia seroprevalences.
The fitted model has a number of uses. Next, the model is used to construct an annual
Ehrlichia seroprevalence forecast. The model could also be used to extrapolate how climate change
or other changes in factors would influence ehrlichiosis risk.
To see how our forecast performs, the 2015 test and factor data were removed from the
analysis, and the proposed model was refitted with data from 2011-2014 only. Forecasts are based
on use of the five significant factors annual temperature, percent forest coverage, percent surface
water coverage, population density, and median household income (also used is are generated random
effects for 2015). Figures 3.12 and 3.13 compare observed and forecasted Ehrlichia seroprevalences
during 2015. The correlation between the two maps is 0.97 (this is a weighted correlation computed
according to (3.16), where ns denotes the number of tests performed within each county during 2015)
and indicates significant skill in forecasting Ehrlichia seroprevalence in dogs one year in advance.
One can get an idea where Ehrlichia seroprevalence is forecasted to be higher/lower than average by
comparing Figures 3.4 and 3.13. Figure 3.14 presents our Ehrlichia forecast for 2016 (this uses all
data and factors from 2011-2015). When 2016 concludes, a future study will compare our current
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Figure 3.12: Observed Ehrlichia seroprevalence in domestic dogs for 2015
In this study, the first Bayesian approach to forecasting and inference for canine Ehrlichia
seroprevalence, in the absence of detailed information on vector ecology, was made. While vector fac-
tors such as distribution and abundance are no doubt important, annual counts of all possible vector
populations are currently economically and logistically infeasible to collect. Such data deficiencies
will likely continue to hinder development of dynamic micro-scale vector-borne disease models, ne-
cessitating development of novel approaches to disease surveillance. As such, we have developed a
model for forecasting spatial and temporal patterns of risk of exposure to Ehrlichia spp. based on
canine seroprevalence data. Data used in this study indicate exposure to Ehrlichia spp. (IDEXX,
2011-2015), but unfortunately lack the detailed molecular assessment that would allow species-level
identification. Also, our data are obtained from a commercial diagnostic lab to which veterinarians
had submitted samples, and as such, these dogs were acquiring veterinary care. This suggests that
our data are a conservative estimate of the prevalence in domestic dogs because dogs at the highest
risk of tick exposure would be dogs that receive no veterinary care, those from lower socioeconomic
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families, or are owned by clients who refuse these additional tests during well visits. Additionally,
a lack of education of tick-borne pathogens may limit testing that veterinarians request; however,
these tests are often run during routine heartworm testing so this latter issue is likely a minimal
concern. Despite these limitations, these data are acquired on a monthly basis (CAPC, 2011-2015),
providing a robust and timely source of information about the dynamic change of canine Ehrlichia
spp. seroprevalence across the contiguous US, and holds promise for longitudinal studies to best
understand the dynamic nature of vector-borne disease over time. From five years of historical di-
agnostic tests, our data show that a Bayesian model can capably quantify Ehrlichia seroprevalence,
which ultimately will support qualitative decision-making and surveillance in disease management
and response. When comparing actual to forecasted Ehrlichia seroprevalence in 2015, a weighted
correlation of 0.97 was achieved, demonstrating significant predictive skill. In the future, we hope
to gauge the effectiveness of interventions designed to reduce the occurrence of ehrlichiosis.
Of the eight factors evaluated as infection drivers, increasing annual temperature, percentage
forest coverage, and percentage surface water coverage were deemed to increase prevalence, and
increasing population density and median household income act to decrease prevalence. In general,
these results support the presumption that increasing urbanization would decrease appropriate tick
habitat. These factors also would potentially impact white-tailed deer, the primary vertebrate
wildlife reservoir hosts of E. chaffeensis and E. ewingii ; however, they are adaptable and do well
across a range of urbanization other than highly urban. Domestic dogs, the natural host of E. canis
and also long-term hosts for E. ewingii (Starkey et al., 2015), would be present across all of the
urbanization zones, but more rural or suburban households are likely to have outdoor dogs which
would have a higher risk of tick exposure. Also, most of these factors are similar to those judged
influential in the incidence of human monocytic ehrlichiosis and Rocky Mountain spotted fever
(Raghavan et al., 2014, 2016). Interestingly, ambient humidity was not judged to be a significant
factor in our model (in contrast to Raghavan et al. (2014) for human monocytic ehrlichiosis, by
Raghavan et al. (2016) for Rocky Mountain Spotted Fever cases, and by Yabsley et al. (2005)
for E. chaffeensis exposure in white-tailed deer). The statistical methods utilized in the three
aforementioned studies, along with their spatial scales, are definitively different than those of our
study. Despite these differences, the contrasting results are more likely explained by the impact
of forest coverage and resulting leaf litter layer on the ability of Amblyomma americanum ticks,
the vector of E. chaffeensis and E. ewingii to undergo interstadial development in the environment
69
(Ogden and Lindsay, 2016). Moreover, the logistic regression analysis for prevalence of antibody to
Ehrlichia in deer (Yabsley et al., 2005), authors found that relative humidity was only significant
for the Eastern US and only during the summer months which corresponds with the spatial and
temporal activity of A. americanum. On a local or regional scale, relative humidity may have been
included in models, but humidity is likely associated with other factors already included in our
model. Percentage forest coverage was judged as a significant factor of Ehrlichia seroprevalence in
our model. We consider this to be important because the interstadial development of ticks vectors of
E. ewingii and E. chaffeensis occurs within leaf litter refuges. Therefore, the rate of tick development
is less likely to change in response to short term variability in ambient humidity, but rather by the
presence or absence of refuge habitat conducive to tick survival (Nieto et al., 2010). Ultimately,
aggregating factors into yearly summaries, as is necessary for our analysis, may hide the association









Figure 3.13: Forecasted Ehrlichia seroprevalence in domestic dogs for 2015
As previously discussed, canine ehrlichiosis is well-recognized as endemic in much of the
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southern half of the US, including the Southeast, Midwest, and Mid-Atlantic states. The Ehrlichia
seroprevalence forecast for 2016 in Figure 8 suggests some changes in local prevalence. The forecast
suggests an increase in prevalence throughout southern Indiana and Ohio, and an increased preva-
lence in central South Carolina, central Georgia, and northern Florida. This coincides with recently
reported increases in the distribution of A. americanum, an important vector of some Ehrlichia
spp. in Indiana and Ohio (Ogden and Lindsay, 2016; Nieto et al., 2010). Although this tick species
is generally widespread in South Carolina, Georgia, and Florida, our 2016 forecasted increase may
be due to climate-related increases in tick abundance. In the western US, the forecast predicts in-
creased prevalence in western Texas, eastern Arizona, and eastern New Mexico, and encroachment
into southern California. In these regions, E. canis is the predominant species associated with canine
ehrlichiosis and the predicted increases may relate to the changing ecology of R. sanguineus in the re-
gion or some other unknown factor. In recent years, an increase in Rocky Mountain Spotted Fever in
humans and dogs following exposure to Rickettsia rickettsii transmitted by R. sanguineus has been
reported in Arizona (Seddighzadeh et al., 2009; Fitak et al., 2014; Demma et al., 2006b,a). These
predicted changes motivate an increased dialog between pet owners and veterinarians to enhance
timely diagnosis and year-round use of tick preventive.
Though the proposed technique could be used to construct long-term forecasts, caution
should be taken. In particular, our approach makes use of forecasted values of the significant factors,
with some factors being assumed to be static throughout time (e.g., forestation and surface water
coverage). This assumption is reasonable in the short-term, but would obviously be problematic over
a much larger time span; e.g., twenty to fifty years. Moreover, in general, when forecasting future
trends one should be cautious of long-term forecasts, due to possible violations of assumed model
forms not apparent in the available data; e.g., median household income is increasing/decreasing
linearly throughout time. Thus, we promote the use of our approach to provide only short-term









Figure 3.14: Forecasted Ehrlichia seroprevalence in domestic dogs for 2016
Finally, an association between canine Ehrlichia seroprevalence and human ehrlichiosis is
gaining appreciation by the Centers for Disease Control and Prevention. As discussed in a 2016 Mor-
bidity and Mortality Weekly Report (Biggs, 2016), dogs are frequently exposed to ticks due to their
close contact with the environment and are susceptible to infections with many of the same tick-borne
pathogens as humans, including R. rickettsii, E. chaffeensis, E. ewingii, and A. phagocytophilum.
Further, the CDC recognizes that “tick-infested dogs can transfer ticks directly to humans during
interactions and serve as transport hosts, carrying ticks in and around dwellings where the ticks can
then transfer to the human occupants.” The CDC recommends physicians question patients about
contact with pets, especially dogs, and a history of tick attachment or recent tick removal from pets
when assessing human exposure. Finally, clustering of tick-borne diseases is common, and infection
with Ehrlichia species and several other vector-borne pathogens such as Rickettsia and Bartonella
have been concurrently observed in humans and pet dogs (Fichtenbaum et al., 1993; Comer et al.,
1999; Dawson et al., 2001). Given that the majority of canine seroreactivity to Ehrlichia spp. is spe-
cific for E. ewingii and E. chaffeensis (Qurollo et al., 2014), communication between veterinarians
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and physicians is of critical importance when zoonotic diseases are suspected.
3.5.3 Anaplasmosis
A primary goal of this work was to evaluate the putative factors (see Table 3.2) with respect
to their association with Anaplasma spp. seroprevalence within domestic canines in the contiguous
United States. To accomplish this task, a full model with all eight factors was fitted to the data.
From this fit, point estimates (means of posterior samples) and 95% highest posterior density (HPD)
credible intervals were obtained for all regression coefficients; for further discussion and details about
HPD intervals see Gelman et al. (2014). Table 3.7 provides the point estimates and HPD intervals
for each of the eight regression coefficients.
Table 3.7: Parameter estimates for the full model of Anaplasma spp. seroprevalence.
Factor Estimate 95% HPD Interval
Annual temperature -0.021 [-0.036, -0.008]
Annual precipitation -0.004 [-0.053, 0.037]
Annual relative humidity -0.001 [-0.008, 0.004]
Elevation 0.032 [0.002, 0.061]
Percentage forest coverage 3.039 [1.914, 4.045]
Percentage surface water coverage 0.398 [0.130, 0.692]
Population density -2.765e-5 [-4.473e-5, -0.976e-5]
Median household income 0.002 [-0.001, 0.005]
From Table 3.7, one can ascertain that 3 of the considered factors were insignificant in the
full model at the considered significance level; i.e., the 95% HPD intervals for the regression coeffi-
cients associated with annual precipitation, annual relative humidity, and median household income
contain zero. In order to develop a parsimonious model that only contains significant factors, 7
reduced models were fit to the data, each containing a different combination of the 3 questionable
explanatory factors. In each of these additional model fits, these 3 factors were again deemed to
be insignificant. Therefore, our selected model makes use of 5 explanatory factors; i.e., annual tem-
perature, percentage forest coverage, percentage surface water coverage, elevation, and population
density. Table 3.8 provides the point estimates of the regression coefficients along with 95% HPD
intervals for the factors belonging to the selected model. In addition, the point estimates of the
other model parameters are ϕ = 0.935, ρ = 0.999, and τ2 = 0.639, which reaffirms the assertion
that strong positive spatial and temporal correlation are present in the data.
In order to assess the adequacy of our selected model, a figure analogous to Fig 3.6 was
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Table 3.8: Parameter estimates for the selected model of Anaplasma spp. seroprevalence.
Factor Estimate 95% HPD Interval
Annual temperature -0.019 [-0.031, -0.004]
Percentage forest coverage 2.881 [1.855, 4.065]
Percentage surface water coverage 0.389 [0.112, 0.675]
Elevation 0.033 [0.005, 0.058]
Population density -3.090e-5 [-4.635e-5, -1.464e-5]
created using the model based estimates of the county level prevalences. In particular, our fitted
model provides a yearly prevalence estimate for each county, regardless of whether the county reports
data. Thus, to obtain a single prevalence estimate for each county, we averaged over the 5 yearly
estimates available from the model fit; i.e., our aggregated estimate for the sth county is given by
p̂s = 5
−1∑5
t=1 p̂st, where p̂st is the prevalence estimate resulting from the selected model for the
sth county during the tth year. Fig 3.15 provides a depiction of these results, after Kriging (again
default settings were used in ArcGIS). By comparing these two figures one will note that the proposed
Bayesian spatio-temporal model appears to provide a good fit to these data. In fact, the correlation
between the sets of estimates depicted in Fig 3.6 and Fig 3.15 is 0.902, thus confirming that a strong
agreement exists between the empirical and model based estimates. Note, this summary measure
did not consider estimates from counties not reporting data.
In order to assess the fidelity of the proposed forecasting procedure, the 2015 test and
factor data were removed, and our approach was used to forecast the 2015 county level prevalences
using the 2011-2014 test and factor data only. Fig 3.16 and Fig 3.17 present the forecasted and
observed prevalences during 2015, respectively. The weighted correlation between the forecasted and
observed prevalences (for counties reporting data in 2015) is 0.987, demonstrating that Anaplasma
spp. seroprevalence can be accurately forecasted through the proposed approach. Here, a weighted
correlation (3.16), with weights being set to be equal to nst, is used to account for different sample
sizes within each county, for further discussion see Bowman et al. (2016). Fig 3.18 provides our 2016
forecast of canine Anaplasma spp. seroprevalence within the contiguous United States.
In this study, we present for the first time a fully Bayesian approach to forecasting canine
Anaplasma spp. seroprevalence in the absence of detailed information on the distribution and abun-
dance of the two primary vectors of disease: Ixodes spp, and Rhipicephalus sanguineus and pathogen
prevalence in vectors. Surveillance of these medically important vectors remains of high importance;









Figure 3.15: Aggregated model-based estimates of Anaplasma spp. seroprevalence.
will remain economically and logistically unfeasible in many areas in the face of changing climate
and habitats. As such, we have developed a model for forecasting spatial and temporal patterns
of risk of exposure to Anaplasma spp. based on canine seroprevalence data. Data in our study
are limited by lack of detailed Anaplasma species specificity; however, from the recent species-level
serologic analysis conducted by Qurollo et al., we can infer that the majority of observed Anaplasma
spp. seroprevalence in the Northeast, upper Midwest and west coast of California is likely the result
of exposure to A. phagocytophilum, and seroprevalence in the southern and western US due to expo-
sure to either A. platys or A phagocytophilum (Qurollo et al., 2014). In California, there is a higher
liklihood of the antibodies being due to A phagocytophilum exposure whereas positives in Texas and
other southeastern states is due to A. platys exposure.
A major strength of our surveillance effort is that Anaplasma spp. seroprevalence data are
acquired on a monthly basis (CAPC, 2011-2015), providing a robust and timely source of information
about the dynamic change of Anaplasma spp. exposure across the contiguous US. These data









Figure 3.16: 2015 forecasted Anaplasma spp. seroprevalence.
spp. prevalence over time. For veterinary healthcare practitioners specifically, this information is
of critical importance as disease is often mild or unapparent in the dog, requiring both a working
knowledge of risk paired with an impetus to pursue further diagnostics to determine when treatment
is necessary for the health of the dog. Similarly, a deeper understanding of risk enhances educational
opportunities, with the potential to prevent the indiscriminate use of antibiotics (Lathers, 2001) in
asymptomatic dogs without thrombocytopenia or other significant blood count changes. Finally,
even if dogs with Anaplasma spp. are asympotomatic, this exposure indicates tick infestation which
may have or will lead to infection with other tick borne pathogens that may need to be considered.
The forecast model uses 5 years of historical data acquired from IDEXX Laboratories, Inc
and previously published relevant covariate factors (McMahan et al., 2016) to help explain variability
in our aggregated dataset and to strengthen inferences from our Bayesian spatio-temporal model.
As previously described in our explanatory model of Anaplasma spp. seroprevalence, the preva-
lence of seropositivity increases with increasing precipitation and forestation coverage and decreases
with increasing temperature, population density, relative humidity, and elevation. Socioeconomic
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Figure 3.17: 2015 observed Anaplasma spp. seroprevalence.
status and deer/vehicle collisions were positively and negatively correlated with canine Anaplasma
seroprevalence, respectively (McMahan et al., 2016).The potential drivers of infection in the cur-
rent model vary some from the previously published model because of the differences in statistical
methods used. For forecasting, a Bayesian model was chosen because of the ability to control for
confounding caused by spatial and temporal autocorrelation seen in disease prevalence data. The
associations of annual temperature, forest coverage, and population density remain similar between
our previous explanatory model and our forecast model. In contrast, percentage of water coverage
was significant in a Bayesian model, but not in the explanatory model (McMahan et al., 2016). Ele-
vation was found to have a positive association in a Bayesian forecast model, whereas the association
was negative in the explanatory model. This can be explained in part by the distribution of the
two Anaplasma spp. of dogs. Anaplasma phagocytophilum is the primary cause of seropositivity in
dogs in many regions of the United States, and this pathogen is found in high prevalences in the
northeastern United States, a region that is higher in elevation and lower temperature, compared to









Figure 3.18: 2016 forecasted Anaplasma spp. seroprevalence.
in our seroprevalence dataset that it is a ”presenceabsence” model presented at a crude spatial scale,
and as such covariates such as elevation are perceived as uniform over large geographical areas. By
extending our model to include climate variables over a similarly large spatial area it was revealed
that the association at the regional level is related to the climatic conditions. Despite the aformen-
tioned limitations, using data from 2011-2014 we evaluated observed versus forecasted Anaplasma
spp. seroprevalence in 2015, resulting in a weighted correlation between the two maps of 0.987.
Given the striking fidelity of our forecast model, we report our 2016 forecast for canine Anaplasma
seroprevalence in the contiguous United States.
Using our described methodology, canine Anaplasma spp. seroprevalence is forecasted to
be high in regions of the US endemic for Ixodes scapularis: the Mid-central and Northeastern
states of Connecticut, Delaware, Maine, Massachusetts, Maryland, Minnesota, New Hampshire,
New Jersey, New York, Pennsylvania, Rhode Island, Vermont and Wisconsin. Six of these states:
New York, Connecticut, New Jersey, Rhode Island, Minnesota, and Wisconsin, account for 90%
of all reported cases of human anaplasmosis due to infection with A. phagocytophilum (Dahlgren
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et al., 2015). Beyond these endemic boundries, we observed moderate to high frequency of canine
Anaplasma spp. seroprevalence in Northern California, North Dakota and Texas. Our forecast of
canine Anaplasma spp. seroprevalence in Texas is notable given a recent study by Movilla et al.
who documented, for the first time, canine seroprevalence of Anaplasma spp. in several states of
Mexico (Movilla et al., 2016). The authors reported the highest seroprevalence in northwestern
Mexico (16.4%), with the lowest in the north-central states of the country (0.6%). Wildlife species
in Texas have been documented to harbor A. phagocytophilum as well (Yabsley et al., 2006). It
is well established that incursions by humans into natural habitats make the boundary between
wildlife, humans and domestic animals more permeable, and thereby make the spillover of vector-
borne disease more likely. Collectively, the presence of Anaplasma spp. in both domestic dogs
in Mexico and wildlife in the south-central US indicate a greater need for annual testing of dogs
for Anaplasma spp. in southern US border states. Similarly, evidence of canine Anaplasma spp.
seroprevalence in Northern California and along the Canadian border suggests annual testing for
Anaplasma spp. in these regions during veterinary wellness visits is strongly advised.
Human infection with A. phagocytophilum has been reported in non-endemic regions of
the United States, including southeastern and south-central states (Dahlgren et al., 2015, 2016),
where high levels of Ixodes spp. transmitting A. phagocytophilum have yet to be documented. As
such, there remains some controversy regarding true establishment of human anaplasmosis outside
of endemic states (Dahlgren et al., 2015, 2016). The Centers for Disease Control and Prevention
(CDC) suggests some of these human cases may be due to patient travel to states with higher
levels of disease, or the misdiagnosis of anaplasmosis in patients actually infected with another tick-
borne disease, such as ehrlichiosis or Rocky Mountain Spotted Fever. Our canine seroprevalence
data indicate that Anaplasma spp. are being transmitted to dogs in Northern Texas and Northern
California, as well as along the Canadian border in North Dakota and Montana, although the
species is unknown. While canine seroprevalence for B. burgdorferi is an established surveillance
tool for human Lyme disease (Mead et al., 2011; Millen et al., 2013), it remains to be determined
whether canine Anaplasma seroprevalence can provide a similar risk assessment tool for human
epidemiologists. Regardless, as A. phagocytophilum is a potential zoonotic pathogen, it is important
to be aware that these organisms are enzootic in non-endemic regions of the United States and,
and in particular, in the regions bordering the south-central US. Finally, it is important to note
that while canine Lyme disease caused by Borrelia burgdorferi and transmitted by Ixodes spp. is
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now increasing in the Great Lakes region of the US as Ixodes ticks converge from the Mid-Central
state and Northeastern states (Eisen et al., 2016), a similar pattern of elevated Anaplasma spp.
seroprevalence was not evident in our current dataset. It is unclear whether Ixodes scapularis ticks
in this region do not harbor Anaplasma spp. or whether canine test data are currently too sparse
in this region to detect notable increases in seroprevalence.
While canine anaplasmosis is most often asymptomatic and self-limiting, there is growing
recognition in human and veterinary medicine that Anaplasma spp. may represent a significant
health threat as a co-morbidity. Indeed, co-infection with Ixodes-borne pathogens is prevalent and
increasingly problematic worldwide (Diuk-Wasser et al., 2016). In humans, most co-infections involve
two of the three major human pathogens, B. burgdorferi sensu lato, A. phagocytophilum, and Babesia
spp. Such co-infections have been documented to occur in up to 28% of I. scapularis ticks in
Lyme disease-endemic areas in the US (Swanson et al., 2006). Co-infection with multiple tick-
borne pathogens can increase Lyme disease severity and has been attributed to long-term sequela in
patients. Human patients with these concurrent illnesses experienced a greater number of symptoms
for a longer duration than patients with Lyme disease alone (Krause et al., 2002; Steere et al., 2003).
Co-exposure of dogs to B.burgdorferi and A. phagocytophilum has been reported, with co-exposure
rates greatest in the Northeast (6.2%) and Mid-Atlantic region (1.8%) of the US (Qurollo et al.,
2014). Veterinary patient outcomes in the presence of co-infection are not as thoroughly defined;
however, clinically ill dogs that are seropositive for B.burgdorferi and A. phagocytophilum have been
noted to be twice as likely to have lameness, joint pain, and joint effusion than dogs with single
infections (Beall et al., 2008; Eberts et al., 2011). In general, veterinary clinicians are increasingly
concerned co-infections complicate interpretation of clinical manifestations of disease and therefore
potentially confound treatment (Qurollo et al., 2014). As such, in Ixodes endemic regions annual
screening for multiple vector-borne pathogens is strongly warranted. Beyond annual screening,
year-round use of acaracides in dogs can reduce tick infestation, thereby reducing the potential for
tick-borne pathogen transmission (Spencer et al., 2003; Wengenmayer et al., 2014).
In summary, we have forecasted the distribution of the canine seroprevalence at the national
level with available canine serology data and easily accessible climate, geographical, and societal
factors. The high degree of fidelity between actual vs. forecasted seroprevalence in this model and
ease of data input provides veterinary and public health officials with an invaluable tool for informing
emerging risk of exposure to Anaplasma spp. disease potential, and importantly the possibility of
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risk of co-infection with other tick-borne disease. Information should be shared with dog owners
to better facilitate appropriate preventative care of healthy animals and diagnosis and treatment
of ill patients. As we continue to learn more about the association between the distributions of
anaplasmosis in humans and dogs, this forecasting model may become useful for public health




A Bayesian generalized additive
model for group testing data
From screening individuals for sexually transmitted diseases (Westreich et al., 2008; Lewis
et al., 2012) to ensuring the safety of the blood supply (Kleinman et al., 2005; Sarov et al., 2007),
group testing (pooled testing) has become a popular cost effective alternative to one at a time
testing. The origins of group testing are often traced to Dorfman (1943), which proposed its use for
the purposes of screening military inductees for syphilis during WWII. In contrast to the standard
one at a time testing of individual specimen (e.g., blood, plasma, urine, etc.), this seminal work
suggested that several specimen would first be amalgamated into a pooled specimen (or group)
which would then be tested. If the pool tested negatively, then each contributing individual could
be diagnosed as such at the expense of a single diagnostic test, with positive pools being resolved
through individual level testing. It is relatively easy to ascertain that if the disease of interest is
relatively rare, as is the case for most infectious diseases, the aforementioned diagnostic process can
be far more cost effective than one at a time testing. For this reason, group testing has gained a great
deal of popularity within infectious disease screening realm, as well as in several alternate application
areas; e.g., animal disease testing (Dhand et al., 2010), environmental monitoring (Heffernan et al.,
2014), and disease transmission studies involving insect vectors (Speybroeck et al., 2012).
Owing to its utilitarian nature, group testing has become the focus of a great deal of statis-
tical research over the last 75 years. In general, research in this area focuses on either the so called
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classification or estimation problems. The former refers to the development, characterization, and
optimization (with respect to further reducing testing cost and/or increasing classification accuracy)
of new group testing strategies; for further discussion and a nice review of existing strategies see Kim
et al. (2007), and the references therein. While the latter, which is the focus of the work presented
herein, considers the use of data collected from a group testing process to estimate quantities of
interest about the population in question. This problem was first considered by Thompson (1962),
which made use of testing responses observed from pools to estimate the proportion of insect vectors
within a natural population. The general premise behind using group testing in this venue is that
information on N units can be collected at the cost of J = N/c assays, where c is the number of
individuals contributing to a pool; i.e., the data collection cost can be greatly reduced. Since this
proposal, many authors have considered the use of group testing data to estimate a population pro-
portion; for a review see Bilder and Tebbs (2005) and Liu et al. (2012), and the references therein.
More recently, the research in this area has shifted and has started to consider the estimation of
parametric regression functions which relate individual level covariates (e.g., age, race, gender, etc.)
to the testing responses observed from assaying pooled specimen; e.g., see Vansteelandt et al. (2000),
Bilder and Tebbs (2009), Chen et al. (2009), and Huang and Tebbs (2009). Further, several au-
thors have considered developing nonparametric and semiparametric analogs to the aforementioned
regression methods; e.g., see Delaigle and Meister (2011), Delaigle and Hall (2012), Wang et al.
(2013), and Delaigle et al. (2014). It is worth while to note, that all of the aforementioned regression
procedures proceed to conduct a frequentist analysis of data collected on “master” pools; i.e., they
cannot incorporate information which could be available from decoding positive pools.
Merging the goals of estimation and classification, Xie (2001) and Zhang et al. (2013) allow
for the incorporation of additional retesting information gained from decoding positive pools, within
a parametric framework. Similarly, Wang et al. (2014b) developed a semiparametric estimator,
which can make use of retesting information if available. The three aforementioned techniques
again proceed to conduct a frequentist analysis of group testing data. In contrast, McMahan et al.
(2017) proposed a general Bayesian framework for the regression analysis of group testing data. The
strengths of this proposal, beyond those previously proposed, are three-fold: first, this approach
can incorporate data from any group testing procedure, second, it can estimate the assay accuracy
probabilities along with regression coefficients, and third, it can incorporate historical information
through the prior specification.
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Inspired by the nonparametric and semiparametric techniques described above, herein a
Bayesian generalized additive model for group testing data is proposed. That is, the proposed ap-
proach considers a linear predictor which depends on unknown smooth functions of some covariates,
as well as linear combinations of other covariates. Thus, through the specification of the structure of
the former and latter, one may obtain an analysis which is complimentary to practically all of those
methods described above. More over, through other specifications, a much more advanced analysis
can be conducted. Both, Gaussian process (Williams and Rasmussen, 2006) and predictive process
(Banerjee et al., 2008) priors are employed for the estimation of the unknown smooth functions.
Similar to McMahan et al. (2017), the proposed approach can incorporate data from any group test-
ing procedure, estimate the assay accuracy probabilities along with unknown regression components,
and incorporate historical information through the prior specification. One could query the rational
behind such an advanced treatment of the considered problem, beyond that of providing general
disease surveillance, and the justification is novel yet intuitive. As a byproduct of the proposed ap-
proach, one obtains a posteri estimates of the infection probability for each individual screened by a
group testing process. This information can then be used to drive “backend screening” procedures
that are aimed at identifying patients who have been missclassified. Thus, the proposed Bayesian
semiparametric regression modeling framework allows one to obtain more precise estimates of the
individuals’ infection probabilities, as well as a more thorough and in depth understanding of the
relationship that exists between available covariates and disease status.
Section 4.1 presents the general modeling framework which can be used to perform a semi-
parametric regression analysis of binary outcomes measured on pooled specimens. The details of
posterior sampling algorithm of the proposed approach are provided in Section 4.2, and Section 4.3
provides a simulation study which investigates the finite sample performance of the new method-
ology. In Section 4.4 the proposed approach is used to analyze group testing data of chlamydia
collected by the State Hygienic Laboratory at the University of Iowa.
4.1 Methodology
In what follows, a general Bayesian framework is developed for the semiparametric regression
analysis of binary outcomes collected from any group testing strategy.
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4.1.1 Notation and preliminaries
Consider the situation in which a group testing strategy is implemented to screen N indi-
viduals for a binary characteristic of interest, such as infection status. In general, let Ỹi denote the
true status of the ith individual, for i = 1, . . . , N , with the standard convention that Ỹi takes value
one if the ith individual is truly positive and zero otherwise. Further, let xi = (xi1, ..., xiq)
′ be a q×1
vector of covariates, which were collected on the ith individual. It is assumed throughout, that con-
ditional on the covariate information the individuals’ statuses are independent; i.e., Ỹi|X ⊥ Ỹi′ |X,
for all i 6= i′, where X = (x1, . . . ,xN )′ and ⊥ indicates statistical independence. Further, it is
assumed that the relationship between an individual’s status and covariate information is given by
the following generalized additive model







where H(·) is a known link function (e.g., logistic, probit, etc.), βl, for l = 0, 1, ..q2, are regression
coefficients, gl(·), for l = 1, ..., q1, are unknown smooth functions, and q1 + q2 = q. For ease of
exposition, it is assumed throughout that H(·) represents the probit link, with the generalization
of the proposed approach to other link functions (e.g., the logistic) being relatively straightforward
after expressing H(·) as a Gaussian scale mixture distribution; e.g., see Polson et al. (2013).
A primary focus of this work is to develop methods which can be used to reliably estimate
and draw inference on gl(·) at any given value in its support, which is denoted by Xl, for l = 1, ..., q1.
To accomplish this task within the Bayesian paradigm, both Gaussian process (GP) and Gaussian
predictive process (GPP) models are used to obliquely represent gl(x), for x ∈ Xl. In general, a
Gaussian process is a stochastic process which is defined by its mean and covariance functions; i.e.,
E[gl(x)] = µl(x) and Cov(x, x
′) = τ−1l ρl(x, x
′;θl), where ρl(x, x
′;θ) is a correlation function (e.g.,
Matérn, exponential, etc.) and θl consists of smoothness and decay parameters. For further details
on Gaussian process models and their various uses see Williams and Rasmussen (2006). In general,
as is done here, it is suggested that the mean function be set to zero (i.e., µl(x) = 0, for all x ∈ Xl)
and that a flexible correlation function (e.g., Matérn) be used, so as not to unduly influence the
analysis. The structure of and salient differences between the GP and GPP models considered here
are elucidated in the subsequent sections of this work. At this point, if the Ỹi where observed then
the model in (4.1) could be fit using the methods outlined in Choudhuri et al. (2007). In contrast,
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when group testing strategies are being employed the Ỹi are never observed due to the process of
testing pools and the inherent effects of imperfect testing. Therefore, in the context of the considered
problem, the Ỹi are best regarded as latent random variables, and one is left to relate the observed
testing outcomes from a group testing process to the individuals’ covariate information through their
latent statuses.
It is important to note that a vast sundry of group testing strategies have been proposed;
e.g., master pool testing (Kim et al., 2007), Dorfman decoding (Dorfman, 1943), halving, Sterretts
procedure (Sterrett, 1957), array testing (Phatarfod and Sudbury, 1994), etc. Therefore, in order
to preserve generality, define Pj , for j = 1, . . . , J , to be the set of indices corresponding to the
individuals that are assigned to the jth group. Further, let Z̃j denote the true status of the jth
pool, with the convention that the pool is said to be positive (Z̃j = 1) if it contains at least on
positive individual, and it is negative (Z̃j = 0) otherwise; i.e., Z̃j = I(
∑
i∈Pj Ỹi > 0), where I(·)
is the usual indicator function. In the presence of imperfect testing, which is ubiquitous among
infectious disease screening studies, the Z̃j like the Ỹi are never directly observed. Rather the
observed data from the group testing process consists of error contaminated measurements of Z̃j ,
which are denoted as Zj , with Zj = 1 denoting the event that the jth pool tested positively,
and Zj = 0 otherwise. To account for imperfect testing, let Sej := Pr(Zj = 1|Z̃j = 1) and
Spj := Pr(Zj = 0|Z̃j = 0) denote the sensitivity and specificity of the assay being used to test the
jth group; i.e., Sej (Spj ) is the probability that the jth pool will test positive (negative) given it is
truly positive (negative). Thus, it can be ascertained that the conditional distribution of Zj , given
Z̃j , Sej , Spj , is Zj |Z̃j , Sej , Spj ∼ Bernoulli{Sej Z̃j + (1− Spj )(1− Z̃j)}.
4.1.2 The model and data augmentation steps
In order to express the joint distribution of the observed data, the following two common
assumptions are adopted throughout: Zj |Ỹ ⊥ X, for j = 1, . . . , J, and Zj |Ỹ ⊥ Zj′ |Ỹ , for any
j 6= j′, where Ỹ = (Ỹ1, . . . , ỸN )′. In addition, for notational convenience, let gil ≡ gl(xil), for
i = 1, . . . , N and l = 1, . . . , q1, and define the following variable aggregations Z = (Z1, . . . , ZJ)
′, Se =
(Se1 , . . . , SeJ )
′, Sp = (Sp1 , . . . , SpJ )
′, gl = (g1l, . . . , gNl)
′ for l = 1, ..., q1, and G = (g1, . . . , gq1).
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where the linear predictor is given by ηi =
∑q1
l=1 gil + x
′
i2β, with β = (β0, ..., βp)
′ being a vector of
regression coefficients corresponding to the covariates xi2 = (1, xi,q1+1, ..., xiq), and Y denotes the
collection of all (i.e., 2N ) possible outcomes of Ỹ .
It is worthwhile to note, that simply evaluating (4.2) is computationally prohibitive, due to
the dimension of Y . Thus, developing a Markov Chain Monte Carlo (MCMC) posterior sampling
algorithm based directly off of (4.2) is not possible. To facilitate the development of such an algo-
rithm, a two-stage data augmentation procedure is considered. The first introduces the individuals’
statuses as latent random variables, and the second exploits the fact that H(·) represents the probit
link. After the first data augmentation step, the joint conditional distribution of Z and Ỹ can be
expressed as
L(Z, Ỹ |Se,Sp,β,G,X) ∝
J∏
j=1
{SZjej (1− Sej )






Ỹi [1−H(ηi)]1−Ỹi . (4.3)
Then, following the approach described in Albert and Chibbs (1993), the second data augmentation
step introduces Ui
ind.∼ N(ηi, 1), for i = 1, ..., N , such that Ui > 0 if Ỹi = 1 and Ui ≤ 0 if Ỹi = 0.
This data augmentation step yields the following joint conditional distribution
L(Z, Ỹ ,U|Se,Sp,β,G,X) ∝
J∏
j=1
{SZjej (1− Sej )







I(Ỹi = 1, Ui > 0) + I(Ỹi = 0, Ui ≤ 0)
}
, (4.4)
where φ(·) denotes the probability density function of a standard normal random variable and
U = (U1, ..., UN )
′.
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4.1.3 Modeling the unknown functions
As was previously mentioned, the proposed approach considers two separate techniques for
modeling gl(x), for x ∈ Xl; i.e., a Gaussian process model and a Gaussian predictive process model.
To illustarte how these two techniques proceed, let {x∗1l, ...., x∗Kll} denote the Kl unique values
among the collection {x1l, ...., xNl}, and define g∗l = (gl(x∗1l), . . . , gl(x∗Kll))
′. Under the Gaussian
process model, any finite collection of observations from the process follows a multivariate normal
distribution. In particular, the vectors g∗l independently follow a multivariate normal distribution




l , where the (k, k








ind∼ N(0,C∗l ), for all l. It is noted that g∗l is a subset of gl, where
gl = (g1l, . . . , gNl)








It is easily ascertained that gl = Mlg
∗
l , and that the linear predictor under the Gaussian Process






i2β, where Mli is the ith row of Ml.
Pairing this representation with the data model presented in (4.4), it can be inferred that
the full conditional distribution of g∗l is that of a multivariate normal distribution with mean vector
µ∗l and Σ
∗
l , where the form, details, and derivation of these quantities are fully provided in Section
4.1.4. The point, in order to draw MCMC samples from this full conditional distribution, one has to
compute quantities such as the inverse and determinant of Σ∗l , which is a Kl×Kl dense matrix. It is
well known that these matrix operations can be computationally expensive if Kl is relatively large,
especially if they are computed within each step of the MCMC algorithm, which is required if a fully
Bayesian approach is being implemented; i.e., if θl is sampled along with the other model parameters.
To circumvent these computational complexities, one could choose to adopt the Gaussian predictive
process model.
The Gaussian predictive process attempts to reduce the dimension of the problem by spec-
ifying a “parent” process based on a strategically chosen sequence of knots, and then interpolates
this process to the points of interest. Let {x̃1l, ..., x̃K̃ll} denote the selected sequence of knots within
Xl, such that K̃l << Kl, and let g̃l = (gl(x̃1l), ..., gl(x̃K̃ll))
′. The Gaussian process model described
above then yields that g̃l|τl,θl
ind.∼ N(0, C̃l), for all l, where C̃l = τ−1l R̃l and the (k, k′)th element of
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R̃l is ρl(x̃kl, x̃k′l;θl). Further, due to the properties of Gaussian process models, one also has that
jointly g̃l and g
∗












where R∗l continues to be defined as described above and R̃
∗
l is a K̃l ×Kl matrix whose (k, k′)th
element is ρl(x̃kl, x
∗
k′l;θl). The Gaussian predictive process exploits this relationship by replacing





l . Thus, the linear predictor under the Gaussian predictive process model can be
represented as ηi =
∑q1
l=1 MlTlg̃l + x
′
i2β. Further, under this model, it is easy to see that the
computational burdens associated with the posterior sampling of the g̃l are generally alleviated,
since the time consuming matrix operations are being computed for matrices of dimension K̃l × K̃l.
A few remaining points warrant attention under both the Gaussian process and Gaussian
predictive process model. First, due to the structure of the model the gl(·) are identifiable up to
a constant and therefore restrictions should be specified to ensure identifiability. For example, a
commonly used restriction for generalized additive models, and the one adopted herein, requires the




kl) = 0 for GP
and
∑K̃l
k=1 gl(x̃kl) = 0 for GPP, for ∀ l = 1, . . . , q1. For further details and discussion, see Friedman
et al. (2001). Second, under either model, one can exploit the relationship depicted in (4.5) to
interpolate a functional estimate of gl(·) to values of x ∈ Xl, with the usual cautions being made
about the process of interpolating to values which exist outside the range of the observed covariate
values.
4.1.4 Prior specification and posterior sampling
In what follows the prior specification and posterior sampling strategy for each parameter is
discussed. For ease of exposition, and without loss, in what follows gl will represent either Mlg
∗
l or
MlTlg̃l under the Gaussian process model or the Gaussian predictive process, respectively, unless
otherwise noted. First, attention is turned to the regression coefficients. After specifying the prior
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where X2 = (x12, ...,xN2)
′. Thus, for the reasons of conditional conjugacy, it is natural to specify
the prior distribution of β to be N(a,Γ), where the prior parameters can be chosen to provide a
diffuse prior or to reflect historical information; for further discussion see McMahan et al. (2017).

















Further, from (4.4), it is evident that the full conditional distribution of Ui is that of a truncated
normal, with the truncation depending on the latent statuses of the individuals; i.e.,
Ui|Ỹi,β,G =

TN{ηi, 1, (0,∞)}, if Ỹi = 1,
TN{ηi, 1, (−∞, 0)}, if Ỹi = 0,
where ηi =
∑q1
l=1 gil + x
′
i2β and TN{µ, σ, (a, b)} denotes a truncated normal distribution with mean
parameter µ, variance σ2, and support set (a, b).
Let Ỹ −i = (Ỹ1, . . . , Ỹi−1, Ỹi+1, . . . , ỸN )
′, Ai = {j : i ∈ Pj} and Pij = {i′ ∈ Pj : i 6= i′}.
Then, from (4.3) one can determine the full conditional distribution of Ỹi, which is given by



















Attention is now turned to the updating of the unknown functions which are being modeled
through the use of either the Gaussian process or Gaussian predictive process model. Under the
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Gaussian process model, one can ascertain from (4.4) that the full conditional distribution of g∗l can
be expressed as










l′ and G(−l) are all the elements of G, with the exception of
those corresponding to gl. Thus, straightforward algebra reveals that the full condition distribution
of g∗l is
g∗l |U,β, τl,θl,G(−l) ∼ N(µ∗l ,Σ
∗
l ),













l′). Under the Gaussian
predictive process model, similar arguments reveal that the full conditional distribution of g̃l is
g̃l|U,β, τl,θl,G(−l) ∼ N(µ̃l, Σ̃l),













l′ 6=l Ml′Tl′ g̃l′).
In some cases, it might be reasonable to assume that the testing accuracy probabilities are
known; i.e., the values of Sej and Spj are fixed known constants. Alternatively, in some settings
these quantities may not be known, in which case the following approach can be implemented in
order to estimate the accuracy probabilities along with the other parameters of the model. Here it
is assumed that the differences in these parameters arise either due to the type of assay being used
or can be attributed to the size of the pool being tested. In either case, it is reasonable to assume
that a total of T different sets of accuracy probabilities need to be estimated. Let Ste and S
t
p, for
t = 1, . . . , T , denote the testing sensitivity and specificity associated with the tth set of accuracy
probabilities, and let the index set M(t) denote the corresponding collection of pool indices; i.e.,
for all j ∈ M(t), one has that Sej = Ste and Spj = Stp. Under this convention and after eliciting
independent priors for all Ste and S
t
p, one has that the full conditional density of Se and Sp is given
by














Due to conditional conjugacy and the fact that parameters of interest are probabilities, beta priors
for Ste and S
t
p are suggested; i.e., π(S
t
e) = beta(γ1t, γ2t) and π(S
t
p) = beta(δ1t, δ2t). It is worthwhile
to note, in many infectious disease screening applications, pilot data exists which could be used to
construct informative priors for these parameters. Alternatively, experience has shown that these
parameters can be well estimated, for moderate sample sizes, through the use of non-informative
priors (i.e., by taking γ1t = γ2t = δ1t = δ2t = 1). This was also illustrated in McMahan et al. (2017).
For any choice of the prior parameters, these specifications lead to the following full conditional
distributions
Ste|Y ∼ beta(γ∗1t, γ∗2t) Stp|Y ∼ beta(δ∗1t, δ∗2t),
where









δ∗1t = δ1t +
∑
j∈M(t)




The remaining parameters consist of the hyperparameters in either the Gaussian process or
Gaussian predictive process model. Again due to conditional conjugacy, independent gamma priors,
with shape and rate parameters of al and bl, are specified for the precision parameter τl. These
specifications lead to the following full conditional distributions
τl|g∗l ,θl ∼ Gamma
(

















under the Gaussian process and Gaussian predictive process models, respectively. As for θl, its
posterior densities under the Gaussian process and Gaussian predictive process models are given by











f(θl|U, g̃l, τl,X) ∝ |C̃l|−1/2 exp
{
−




respectively, where | · | denotes the determinant of a matrix and η =
∑q1
l=1 MlTlg̃l + X2β. Note, θl
is implicitly apart of C∗l , C̃l, and Tl, thus determining a conjugate prior for these parameters is not
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straightforward, under any potential correlation function. Thus, it is suggested that a Metropolis-
Hastings algorithm be used within MCMC posterior sampling algorithm to draw samples of θl.
4.2 Posterior Sampling Algorithm






l = 0, for l = 1, . . . , q1. Also initialize Ỹ
(0)
i , for i = 1, . . . , N , based
on the group testing outcomes Z. Set s = 1.
(2) For t = 1, . . . , T , generate

















i from the truncated normal distribution; i.e.,
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(s)





i ∼ TN{ηi, 1, (−∞, 0)}, if Ỹ
(s−1)
i = 1,
where ηi, i = 1, . . . , N , are evaluated at G
(s−1) and β(s−1). Set U(s) = (U
(s)















where a and Γ are prior mean and covariance matrix of β.
(5) To update the g
(s)
l , for l = 1, . . . , q1, two different approaches (i.e., GP and GPP) were
proposed. For GP,
(5.1) First sample g
∗(s)
l ∼ N(µ∗l ,Σ
∗
l )
(5.2) Then sample ĝl(x
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(5.a) First sample g̃
(s)
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(5.b) Then sample ĝl(x
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(6) To sample τ
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l using regular random walk Metropolis algorithm.
(8) For i = 1, . . . , N , sample Ỹ
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In this section, several simulation studies are conducted to evaluate the finite sample perfor-
mance of the proposed approaches. In the simulation study, the following two models are considered
M1: Φ−1{Pr(Ỹi = 1|xi)} = β0 + g1(xi1) + g2(xi2) + xi3β1 + xi4β2, where
g1(x) = 0.7 exp{(−I(xi > 0)1.22 − I(xi < 0)1.2−2)x2i /6.25} − 0.468,
g2(x) = 0.6 exp
{























6 + 6 exp(1 + 1.5x)
− 0.406
where β = (β0, β1, β2)
′ = (−1.5, 0.5, 0.5)′, xi1 and xi2 are independently generated from Uniform(−3, 3)
and are rounded to the second decimal place, xi3 ∼ N(0, 1), and xi4 ∼ Bernoulli(0.5). In addition, to
be identifiable, all the integrals of functions over the support (i.e., (-3,3)) in the considered models
are forced to equal zero; i.e.,
∫ 3
−3 gl(x)dx = 0, for l = 1, 2. Proceeding in this fashion allows for
fitting the model using GP approach for a large number of N because the MCMC procedure will at
most involve decomposition of matrix of dimension K = 601. To use the GPP approach, 101 equally
spaced points from -3 to 3 (L = 101) are used as knots so that two endpoints and original point are
included. In doing so, the estimated function value at zero will be included in g̃l. Both of GP and
GPP approaches were used to fit the model for comparative purposes.
To proceed, first for each considered model configuration, the individual-level data were
generated; i.e., the data of the form {(Ỹi,xi), for i = 1, . . . , N}, where the ith individual’s covariate
information xi = (1, xi1, xi2, xi3, xi4)
′ was simulated according to the procedure described above and
the individual’s true status Ỹi was subsequently generated from a Bernoulli distribution with success
probability Φ{g1(xi1) + g2(xi2) + x′i2β}, where xi2 = (1, xi3, xi4)′. To create the group testing data,
three common group testing algorithms were used to screen the N individuals; i.e., master pool
testing (MPT), Dorfman testing (DT), and array testing (AT). For MPT, each of the individuals is
assigned to exactly one group, then the individual specimens within the same group are physically
combined to form the pooled specimens. All of the pooled specimens are then tested for the presence
of the binary characteristic of interest, with no further steps being taken regardless of the testing
results. DT will further test the individual specimens that belong to the pools with positive diagnosed
status. AT completes the tests in two stages. In the first stage, individual specimens are assigned to
an array, then the row and column pools are formed and tested. These testing results will provide
guidance (Kim et al., 2007) to which individual specimen should be further tested in the second
stage. For MPT and DT, a common size c = 5 was used for the initial pool. For AT, a 5× 5 array
was used. As mentioned above, testing errors were acknowledged. Therefore, the testing results
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were simulated from Bernoulli{Sej Z̃j + (1 − Spj )(1 − Z̃j)}, where Z̃j = I(
∑
i∈Pj Ỹi > 0) and Pj
contains indices of individuals that belongs to the jth pool. To mimic the real situation, multiple
assays with different testing accuracies were assumed to be used. For MPT, DT and AT, the initial
master pool testing used the assay with accuracies S1e and S
1
p . For individual retests with DT and
AT, the assay with accuracies S2e and S
2
p are used.
In order to access performance of the proposed methodology, two scenarios were considered.
In the first scenario, the testing accuracies are assumed to be known and constant; i.e., S1e = 0.95,
S1p = 0.98, S
2
e = 0.98 and S
2
p = 0.99. For each combination of the underlying models (i.e., M1, M2)
and group testing algorithm (MPT, DT, AT), a dataset containing pool testing responses (pools
were formed randomly) was generated: {Zj , j = 1, . . . , J ; xi, i = 1, . . . , N} and then based on this
dataset, functions g1(·), g2(·) and regression coefficient β = (β0, β1, β2)′ were estimated. In addition,
for comparative purpose, estimates were obtained through the analysis of individual level testing (IT,
c = 1) results, where testing accuracies are assumed to be S2e and S
2
p . In scenario 2, the estimation of
testing accuracies is investigated. Specifically, the settings for sensitivity and specificity are the same
as those in the first scenario, but are assumed to be unknown. Consequently, the testing accuracies,
along with regression coefficients and functions g1(·) and g2(·), were estimated by analyzing the data
collected from screening N = 5000 individuals according to DT and AT.
For each scenario and model configuration, 500 independent datasets were generated and
analyzed using two proposed approaches (i.e., GP and GPP). Conjugate priors are assigned to
parameters τ1, τ2,β,Se, and Sp; in particular, τ1 ∼ Gamma(2,1),τ2 ∼ Gamma(2,1), β0 ∼ N(0, 1000),
β1 ∼ N(0, 1000), β2 ∼ N(0, 1000) and Beta(1, 1) is specified as the prior distribution for all testing
accuracies. In addition, correlation of the Gaussian process is determined by the Matérn function,
whose formula is given by













where κν is the modified Bessel function of the third kind of order ν. In the Matérn function,
ν controls the smoothness of sample path of the Gaussian process and φ controls the decay rate of
the correlation function. As common in the literature (Banerjee et al., 2008), ν is fixed (i.e., ν = 2)
and φ has prior U(0.07, 0.75), which suggests the effective spatial ranges are roughly from 0.4 to 4
(i.e., approximately 6φ is the distance at which the correlation drops to 0.05). For each dataset,
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after a burn-in period of 2000 samples, 1000 thinned samples were collected by retaining every 5th
sample from the chain. Based on the thinned chain, regression parameters, testing accuracies, and
functions g1(·) and g2(·) were estimated.
Table 4.1 present the simulation results for regression coefficients (i.e., β1 and β2) under
scenario one, across all considered models (M1, M2), group testing algorithms (IT, MT, DT and
AT), and model fitting procedures (GP and GPP) when N = 5000. In particular, the tables provide
empirical bias (Bias) and sample standard deviation (SD) of 500 point estimates (i.e., posterior
means), mean of posterior standard deviations (SE), empirical coverage probabilities associated
with 95% credible intervals (CP), and average of the model fitting time. From the tables, the
first thing noticed is both of the proposed approaches can estimate the regression coefficients very
accurately across all considered settings; i.e., the bias of estimates are almost zero, SE and SD are
in agreement with each other, and the empirical coverage probabilities are at their nominal level.
However, with respect to the model fitting time, the GPP method is 6∼7 times faster than GP
method on average. It is also noted that estimates based on DT and AT data usually have smaller
standard deviation than the ones obtained using IT data. This suggests that more precise inference
can be obtained from analyzing group testing decoding data, when compared to IT data; similar
findings were reported in Zhang et al. (2013).
Table 4.2 summarizes the simulation results under scenario 2. It is first noted that the
proposed approaches can estimate the regression coefficients and unknown testing accuracies with a
high degree of precision, across all considered configurations; i.e., the estimates exhibits little, if any,
evidence of bias, SD and SE are in agreement, and their associated empirical coverage probabilities
attain the nominal level. Furthermore, these findings indicate that estimating the unknown testing
accuracies does not seem to affect the estimation of regression coefficients; i.e, the SD and SE are
at the same level as in the first scenario.
One of the primary goals of the simulation studies is to assess the performance of the
proposed approaches in terms of estimating the function g1(·) and g2(·). Figure 4.1 and 4.2 present
the results of estimating function g1(·) and g2(·) under model M1, and Figure 4.3 and 4.4 present
the results of estimating function g1(·) and g2(·) under model M2, when N = 5000 and sensitivity
and specificity are fixed. From the figures, it is clear that both proposed approaches (i.e., GP and
GPP) can estimate the value of function accurately; i.e., the median of 500 estimates of the function
almost coincides with the true function and the 95% confidence band does cover the true function.
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Table 4.1: Simulation study: Presented results include the empirical bias (Bias) of the 500 point es-
timates of regression coefficients, there sample standard deviation (SD), the average of 500 posterior
variance (SE), the empirical coverage probabilities (CP) associated with 95% credible intervals, and
average model fitting time (Time, in seconds), when N = 5000. Each dataset was analyzed using
two proposed model fitting procedures (i.e., GP and GPP) when sensitivity and specificity are fixed.
Model Measure IT MT DT AT
M1(GP)
β1 = 0.5
Bias(SD) 0.00(0.03) 0.01(0.07) 0.00(0.03) 0.00(0.03)
CP(SE) 0.94(0.03) 0.92(0.07) 0.94(0.03) 0.94(0.03)
β2 = 0.5
Bias(SD) 0.01(0.05) 0.02(0.13) 0.01(0.05) 0.01(0.05)
CP(SE) 0.94(0.05) 0.94(0.13) 0.94(0.05) 0.94(0.05)
Time 17230 16854 16998 17334
M1(GPP)
β1 = 0.5
Bias(SD) 0.00(0.03) 0.02(0.07) 0.00(0.03) 0.00(0.03)
CP(SE) 0.94(0.03) 0.91(0.07) 0.94(0.03) 0.94(0.03)
β2 = 0.5
Bias(SD) 0.01(0.05) 0.02(0.13) 0.01(0.05) 0.01(0.05)
CP(SE) 0.94(0.05) 0.94(0.13) 0.94(0.05) 0.94(0.05)
Time 2891 2597 2684 2679
M2(GP)
β1 = 0.5
Bias(SD) 0.01(0.03) 0.01(0.06) 0.01(0.03) 0.01(0.03)
CP(SE) 0.94(0.03) 0.95(0.06) 0.94(0.03) 0.93(0.03)
β2 = 0.5
Bias(SD) 0.00(0.05) 0.01(0.13) 0.00(0.06) 0.00(0.05)
CP(SE) 0.93(0.05) 0.94(0.13) 0.93(0.05) 0.94(0.05)
Time 18542 18568 19000 18910
M2(GPP)
β1 = 0.5
Bias(SD) 0.01(0.03) 0.01(0.06) 0.01(0.03) 0.01(0.03)
CP(SE) 0.95(0.03) 0.95(0.06) 0.94(0.03) 0.93(0.03)
β2 = 0.5
Bias(SD) 0.00(0.05) 0.01(0.13) 0.00(0.06) 0.00(0.05)
CP(SE) 0.94(0.05) 0.93(0.13) 0.95(0.05) 0.94(0.05)
Time 3161 2814 2852 2822
Similar results were obtained across all considered models under scenario 2, therefore are omitted
here.
4.4 Real Data Analysis
In this section, the proposed methodology was used to analyse the group testing data col-
lected by the State Hygienic Laboratory (SHL) at the University of Iowa with the aim of testing
Iowa residents for chlamydia and gonorrhea. Due to the limited budge, the SHL switched from
individual testing to group testing in the late 1990s, which has been shown to save large amount of
money since then.
In particular, the data used here is collected from screening N = 13862 female individuals for
chlamydia during the 2014 calendar year. Both endocervical swab and urine specimens were collected
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Figure 4.1: Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the first function, under model M1 when
N = 5000 and sensitivity and specificity are fixed. From top to bottom corresponds to IT, MT,
DT and AT data, respectively. Left and right columns correspond to GP and GPP approaches,
respectively.















































































































Figure 4.2: Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the second function, under model M1 when
N = 5000 and sensitivity and specificity are fixed. From top to bottom corresponds to IT, MT,
DT and AT data, respectively. Left and right columns correspond to GP and GPP approaches,
respectively.































































































































Figure 4.3: Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the first function, under model M2 when
N = 5000 and sensitivity and specificity are fixed. From top to bottom corresponds to IT, MT,
DT and AT data, respectively. Left and right columns correspond to GP and GPP approaches,
respectively.































































































































Figure 4.4: Presented results include the true function (solid), 2.5% (dotted), 50% (dashed) and
97.5% (dash-dotted) quantiles of the 500 estimates of the second function, under model M2 when
N = 5000 and sensitivity and specificity are fixed. From top to bottom corresponds to IT, MT,
DT and AT data, respectively. Left and right columns correspond to GP and GPP approaches,
respectively.































































































































Table 4.2: Simulation study: Presented results include the empirical bias (Bias) of the 500 point es-
timates of regression coefficients, there sample standard deviation (SD), the average of 500 posterior
variance (SE) and the empirical coverage probabilities (CP) associated with 95% credible intervals,
when N = 5000. Each dataset was analyzed using two proposed model fitting procedures (i.e., GP
and PP) when sensitivity and specificity are unknown.
Model Measure β1 = 0.5 β2 = 0.5 S
1
e = 0.95 S
1
p = 0.98 S
2





Bias(SD) 0.01(0.03) 0.01(0.05) -0.02(0.03) -0.01(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.92(0.03) 0.96(0.05) 0.97(0.04) 0.99(0.01) 0.99(0.01) 0.96(0.01)
AT
Bias(SD) 0.01(0.03) 0.01(0.05) 0.00(0.01) 0.00(0.01) 0.00(0.01) -0.01(0.01)
CP(SE) 0.93(0.03) 0.93(0.05) 0.95(0.01) 0.96(0.01) 0.96(0.01) 0.95(0.01)
M1(PP)
DT
Bias(SD) 0.01(0.03) 0.01(0.05) -0.02(0.03) -0.01(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.91(0.03) 0.95(0.05) 0.97(0.04) 1.00(0.01) 0.99(0.01) 0.96(0.01)
AT
Bias(SD) 0.01(0.03) 0.01(0.05) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.93(0.03) 0.93(0.05) 0.96(0.01) 0.97(0.01) 0.97(0.01) 0.95(0.01)
M2(GP)
DT
Bias(SD) 0.01(0.03) 0.02(0.06) -0.02(0.03) 0.00(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.95(0.03) 0.91(0.05) 0.98(0.04) 1.00(0.01) 1.00(0.01) 0.95(0.01)
AT
Bias(SD) 0.01(0.03) 0.01(0.05) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.96(0.03) 0.94(0.05) 0.96(0.01) 0.96(0.01) 0.97(0.01) 0.96(0.01)
M2(PP)
DT
Bias(SD) 0.01(0.03) 0.02(0.06) -0.02(0.03) 0.00(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.95(0.03) 0.92(0.05) 0.97(0.04) 1.00(0.01) 0.99(0.01) 0.95(0.01)
AT
Bias(SD) 0.01(0.03) 0.01(0.05) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
CP(SE) 0.96(0.03) 0.93(0.05) 0.96(0.01) 0.96(0.01) 0.97(0.01) 0.96(0.01)
by the SHL. The swab specimens were tested using Dorfman’s testing algorithm; i.e., swab master
pools were first formed by combining individual specimens chronologically as they arrive at the SHL,
and tested. Then swab specimens contributing to positive master pools are retested individually.
All the urine specimens are tested individually. Finally, the data considered here consists of testing
results for 4316 individual urine specimens, 2273 swab master pools of size c = 4, 12 swab master
pools of size c = 3, one swab master pool of size c = 2, 416 individual swab specimens, as well as
Dorfman retesting results on positive swab master pools. Other than the testing responses data,
the data set also contains the value of six predictor variables for each individual; i.e., age (in years,
denoted by x1), the other five binary variables x2, . . . , x6. In specific, x2 = 1 if the individual is
Caucasian (0, otherwise), x3 = 1 if a new sexual partner was reported in the last 90 days, x4 = 1
if multiple partners were reported in the last 90 days, x5 = 1 if the individual had contact with
a partner having any STD reported in the previous year, and x6 = 1 if the individual showed
symptoms of infection (e.g., painful intercourse, etc.).
The goal here is to relate an individuals available covariates to its chlamydia disease status
103
using the proposed approach. Recall that the proposed model is a partial linear model that contains
both linear and nonlinear effects. Therefore, the effect of age (x1) will be estimated nonparametri-
cally. In addition, it is of interest to detect if the effect of the interaction term x1x2, x1x3 and x1x4
are linear. Therefore, the considered regression model is given by
Φ−1{Pr(Ỹi|xi)} = g1(xi1) + g2(xi1xi2) + g3(xi1xi3) + g4(xi1xi4) + β0 + xi5β1 + xi6β2.
In the analysis, we assumed there are three sets of testing accuracies; i.e., S1e and S
1
p for
pooled swab specimens, S2e and S
2





specimens tested individually. After a burn-in period of 2000 iterations, 1000 thinned posterior
samples were collected by taking every 5th iterate in the subsequent chain. Figure 4.5 provides
the estimates of four functions. Specifically, 2.5%, 50%, and 97.5% pointwise quantile curves are
provided. To obtain identifiability, all functions gl(·), for l = 1, 2, 3, 4, are restricted to be zero
Figure 4.5: Pointwise quantile curves of four functions. The dashed, solid, and dash-dotted lines
correspond to the 2.5%, 50%, and 97.5% quantiles of the posterior samples, respectively.
































































at the point of x1 (i.e., sample mean of all individuals’ age), therefore all confidence bands shrink
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towards zero at x1. From figure 4.5, it is first noted that age effects exhibits some nonlinearity,
which reinforces the necessity of the proposed nonparametric technique. On the other hand, the
three interaction terms do not exhibit much nonlinearity; i.e., the 95% confidence bands can contain
a horizontal line, which suggests it is reasonable to assume that the effects of the covariates x2, x3
and x4 are linear shift. Therefore, the model to be used to analyze this dataset is given by
Φ−1{Pr(Ỹi|xi)} = g1(xi1) + β0 + xi2β1 + xi3β2 + xi4β3 + xi5β4 + xi6β5. (4.7)
Table 4.3 provides a summary of the parameter estimates (posterior mean) for regression coefficients,
sensitivities and specificities for model (4.7). Figure 4.6 provides 2.5%, 50%, and 97.5% pointwise
quantile curves (based on the posterior samples) as a function of the age (i.e., g1(x1)), obtained from
analyzing the real data based on model (4.7).
Table 4.3: Real Data Analysis: Presented results include the estimates (i.e., posterior mean) of
regression coefficients, and their the 95% highest posterior density(HPD) interval.
Predictor Estimates 95% HPD Interval
Race -0.174 (-0.260, -0.100)
New Partner 0.145 (0.075, 0.209)
Multiple Partner 0.178 (0.084, 0.269)
Contact with STD 0.761 (0.630, 0.878)
Symptom 0.152 (0.084, 0.223)
S1e 0.983 (0.972, 0.992)
S2e 0.945 (0.913, 0.975)
S3e 0.942 (0.900, 0.976)
S1p 0.974 (0.964, 0.981)
S2p 0.989 (0.983, 0.995)
S3p 0.989 (0.985, 0.993)
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Figure 4.6: Pointwise quantile curves of age. The dashed, solid, and dash-dotted lines correspond
to the 2.5%, 50%, and 97.5% quantiles of the posterior samples, respectively.























Appendix A Chapter 2 Supplementary Materials
A.1: Implementation Details
Herein further details are provided regarding the sampling strategies that were used to implement
the proposed methodology. In particular, the sampling strategies tailored to implement the proposed
methodology, both in the presence and absence of measurement error, for the models considered in
the simulation study and data application are provided below. Further, a technique for specifying
θ∗ is provided. Note, following the presented development one can easily derive similar sampling
strategies for other parametric models.
A.1.1: Non-Error Laden Observations
Consider the situation in which the pooled biomarker levels are measured without error; i.e., Ỹpj
is directly observed. In this scenario and under the assumptions discussed in Section 2 of the
corresponding manuscript, the probability density function of the observed biomarker measurement
for the jth pool can be expressed as













h∗j (ỹ(−1)j |xj ,θ
∗)
h∗j (ỹ(−1)j |xj ,θ
∗)dỹ(−1)j ,
where hj(ỹ(−1)j |xj ,θ) =
∏cj
i=2 f(ỹij |xij ,θ) and h∗j (ỹ(−1)j |xj ,θ
∗) is an importance distribution,








for m = 1, ...,M , can be drawn. When the individual level biomarker levels are assumed to follow a
distribution whose support consists of the whole real line, then one can specify h∗j (ỹ(−1)j |xj ,θ
∗) =
hj(ỹ(−1)j |xj ,θ
∗). Alternatively, if the individual level biomarker levels are assumed to follow a
distribution with strictly positive support, then the support of the importance distribution, for
the reasons of computational efficiency, should be constrained such that
∑cj
i=2 ỹij ≤ cj Ỹpj , for
j = 1, . . . , J . Note, in all of the expressions above, θ∗ is a predetermined value of θ and can be
specified via the technique described below.
Under the assumption that the individual biomarker levels, Ỹij , follow a distribution whose
support is the entire real line (e.g., the normal distribution or t-distribution), it is suggested that one
specify h∗j (ỹ(−1)j |xj ,θ
∗) = hj(ỹ(−1)j |xj ,θ
∗), for the purposes of obtaining the MCMLE according to
the methodology described in Section 2 of the corresponding manuscript. It is worth while to point
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out that under the assumption of normality an analytical expression for the MLE can be obtained,
see the discussion provided in Appendix A.4 below.
For parametric models having strictly positive support, the following technique can be
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)′, for m = 1, ...,M . This technique was
also considered in Frigyik et al. (2010) and Mitchell et al. (2014). Consider drawing Zmij inde-
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Note, based on the distribution of Zmj = (Z
m
1j , ..., Z
m
cjj
)′ one can derive the resulting distribution
of the Ỹ
m
(−1)j . Typically, the distribution of Ỹ
m
(−1)j does not have an inviting form which is easily
sampled from, but the aforementioned process can be implemented in order to draw the Monte
Carlo samples. The form of the importance distribution is only needed to appropriately calculate
the weights in the Monte Carlo approximation of the log-likelihood.
The importance distribution, from which Ỹ
m
(−1)j is being sampled, for the log-normal and
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under the log link,
and bij = ax
′
ijβ
∗ under the inverse link.
A.1.2: Error Laden Observations
Consider the scenario in which the pooled biomarker assessments are subject to additive measure-
ment error; i.e., Ypj = Ỹpj + εpj , where εpj ∼ fε. It is assumed that fε is known. In practice, if
the distribution of the measurement error is unknown then fε can be replaced by an estimate, see
Section 5 of the corresponding manuscript for a discussion of how this can be done. Under these
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assumptions, the probability density function of Ypj can be expressed as












hj(ỹ(−1)j , εpj |xj ,θ)dỹ(−1)jdεpj ,
where hj(ỹ(−1)j , εpj |xj ,θ) = fε(εpj )
∏cj
i=2 f(ỹij |xij ,θ). Again the goal is to develop an importance
distribution h∗j (ỹ(−1)j , εpj |xj ,θ




2j , . . . , Ỹ
m
cjj
)′ and εmpj , for
m = 1, ...,M , can be drawn. Further, in all of the expressions above, θ∗ is a predetermined value of
θ and can be specified via the technique described below.
Under the assumption that the individual biomarker levels, Ỹij , follow a distribution whose
support is the entire real line (e.g., the normal distribution or t-distribution), it is suggested that
one specify h∗j (ỹ(−1)j , εpj |xj ,θ
∗) = hj(ỹ(−1)j , εpj |xj ,θ
∗), for the purposes of obtaining the MCMLE
according to the methodology described in Section 2 of the corresponding manuscript. It is worth
while to point out that under the assumption of normality an analytical expression for the MLE
can be obtained when a common pool size is being utilized (i.e., cj = c for all j), see the discussion
provided in Appendix A.4 below.
For parametric models having strictly positive support, the following technique can be em-
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sample εmpj from fε(ε)I(Ypj > ε) and Z
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pj for all j and m. The density function of the

















∗) is provided in Section A.1 for both the log-normal and gamma regression
models, with the unobserved Ỹpj being replaced by Ypj − εmpj .
A.1.3: Choosing θ∗
In order to efficiently implement the proposed methodology one must specify an appropriate initial
value θ∗ for the importance distributions developed in Sections A.1 and A.2. Herein a technique
for determining an appropriate initial value of θ∗ is proposed. This approach was utilized for all of
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the simulation studies and the data analysis presented in the corresponding manuscript. Further,
this approach can be implemented for the case in which the observed observations are subject to or
free of measurement error, and as such the discussion is focused on the latter scenario (i.e., Ỹpj are
observed). In the case that the observed data consists of the error laden measurements (i.e., Ypj ) one
should simply replace Ỹpj by Ypj in the following expressions in order to determine an appropriate
initial value of θ∗. Additionally, the techniques for specifying θ∗ are dependent on the underlying
distributional assumptions, and are as such presented for the parametric models considered in the
corresponding manuscript. Similar techniques could be developed for other parametric models.
Normal regression model: Under this model the individual biomarker concentrations are as-
sumed to conditionally, given the covariates, follow a normal distribution; i.e. Ỹij ∼ N(x′ijβ, σ2).
Consequently, under the assumptions presented in the corresponding manuscript, the biomarker
concentration of the jth pool also follows a normal distribution; i.e., Ỹpj ∼ N(x′jβ, σ2/cj), where∑cj
i=1 xij/cj = xj . Thus, β and σ can be estimated using the techniques outlined in Appendix A.4.
These estimators provide an initial value which can be used to implement the proposed methodology.
Log-normal regression model: Under this model the individual biomarker concentrations are
assumed to conditionally, given the covariates, follow a log-normal distribution. Consequently, the
method presented in Section 4 of Mitchell et al. (2014) is recommended to determine θ∗.
Shifted T regression model: Under this model the individual biomarker concentrations are
assumed to conditionally, given the covariates, follow a shifted t-distribution. For this regression
model, one has that



















i=1 xij/cj = xj . In order to identify a good initial value θ
∗ = (β∗
′
, ν∗)′ for the proposed
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methodology, the following approach was considered. Obtain β∗ as the ordinary least squares
estimator


















J − p− 1
.
Gamma regression model: Under this model the individual biomarker concentrations are as-
sumed to conditionally, given the covariates, follow a gamma distribution. For this regression model,
one has that





where η(·) is the link function, which is most commonly specified to be either the log or inverse link,
and σ is the Coefficent of Variation. Based on these characteristics, one has that the variance of the









































In order to identify a good initial value θ∗ = (β∗
′
, σ∗)′ for the proposed methodology, the
following approach was considered. First, consider approximating the expected value of Ỹij through
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∂u |u=u0 . Based on this first order approximation, one can also approximate


















































Consequently, iteratively reweighted least squares is implemented to obtain β∗. In particular the
following steps can be used to obtain β∗:
1) Choose an initial value of β(0) and set t = 0.
2) Compute xtj , α
(t)









































































−2 for j = 1, . . . , J .
4) Set t = t+ 1 an return to step 2).
Steps 2)-4) are iterated until convergence (i.e., ||β(t+1)−β(t)|| is less than some specified tolerance)
and β∗ is taken to be β(t+1) at the point of convergence. In the simulation section of the correspond-
ing manuscript, the initial value was specified to be β0 = (1, 0, . . . , 0)′ and a convergence tolerance
of 10−4 was utilized.
Further, based on (9), a natural initial value of the Coefficent of Variation is given by
σ∗ =
√√√√√ 1


































Herein the regularity conditions under which the asymptotic properties of the proposed methodology,
which are presented in Section 3 of the corresponding manuscript, can be established are provided:
i) The parameter space Θ is a compact subset of Rk.
ii) fε(Ypj |Ỹpj )wj(Ỹ j ,xj ,θ,θ
∗) is continuous in θ for all θ ∈ Θ, for j = 1, ..., J .
iii) E
[
supθ∈Θ fε(Ypj |Ỹpj )wj(Ỹ j ,xj ,θ,θ
∗)
∣∣∣Ypj ,θ∗] <∞, for j = 1, ..., J .
iv) The maximum likelihood estimate θ̂ is unique, in the interior of Θ.
v) θ̂M
P→ θ̂ as M →∞.
vi) gj(Ypj |xj ,θ) can be differentiated twice with respect to θ under the integral sign.
vii) B = −∇2l(θ̂) is positive definite.
viii) ∇3lM (θ|Y p,x,θ∗) is bounded in probability uniformly in a neighborhood of θ̂.
All of the aforementioned conditions are easy to verify with the exception of iii), and as such Lemma
1, established in Appendix A.3, provides sufficient conditions for verifying iii) based on the assumed
model for the individual level data.
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A.3: Asymptotic Properties
A.3.1: A proof of Lemma 1
Lemma 1: To establish regularity condition iii), it is sufficient to show that fε(y|ỹ) is uniformly




f (y|x,θ) dy <∞, ∀ x.
Proof: Recall wj(ỹj ,xj ,θ,θ






fε(Ypj |ỹpj )wj(ỹj ,xj ,θ,θ
∗)
∣∣∣∣Ypj ,θ∗] = ∫ sup
θ∈Θ








f(ỹij |xij ,θ)dỹj .






fε(Ypj |Ỹpj )wj(Ỹ j ,xj ,θ,θ
∗)








A.3.2: A sketch of the proof of Theorem 2









where Σ = B−1AB−1 and B = −∇2l(θ̂|Y p,x).
Proof: The Taylor series expansion of ∇lM (θ|Y p,x,θ∗), about θ̂M , provides
∇lM (θ̂|Y p,x,θ∗) = ∇lM (θ̂M |Y p,x,θ∗) +∇2lM (θ̂M |Y p,x,θ∗)(θ̂ − θ̂M ) + RM ,
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p→ 0 and that B̂(θ̂M |θ∗) = −∇2lM (θ̂M |Y p,x,θ∗)
p→ B; i.e., B̂(θ̂M |θ∗) is
a consistent estimator of B. Consequently, for M sufficiently large it is expected that B̂(θ̂M |θ∗) is
nonsingular so that upon rearrangement one has
√










p→ 0. Therefore, establishing (11) is tantamount to establishing (10). Note,


















gMj (Ypj |xj ,θ,θ
∗)













∗). Thus, by the Weak Law of Large
Numbers, as M →∞, then
∂
∂θr




























= gj(Ypj |xj ,θ),
for any fixed value of θ. Further, by the Central Limit Theorem, one has that
√
















































and W(θ|θ∗) = Cov{D1(θ)}. Thus, by an application of the delta method one can obtain that
√
M{∇lM (θ|Y p,x,θ∗)−∇l(θ|Y p,x)}
d→ N{0,U(θ)W(θ|θ∗)U(θ)′},
for any fixed value of θ, where U(θ) is a k × J(k + 1) matrix, whose elements are given by
U(θ)r,s =

{gj(Ypj |xj ,θ)}−1 if s = (j − 1)(k + 1) + r,
−{ ∂∂θr gj(Ypj |xj ,θ)}{gj(Ypj |xj ,θ)}
−2 if s = j(k + 1),
0 o.w.
(13)




where A = U(θ̂)W(θ̂|θ∗)U(θ̂)′}. Note∇l(θ̂|Y p,x) = 0 since θ̂ is the maximum likelihood estimate.
Combining this result with (12) and by an application of Slutsky’s theorem yields the desired result;




where Σ = B−1AB−1.
A.3.3: Estimating B and A
From the results discussed in the above section, one has that B̂(θ̂M |θ∗) is a consistent estimator
of B and is easily computed based on the Monte Carlo sample Ỹ
1
j , . . . , Ỹ
M
j from the importance
distribution h∗j (Ỹ j |xj ,θ
∗), for j = 1, ..., J . Similarly, consider UM (θ), a k×J(k+ 1) matrix, whose
elements are given by
UM (θ)r,s =

{gMj (Ypj |xj ,θ,θ
∗)}−1 if s = (j − 1)(k + 1) + r,
−{ ∂∂θr g
M
j (Ypj |xj ,θ,θ
∗)}{gMj (Ypj |xj ,θ,θ
∗)}−2 if s = j(k + 1),
0 o.w.
Note, that for a fixed value of θ, UM (θ)
p→ U(θ). Consequently, a natural estimator of U(θ̂) is
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given by UM (θ̂M ), since θ̂M
p→ θ̂. Again, for a fixed value of θ, the proposed estimator of W(θ|θ∗)
is given by
WM (θ|θ∗) = (M − 1)−1{D(θ)−DM (θ)1′M}′{D(θ)−D
M
(θ)1′M}
where D(θ) = [D1(θ), ...,DM (θ)] is a J(k+1)×M matrix and 1M is an M×1 vector of all ones, and
note WM (θ|θ∗) p→W(θ|θ∗). Thus, a natural estimator of W(θ̂|θ∗) is WM (θ̂M |θ∗). Consequently,
an estimator of A is given by A(θ̂M |θ∗) = UM (θ̂M )W(θ̂M |θ∗)U(θ̂M )′.
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A.4: Analytic Expressions For The MLEs Under
Normality
Under the assumption that the biomarker levels of the individuals obey the normal errors regression
model (i.e., Ỹij |xij ∼ N(µij , σ2), where µij = x′ijβ, xij is a vector of covariates for the ith individual






can be expressed in closed form based on Ỹpj or Ypj when a common pool size is utilized (i.e.,
cj = c for all j), where it is assumed that Ypj is subject to normal additive measurement error; i.e.,
Ypj = Ỹpj + εpj , where εpj
iid∼ N(0, τ2). For the scenario in which the observed observations are free





Ỹ p and σ̂
2 = cJ−1(Ỹ p −Xβ̂)′(Ỹ p −Xβ̂),
where X = (x1, . . . ,xJ)




i=1 xij , and Ỹ p = (Ỹp1 , . . . , ỸpJ )
′. Similarly, the MLE of θ0 in






2 = cJ−1(Yp −Xβ̂)′(Yp −Xβ̂)− cτ2,
where Yp = (Yp1 , ..., YpJ )
′. Note, it is assumed that the distribution of the measurement error is
known (i.e., τ2 is known a priori). In practice, this quantity would have to be estimated, see Section
5 of the corresponding manuscript for a discussion of how this can be accomplished. Further, the
above closed form expressions for the MLE can easily be extended to allow for the effect of multiple






CỸ p and σ̂
2 = J−1(Ỹ p −Xβ̂)′C(Ỹ p −Xβ̂), (14)
where C is a J × J diagonal matrix whose jth diagonal element is cj . Analogous expressions for
error laden observations do not appear to exist in closed form.
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Table 4: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 50 in the absence of
measurement error. Also included are the average estimated standard errors (SE) and the empirical
coverage probabilities (Cov) associated with 95% Wald confidence intervals. Three model fitting
procedures were implemented, the proposed methodology (MCMLE), the analytical approach de-
scribed in Appendix A.1.3 (MLE), and the MCEM algorithm, with the latter two techniques only
being applicable for models M1 and M2, respectively.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.96(0.10) 0.92(0.07) 0.93(0.06) 0.92(0.05) 0.92(0.04)
M1(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.94(0.05) 0.94(0.04) 0.93(0.03) 0.94(0.03)
β2
Bias(SD) 0.00(0.14) 0.00(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.97(0.14) 0.92(0.10) 0.94(0.08) 0.94(0.07) 0.93(0.06)
β0
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.96(0.10) 0.94(0.07) 0.94(0.06) 0.93(0.05) 0.93(0.04)
M1(MLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.96(0.05) 0.94(0.04) 0.94(0.04) 0.95(0.03)
β2
Bias(SD) 0.00(0.14) 0.00(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.97(0.14) 0.92(0.10) 0.96(0.08) 0.94(0.07) 0.94(0.06)
β0
Bias(SD) 0.00(0.10) 0.00(0.08) 0.01(0.06) 0.01(0.05) 0.01(0.05)
Cov(SE) 0.96(0.10) 0.91(0.07) 0.93(0.06) 0.93(0.05) 0.96(0.05)
M2(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.07) 0.93(0.05) 0.94(0.04) 0.96(0.04) 0.93(0.03)
β2
Bias(SD) 0.00(0.14) -0.01(0.11) 0.00(0.09) -0.01(0.08) 0.00(0.07)
Cov(SE) 0.95(0.14) 0.93(0.10) 0.94(0.08) 0.93(0.07) 0.93(0.06)
β0
Bias(SD) 0.00(0.10) 0.00(0.08) 0.01(0.06) 0.01(0.05) 0.01(0.05)
Cov(SE) 0.96(0.10) 0.91(0.07) 0.93(0.06) 0.93(0.05) 0.96(0.05)
M2(MCEM) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.07) 0.93(0.05) 0.94(0.04) 0.96(0.04) 0.93(0.03)
β2
Bias(SD) 0.00(0.14) -0.01(0.11) 0.00(0.09) -0.01(0.08) 0.00(0.07)
Cov(SE) 0.95(0.14) 0.93(0.10) 0.94(0.08) 0.93(0.07) 0.93(0.06)
β0
Bias(SD) -0.01(0.25) 0.02(0.19) 0.00(0.15) -0.01(0.14) 0.01(0.12)
Cov(SE) 0.94(0.23) 0.93(0.18) 0.94(0.15) 0.93(0.13) 0.95(0.12)
M3(MCMLE) β1
Bias(SD) -0.02(0.18) 0.00(0.13) 0.00(0.11) -0.01(0.10) -0.01(0.09)
Cov(SE) 0.92(0.16) 0.95(0.13) 0.94(0.11) 0.95(0.09) 0.93(0.08)
β2
Bias(SD) 0.00(0.34) -0.02(0.27) 0.01(0.22) 0.00(0.19) 0.00(0.17)
Cov(SE) 0.93(0.32) 0.93(0.25) 0.94(0.21) 0.94(0.18) 0.94(0.17)
β0
Bias(SD) -0.01(0.10) 0.00(0.07) -0.01(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.94(0.07) 0.93(0.06) 0.93(0.05) 0.94(0.04)
M4(MCMLE) β1
Bias(SD) 0.01(0.08) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.93(0.07) 0.95(0.05) 0.92(0.04) 0.95(0.04) 0.93(0.03)
β2
Bias(SD) 0.00(0.15) 0.00(0.10) 0.01(0.08) -0.01(0.08) 0.00(0.07)
Cov(SE) 0.94(0.14) 0.94(0.10) 0.93(0.08) 0.92(0.07) 0.93(0.06)
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.93(0.03) 0.96(0.03) 0.95(0.02) 0.93(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.93(0.04) 0.93(0.03) 0.94(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.09) 0.00(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.92(0.08) 0.94(0.06) 0.95(0.05) 0.94(0.04) 0.96(0.04)
121
Table 5: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 200 in the absence of
measurement error. Also included are the average estimated standard errors (SE) and the empirical
coverage probabilities (Cov) associated with 95% Wald confidence intervals. Three model fitting
procedures were implemented, the proposed methodology (MCMLE), the analytical approach de-
scribed in Appendix A.1.3 (MLE), and the MCEM algorithm, with the latter two techniques only
being applicable for models M1 and M2, respectively.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.94(0.05) 0.93(0.04) 0.93(0.03) 0.94(0.02) 0.96(0.02)
M1(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.95(0.02) 0.96(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.94(0.04) 0.95(0.04) 0.93(0.03)
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.94(0.05) 0.93(0.04) 0.93(0.03) 0.95(0.03) 0.96(0.02)
M1(MLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.95(0.03) 0.96(0.02) 0.95(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.94(0.04) 0.96(0.04) 0.93(0.03)
β0
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.04) 0.95(0.04) 0.94(0.03) 0.95(0.03) 0.94(0.02)
M2(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.02) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.96(0.03) 0.95(0.02) 0.94(0.02) 0.93(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.96(0.05) 0.94(0.04) 0.93(0.04) 0.96(0.03)
β0
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.04) 0.95(0.04) 0.94(0.03) 0.96(0.03) 0.93(0.02)
M2(MCEM) β1
Bias(SD) 0.00(0.04) 0.00(0.02) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.00(0.04) 0.96(0.03) 0.95(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.96(0.05) 0.94(0.04) 0.94(0.04) 0.96(0.03)
β0
Bias(SD) -0.01(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.06) -0.01(0.06)
Cov(SE) 0.95(0.12) 0.94(0.09) 0.94(0.08) 0.97(0.07) 0.95(0.06)
M3(MCMLE) β1
Bias(SD) -0.01(0.08) 0.00(0.06) -0.01(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.97(0.08) 0.95(0.06) 0.92(0.05) 0.94(0.05) 0.94(0.04)
β2
Bias(SD) 0.02(0.16) 0.00(0.13) -0.01(0.11) -0.01(0.10) 0.01(0.08)
Cov(SE) 0.95(0.17) 0.95(0.13) 0.94(0.11) 0.95(0.09) 0.96(0.09)
β0
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.94(0.05) 0.96(0.04) 0.96(0.03) 0.93(0.02) 0.96(0.02)
M4(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.94(0.04) 0.95(0.03) 0.93(0.02) 0.96(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.94(0.04) 0.94(0.04) 0.96(0.03)
β0
Bias(SD) 0.01(0.02) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.95(0.03) 0.95(0.02) 0.94(0.01) 0.95(0.01) 0.94(0.01)
M5(MCMLE) β1
Bias(SD) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.96(0.02) 0.94(0.01) 0.95(0.01) 0.95(0.01) 0.93(0.01)
β2
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.97(0.03) 0.94(0.02) 0.95(0.02) 0.96(0.02)
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Table 6: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 50 in the presence of
measurement error (τ = 0.05). Also included are the average estimated standard errors (SE) and
the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.01(0.11) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.93(0.10) 0.94(0.07) 0.93(0.06) 0.94(0.05) 0.93(0.04)
M1(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.94(0.07) 0.94(0.05) 0.94(0.04) 0.91(0.04) 0.93(0.03)
β2
Bias(SD) -0.01(0.15) 0.01(0.10) 0.00(0.09) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.93(0.14) 0.94(0.10) 0.93(0.08) 0.95(0.07) 0.93(0.06)
β0
Bias(SD) 0.01(0.11) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.94(0.07) 0.94(0.06) 0.95(0.05) 0.94(0.05)
M1(MLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.94(0.04) 0.92(0.04) 0.95(0.03)
β2
Bias(SD) -0.01(0.15) 0.00(0.10) 0.00(0.09) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.94(0.14) 0.95(0.10) 0.94(0.08) 0.95(0.07) 0.94(0.07)
β0
Bias(SD) -0.01(0.12) 0.00(0.09) 0.00(0.07) 0.00(0.07) 0.01(0.06)
Cov(SE) 0.95(0.11) 0.93(0.08) 0.94(0.07) 0.93(0.07) 0.93(0.06)
M2(MCMLE) β1
Bias(SD) -0.01(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.93(0.08) 0.94(0.06) 0.92(0.05) 0.92(0.04) 0.91(0.04)
β2
Bias(SD) 0.00(0.15) 0.00(0.12) 0.00(0.10) 0.00(0.09) 0.00(0.08)
Cov(SE) 0.94(0.15) 0.92(0.11) 0.92(0.09) 0.93(0.08) 0.94(0.07)
β0
Bias(SD) -0.01(0.25) 0.00(0.19) -0.01(0.16) 0.00(0.14) 0.01(0.12)
Cov(SE) 0.94(0.24) 0.93(0.18) 0.95(0.15) 0.92(0.13) 0.95(0.12)
M3(MCMLE) β1
Bias(SD) 0.01(0.19) 0.00(0.13) 0.00(0.11) 0.01(0.10) 0.00(0.09)
Cov(SE) 0.95(0.17) 0.94(0.13) 0.95(0.11) 0.93(0.09) 0.94(0.08)
β2
Bias(SD) 0.00(0.35) 0.01(0.25) 0.00(0.22) 0.00(0.20) -0.01(0.18)
Cov(SE) 0.94(0.34) 0.94(0.25) 0.95(0.21) 0.93(0.19) 0.93(0.17)
β0
Bias(SD) -0.01(0.12) 0.00(0.08) 0.00(0.07) 0.00(0.06) -0.01(0.06)
Cov(SE) 0.94(0.11) 0.95(0.08) 0.95(0.07) 0.94(0.06) 0.93(0.06)
M4(MCMLE) β1
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.96(0.08) 0.95(0.06) 0.92(0.05) 0.92(0.04) 0.95(0.04)
β2
Bias(SD) 0.00(0.16) 0.00(0.11) -0.01(0.09) 0.00(0.08) 0.00(0.07)
Cov(SE) 0.92(0.15) 0.93(0.11) 0.94(0.09) 0.94(0.08) 0.94(0.07)
β0
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.93(0.05) 0.96(0.03) 0.93(0.03) 0.93(0.02) 0.94(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.96(0.03) 0.92(0.02) 0.96(0.02) 0.93(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.96(0.08) 0.94(0.06) 0.94(0.05) 0.92(0.04) 0.95(0.04)
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Table 7: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 200 in the presence
of measurement error (τ = 0.05). Also included are the average estimated standard errors (SE)
and the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.93(0.05) 0.94(0.04) 0.97(0.03) 0.96(0.03) 0.93(0.02)
M1(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.94(0.04) 0.94(0.03) 0.94(0.02) 0.95(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.96(0.04) 0.96(0.04) 0.94(0.03)
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.93(0.05) 0.94(0.04) 0.97(0.03) 0.96(0.03) 0.93(0.02)
M1(MLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.94(0.04) 0.94(0.03) 0.94(0.02) 0.95(0.02) 0.95(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.96(0.04) 0.96(0.04) 0.94(0.03)
β0
Bias(SD) 0.01(0.08) 0.01(0.04) 0.00(0.04) 0.00(0.03) 0.01(0.03)
Cov(SE) 0.93(0.08) 0.95(0.04) 0.93(0.04) 0.94(0.03) 0.95(0.03)
M2(MCMLE) β1
Bias(SD) -0.01(0.06) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.92(0.06) 0.96(0.03) 0.96(0.02) 0.95(0.02) 0.93(0.02)
β2
Bias(SD) -0.01(0.10) 0.00(0.05) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.1) 0.95(0.06) 0.93(0.05) 0.94(0.04) 0.96(0.04)
β0
Bias(SD) 0.00(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.06) -0.01(0.06)
Cov(SE) 0.95(0.12) 0.94(0.09) 0.94(0.08) 0.97(0.07) 0.95(0.06)
M3(MCMLE) β1
Bias(SD) 0.00(0.09) 0.00(0.06) -0.01(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.95(0.06) 0.92(0.05) 0.94(0.05) 0.94(0.04)
β2
Bias(SD) 0.00(0.17) 0.00(0.13) -0.01(0.11) -0.01(0.10) 0.01(0.08)
Cov(SE) 0.95(0.17) 0.95(0.13) 0.94(0.11) 0.95(0.09) 0.96(0.09)
β0
Bias(SD) 0.01(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.05) 0.94(0.04) 0.95(0.03) 0.94(0.03) 0.95(0.03)
M4(MCMLE) β1
Bias(SD) -0.01(0.04) -0.01(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.95(0.03) 0.94(0.02) 0.93(0.02) 0.95(0.02)
β2
Bias(SD) -0.02(0.07) 0.00(0.06) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.07) 0.93(0.05) 0.96(0.05) 0.95(0.04) 0.95(0.04)
β0
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.94(0.02) 0.95(0.02) 0.95(0.01) 0.96(0.01) 0.96(0.01)
M5(MCMLE) β1
Bias(SD) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.93(0.02) 0.94(0.01) 0.93(0.01) 0.96(0.01) 0.93(0.01)
β2
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.96(0.04) 0.95(0.03) 0.94(0.02) 0.96(0.02) 0.94(0.02)
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Table 8: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 50 in the presence of
measurement error (τ = 0.10). Also included are the average estimated standard errors (SE) and
the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.11) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.93(0.10) 0.94(0.07) 0.94(0.06) 0.95(0.05) 0.94(0.05)
M1(MCMLE) β1
Bias(SD) 0.00(0.08) 0.00(0.05) 0.00(0.05) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.92(0.07) 0.93(0.05) 0.93(0.04) 0.93(0.04) 0.94(0.03)
β2
Bias(SD) 0.00(0.15) 0.01(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.14) 0.94(0.10) 0.94(0.08) 0.95(0.07) 0.96(0.07)
β0
Bias(SD) 0.00(0.11) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.93(0.10) 0.94(0.07) 0.94(0.06) 0.95(0.05) 0.95(0.05)
M1(MLE) β1
Bias(SD) 0.00(0.08) 0.00(0.05) 0.00(0.05) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.93(0.07) 0.93(0.05) 0.93(0.04) 0.93(0.04) 0.95(0.04)
β2
Bias(SD) 0.00(0.15) 0.01(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.15) 0.94(0.11) 0.95(0.09) 0.95(0.08) 0.97(0.07)
β0
Bias(SD) -0.01(0.12) 0.01(0.10) 0.01(0.09) 0.00(0.08) 0.00(0.08)
Cov(SE) 0.95(0.13) 0.94(0.10) 0.94(0.09) 0.94(0.08) 0.95(0.08)
M2(MCMLE) β1
Bias(SD) 0.01(0.09) 0.00(0.06) 0.00(0.06) 0.00(0.05) 0.01(0.05)
Cov(SE) 0.94(0.09) 0.95(0.06) 0.94(0.05) 0.92(0.05) 0.94(0.04)
β2
Bias(SD) 0.02(0.16) 0.00(0.13) 0.00(0.10) 0.01(0.09) 0.00(0.09)
Cov(SE) 0.94(0.16) 0.93(0.12) 0.94(0.10) 0.93(0.09) 0.94(0.08)
β0
Bias(SD) 0.02(0.24) 0.00(0.20) -0.01(0.16) -0.02(0.14) 0.00(0.13)
Cov(SE) 0.95(0.24) 0.93(0.18) 0.95(0.15) 0.91(0.13) 0.93(0.12)
M3(MCMLE) β1
Bias(SD) 0.01(0.19) 0.00(0.13) 0.01(0.11) 0.00(0.10) 0.00(0.09)
Cov(SE) 0.92(0.17) 0.95(0.13) 0.94(0.11) 0.94(0.09) 0.93(0.08)
β2
Bias(SD) 0.01(0.33) -0.01(0.27) 0.01(0.22) 0.02(0.18) 0.00(0.18)
Cov(SE) 0.96(0.34) 0.93(0.25) 0.95(0.21) 0.95(0.19) 0.93(0.17)
β0
Bias(SD) -0.01(0.13) 0.00(0.10) 0.00(0.08) 0.00(0.08) 0.00(0.07)
Cov(SE) 0.93(0.12) 0.93(0.10) 0.94(0.08) 0.94(0.08) 0.95(0.07)
M4(MCMLE) β1
Bias(SD) -0.01(0.09) 0.00(0.06) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.95(0.09) 0.95(0.06) 0.94(0.05) 0.94(0.05) 0.91(0.04)
β2
Bias(SD) 0.00(0.17) -0.01(0.13) 0.00(0.10) 0.00(0.09) 0.00(0.08)
Cov(SE) 0.93(0.16) 0.93(0.12) 0.94(0.10) 0.95(0.09) 0.95(0.08)
β0
Bias(SD) 0.01(0.05) 0.01(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.94(0.05) 0.92(0.04) 0.92(0.03) 0.95(0.02) 0.94(0.02)
M5(MCMLE) β1
Bias(SD) -0.01(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.97(0.04) 0.94(0.03) 0.94(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.08) 0.92(0.06) 0.94(0.05) 0.95(0.04) 0.93(0.04)
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Table 9: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 100 in the presence
of measurement error (τ = 0.10). Also included are the average estimated standard errors (SE)
and the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) -0.01(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.94(0.07) 0.93(0.05) 0.93(0.04) 0.95(0.04) 0.95(0.03)
M1(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.94(0.05) 0.96(0.04) 0.94(0.03) 0.95(0.03) 0.94(0.02)
β2
Bias(SD) 0.01(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.95(0.07) 0.93(0.06) 0.95(0.05) 0.96(0.05)
β0
Bias(SD) -0.01(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.94(0.07) 0.94(0.05) 0.94(0.04) 0.96(0.04) 0.96(0.03)
M1(MLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.95(0.05) 0.97(0.04) 0.95(0.03) 0.95(0.03) 0.94(0.02)
β2
Bias(SD) 0.01(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.10) 0.95(0.07) 0.94(0.06) 0.96(0.05) 0.96(0.05)
β0
Bias(SD) 0.00(0.09) 0.00(0.07) 0.00(0.06) 0.00(0.06) 0.00(0.05)
Cov(SE) 0.95(0.09) 0.94(0.07) 0.94(0.06) 0.95(0.06) 0.94(0.05)
M2(MCMLE) β1
Bias(SD) -0.01(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.97(0.06) 0.94(0.04) 0.95(0.04) 0.94(0.03) 0.94(0.03)
β2
Bias(SD) 0.00(0.11) 0.00(0.09) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.11) 0.94(0.08) 0.95(0.07) 0.95(0.07) 0.94(0.06)
β0
Bias(SD) -0.01(0.17) -0.01(0.13) 0.00(0.11) 0.00(0.10) 0.00(0.08)
Cov(SE) 0.95(0.17) 0.94(0.13) 0.95(0.11) 0.92(0.09) 0.96(0.09)
M3(MCMLE) β1
Bias(SD) 0.00(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.94(0.12) 0.95(0.09) 0.94(0.08) 0.94(0.07) 0.95(0.06)
β2
Bias(SD) 0.01(0.24) 0.02(0.18) 0.01(0.15) 0.00(0.14) 0.00(0.12)
Cov(SE) 0.93(0.24) 0.96(0.18) 0.95(0.15) 0.93(0.13) 0.95(0.12)
β0
Bias(SD) -0.01(0.09) 0.00(0.07) 0.00(0.06) 0.00(0.06) 0.00(0.05)
Cov(SE) 0.95(0.09) 0.96(0.07) 0.93(0.06) 0.96(0.06) 0.94(0.05)
M4(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.93(0.06) 0.94(0.04) 0.94(0.04) 0.94(0.03) 0.94(0.03)
β2
Bias(SD) 0.01(0.12) 0.00(0.09) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.94(0.11) 0.95(0.08) 0.96(0.07) 0.95(0.07) 0.96(0.06)
β0
Bias(SD) 0.00(0.03) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.95(0.02) 0.93(0.02) 0.95(0.02) 0.95(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.94(0.03) 0.95(0.02) 0.94(0.02) 0.95(0.01) 0.95(0.01)
β2
Bias(SD) 0.00(0.06) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.96(0.06) 0.94(0.04) 0.96(0.03) 0.96(0.03) 0.96(0.03)
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Table 10: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 200 in the presence
of measurement error (τ = 0.10). Also included are the average estimated standard errors (SE)
and the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.96(0.05) 0.95(0.04) 0.95(0.03) 0.93(0.03) 0.95(0.02)
M1(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.96(0.04) 0.95(0.03) 0.95(0.02) 0.94(0.02) 0.95(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.97(0.07) 0.95(0.05) 0.94(0.04) 0.95(0.04) 0.96(0.03)
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.96(0.05) 0.95(0.04) 0.96(0.03) 0.93(0.03) 0.95(0.02)
M1(MLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.96(0.04) 0.95(0.03) 0.95(0.02) 0.94(0.02) 0.95(0.02)
β2
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03)
Cov(SE) 0.97(0.07) 0.95(0.05) 0.95(0.04) 0.95(0.04) 0.96(0.03)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.06) 0.93(0.05) 0.95(0.04) 0.95(0.04) 0.94(0.04)
M2(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.94(0.03) 0.93(0.03) 0.95(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.06) 0.01(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.94(0.06) 0.95(0.05) 0.95(0.05) 0.93(0.04)
β0
Bias(SD) 0.00(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.96(0.12) 0.95(0.09) 0.93(0.08) 0.93(0.07) 0.94(0.06)
M3(MCMLE) β1
Bias(SD) 0.00(0.08) 0.01(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.96(0.08) 0.94(0.06) 0.95(0.05) 0.96(0.05) 0.94(0.04)
β2
Bias(SD) 0.00(0.16) 0.00(0.13) 0.00(0.11) -0.01(0.09) 0.00(0.09)
Cov(SE) 0.97(0.17) 0.95(0.13) 0.92(0.11) 0.95(0.10) 0.94(0.09)
β0
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.06) 0.94(0.05) 0.93(0.04) 0.94(0.04) 0.94(0.04)
M4(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.92(0.04) 0.95(0.03) 0.94(0.03) 0.94(0.02) 0.95(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.95(0.08) 0.94(0.06) 0.96(0.05) 0.96(0.05) 0.94(0.04)
β0
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.95(0.02) 0.94(0.02) 0.94(0.01) 0.95(0.01) 0.96(0.01)
M5(MCMLE) β1
Bias(SD) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.96(0.02) 0.96(0.01) 0.95(0.01) 0.95(0.01) 0.95(0.01)
β2
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.94(0.03) 0.94(0.02) 0.96(0.02) 0.95(0.02)
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Table 11: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 50 in the presence of
measurement error (τ = 0.20). Also included are the average estimated standard errors (SE) and
the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.11) 0.00(0.09) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.94(0.11) 0.92(0.08) 0.94(0.07) 0.94(0.06) 0.92(0.06)
M1(MCMLE) β1
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.95(0.08) 0.94(0.06) 0.95(0.05) 0.94(0.04) 0.92(0.04)
β2
Bias(SD) -0.01(0.14) 0.00(0.12) 0.00(0.09) -0.01(0.09) 0.00(0.08)
Cov(SE) 0.96(0.15) 0.94(0.11) 0.96(0.10) 0.94(0.09) 0.96(0.08)
β0
Bias(SD) 0.00(0.11) 0.00(0.09) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.11) 0.93(0.08) 0.95(0.07) 0.95(0.06) 0.94(0.06)
M1(MLE) β1
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.95(0.08) 0.94(0.06) 0.96(0.05) 0.95(0.05) 0.94(0.04)
β2
Bias(SD) -0.01(0.14) 0.00(0.12) 0.00(0.10) -0.01(0.09) 0.00(0.08)
Cov(SE) 0.96(0.16) 0.95(0.12) 0.96(0.10) 0.95(0.09) 0.96(0.09)
β0
Bias(SD) -0.01(0.16) 0.00(0.13) 0.00(0.12) 0.01(0.11) 0.00(0.11)
Cov(SE) 0.95(0.15) 0.94(0.13) 0.94(0.12) 0.93(0.11) 0.94(0.10)
M2(MCMLE) β1
Bias(SD) 0.01(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.06) 0.00(0.05)
Cov(SE) 0.92(0.09) 0.93(0.07) 0.92(0.06) 0.93(0.06) 0.93(0.05)
β2
Bias(SD) 0.01(0.19) 0.01(0.14) 0.01(0.13) 0.00(0.12) 0.00(0.11)
Cov(SE) 0.95(0.18) 0.95(0.14) 0.92(0.12) 0.93(0.11) 0.94(0.11)
β0
Bias(SD) -0.01(0.25) 0.01(0.19) -0.01(0.15) 0.01(0.14) 0.00(0.13)
Cov(SE) 0.93(0.24) 0.95(0.18) 0.95(0.16) 0.94(0.14) 0.93(0.12)
M3(MCMLE) β1
Bias(SD) 0.00(0.19) -0.01(0.14) -0.01(0.11) 0.00(0.10) 0.00(0.09)
Cov(SE) 0.93(0.17) 0.92(0.13) 0.93(0.11) 0.95(0.10) 0.94(0.09)
β2
Bias(SD) 0.01(0.37) 0.00(0.27) 0.01(0.22) -0.01(0.20) 0.00(0.19)
Cov(SE) 0.94(0.34) 0.95(0.26) 0.96(0.22) 0.93(0.19) 0.94(0.18)
β0
Bias(SD) 0.00(0.16) 0.00(0.13) 0.00(0.12) 0.00(0.10) 0.00(0.11)
Cov(SE) 0.94(0.16) 0.95(0.13) 0.93(0.11) 0.95(0.10) 0.92(0.10)
M4(MCMLE) β1
Bias(SD) 0.00(0.10) 0.00(0.07) 0.00(0.06) 0.00(0.06) 0.00(0.05)
Cov(SE) 0.93(0.10) 0.95(0.07) 0.92(0.06) 0.94(0.05) 0.93(0.05)
β2
Bias(SD) -0.02(0.19) -0.01(0.15) 0.00(0.13) -0.01(0.11) 0.00(0.11)
Cov(SE) 0.94(0.18) 0.92(0.14) 0.93(0.12) 0.93(0.11) 0.92(0.11)
β0
Bias(SD) 0.01(0.06) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.93(0.05) 0.94(0.04) 0.93(0.03) 0.94(0.03) 0.95(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.96(0.04) 0.95(0.03) 0.94(0.02) 0.93(0.02) 0.93(0.02)
β2
Bias(SD) 0.01(0.09) 0.00(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.09) 0.95(0.06) 0.93(0.05) 0.94(0.05) 0.93(0.04)
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Table 12: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 100 in the presence
of measurement error (τ = 0.20). Also included are the average estimated standard errors (SE)
and the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.93(0.06) 0.94(0.05) 0.94(0.04) 0.95(0.04)
M1(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.94(0.05) 0.94(0.04) 0.93(0.03) 0.96(0.03) 0.94(0.03)
β2
Bias(SD) 0.00(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.94(0.11) 0.94(0.08) 0.95(0.07) 0.94(0.06) 0.94(0.06)
β0
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.05) 0.00(0.05) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.94(0.06) 0.94(0.05) 0.94(0.05) 0.96(0.04)
M1(MLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.94(0.05) 0.95(0.04) 0.94(0.04) 0.97(0.03) 0.94(0.03)
β2
Bias(SD) 0.00(0.10) 0.00(0.08) 0.00(0.07) 0.00(0.07) 0.00(0.06)
Cov(SE) 0.95(0.11) 0.95(0.08) 0.95(0.07) 0.94(0.06) 0.95(0.06)
β0
Bias(SD) 0.00(0.11) 0.00(0.10) 0.00(0.08) 0.00(0.08) 0.00(0.07)
Cov(SE) 0.94(0.11) 0.94(0.09) 0.95(0.08) 0.94(0.08) 0.96(0.07)
M2(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.07) 0.93(0.05) 0.95(0.04) 0.94(0.04) 0.92(0.04)
β2
Bias(SD) 0.00(0.13) 0.00(0.10) 0.00(0.08) 0.01(0.08) 0.00(0.07)
Cov(SE) 0.95(0.13) 0.93(0.11) 0.96(0.09) 0.94(0.08) 0.96(0.07)
β0
Bias(SD) -0.01(0.17) 0.00(0.13) 0.00(0.11) 0.01(0.10) 0.00(0.09)
Cov(SE) 0.95(0.17) 0.95(0.13) 0.95(0.11) 0.94(0.10) 0.95(0.09)
M3(MCMLE) β1
Bias(SD) 0.00(0.12) 0.00(0.09) 0.00(0.08) 0.00(0.07) 0.01(0.06)
Cov(SE) 0.96(0.12) 0.95(0.09) 0.94(0.08) 0.94(0.07) 0.94(0.06)
β2
Bias(SD) 0.01(0.24) 0.01(0.19) 0.01(0.17) 0.00(0.15) 0.00(0.13)
Cov(SE) 0.95(0.24) 0.95(0.18) 0.93(0.16) 0.93(0.14) 0.94(0.13)
β0
Bias(SD) 0.00(0.11) 0.00(0.09) -0.01(0.08) 0.00(0.08) 0.00(0.07)
Cov(SE) 0.94(0.11) 0.96(0.09) 0.94(0.08) 0.93(0.08) 0.95(0.07)
M4(MCMLE) β1
Bias(SD) 0.00(0.07) 0.00(0.05) 0.00(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.95(0.07) 0.95(0.05) 0.92(0.04) 0.93(0.04) 0.94(0.04)
β2
Bias(SD) -0.01(0.13) 0.00(0.10) 0.00(0.09) 0.00(0.08) 0.00(0.08)
Cov(SE) 0.95(0.13) 0.95(0.10) 0.95(0.09) 0.95(0.08) 0.94(0.08)
β0
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.94(0.04) 0.93(0.03) 0.96(0.02) 0.95(0.02) 0.94(0.02)
M5(MCMLE) β1
Bias(SD) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.94(0.03) 0.94(0.02) 0.95(0.02) 0.96(0.01) 0.96(0.01)
β2
Bias(SD) 0.00(0.06) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.93(0.06) 0.94(0.04) 0.95(0.04) 0.96(0.03) 0.94(0.03)
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Table 13: Simulation study: Presented results include the empirical bias (Bias) of the 500 estimated
regression coefficients and there sample standard deviation (SD) obtained from analyzing data gen-
erated according to models M1-M5, for all considered pool sizes when J = 200 in the presence
of measurement error (τ = 0.20). Also included are the average estimated standard errors (SE)
and the empirical coverage probabilities (Cov) associated with 95% Wald confidence intervals. Two
model fitting procedures were implemented, the proposed methodology (MCMLE) and the analyt-
ical approach described in Appendix A.1.3 (MLE), with the latter technique only being applicable
for model M1.
Model Measure c = 1 c = 2 c = 3 c = 4 c = 5
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.94(0.05) 0.94(0.04) 0.95(0.03) 0.96(0.03) 0.95(0.03)
M1(MCMLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.94(0.03) 0.96(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.06) -0.01(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.95(0.06) 0.94(0.05) 0.95(0.05) 0.94(0.04)
β0
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.04) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.94(0.05) 0.95(0.04) 0.95(0.04) 0.96(0.03) 0.95(0.03)
M1(MLE) β1
Bias(SD) 0.00(0.04) 0.00(0.03) 0.00(0.02) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.95(0.04) 0.94(0.03) 0.96(0.02) 0.94(0.02) 0.94(0.02)
β2
Bias(SD) 0.00(0.08) 0.00(0.06) -0.01(0.05) 0.00(0.04) 0.00(0.04)
Cov(SE) 0.94(0.08) 0.95(0.06) 0.95(0.05) 0.95(0.05) 0.94(0.04)
β0
Bias(SD) 0.00(0.08) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.94(0.08) 0.93(0.06) 0.93(0.06) 0.92(0.06) 0.94(0.05)
M2(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.02)
Cov(SE) 0.93(0.05) 0.94(0.04) 0.94(0.03) 0.95(0.03) 0.96(0.03)
β2
Bias(SD) -0.01(0.09) 0.01(0.07) 0.00(0.07) 0.00(0.06) 0.00(0.05)
Cov(SE) 0.96(0.09) 0.95(0.07) 0.93(0.06) 0.93(0.06) 0.94(0.05)
β0
Bias(SD) 0.00(0.13) 0.00(0.09) 0.00(0.08) 0.01(0.07) 0.00(0.06)
Cov(SE) 0.94(0.12) 0.95(0.09) 0.95(0.08) 0.97(0.07) 0.95(0.06)
M3(MCMLE) β1
Bias(SD) 0.01(0.09) 0.00(0.07) 0.00(0.06) 0.00(0.05) 0.00(0.05)
Cov(SE) 0.97(0.09) 0.95(0.07) 0.95(0.06) 0.94(0.05) 0.95(0.05)
β2
Bias(SD) 0.02(0.17) 0.01(0.13) 0.00(0.11) 0.00(0.09) 0.00(0.10)
Cov(SE) 0.95(0.17) 0.95(0.13) 0.96(0.11) 0.96(0.10) 0.93(0.09)
β0
Bias(SD) 0.00(0.08) 0.00(0.06) 0.00(0.06) 0.00(0.06) 0.01(0.05)
Cov(SE) 0.96(0.08) 0.96(0.06) 0.93(0.06) 0.93(0.05) 0.94(0.05)
M4(MCMLE) β1
Bias(SD) 0.00(0.05) 0.00(0.04) 0.00(0.03) 0.00(0.03) 0.00(0.03)
Cov(SE) 0.95(0.05) 0.95(0.04) 0.94(0.03) 0.93(0.03) 0.95(0.03)
β2
Bias(SD) 0.01(0.09) 0.00(0.07) 0.00(0.07) 0.00(0.06) -0.01(0.06)
Cov(SE) 0.95(0.09) 0.95(0.07) 0.94(0.06) 0.94(0.06) 0.94(0.05)
β0
Bias(SD) 0.00(0.02) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.95(0.03) 0.95(0.02) 0.95(0.02) 0.96(0.01) 0.94(0.01)
M5(MCMLE) β1
Bias(SD) 0.00(0.02) 0.00(0.01) 0.00(0.01) 0.00(0.01) 0.00(0.01)
Cov(SE) 0.96(0.02) 0.94(0.01) 0.95(0.01) 0.96(0.01) 0.95(0.01)
β2
Bias(SD) 0.00(0.05) 0.00(0.03) 0.00(0.03) 0.00(0.02) 0.00(0.02)
Cov(SE) 0.93(0.04) 0.94(0.03) 0.95(0.03) 0.96(0.02) 0.95(0.02)
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